0001171843-18-007598.txt : 20181105 0001171843-18-007598.hdr.sgml : 20181105 20181105165025 ACCESSION NUMBER: 0001171843-18-007598 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 86 CONFORMED PERIOD OF REPORT: 20180930 FILED AS OF DATE: 20181105 DATE AS OF CHANGE: 20181105 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HMS HOLDINGS CORP CENTRAL INDEX KEY: 0001196501 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389] IRS NUMBER: 113656261 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-50194 FILM NUMBER: 181160496 BUSINESS ADDRESS: STREET 1: 5615 HIGH POINT DRIVE CITY: IRVING STATE: TX ZIP: 75038 BUSINESS PHONE: 214-453-3000 MAIL ADDRESS: STREET 1: 5615 HIGH POINT DRIVE CITY: IRVING STATE: TX ZIP: 75038 10-Q 1 f10q_110518p.htm FORM 10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2018

☐

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number 000-50194

HMS HOLDINGS CORP.

(Exact name of registrant as specified in its charter)

Delaware		11-3656261
(State or Other Jurisdiction of Incorporation or Organization)		(I.R.S. Employer Identification No.)

5615 High Point Drive, Irving, TX		75038
(Address of principal executive offices)		(Zip Code)

(214) 453-3000

(Registrant’s Telephone Number, Including Area Code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for shorter period that the registrant was required to submit such files). ☒ Yes ☐ No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer ☒		Accelerated filer ☐

Non-accelerated filer ☐		Smaller reporting company ☐

		Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of November 2, 2018, there were approximately 83,907,132 shares of the registrant’s common stock (par value $0.01 per share) outstanding.

HMS HOLDINGS CORP. AND SUBSIDIARIES

QUARTERLY REPORT ON FORM 10-Q

FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2018

INDEX

		Page

Glossary of Terms and Abbreviations		3

PART I – FINANCIAL INFORMATION

Item 1.	Financial Statements	6

	Consolidated Balance Sheets September 30, 2018 (unaudited) and December 31, 2017	6

	Consolidated Statements of Income Three and Nine Months Ended September 30, 2018 and 2017 (unaudited)	7

	Consolidated Statement of Shareholders’ Equity Nine months ended September 30, 2018 (unaudited)	8

	Consolidated Statements of Cash Flows Nine Months Ended September 30, 2018 and 2017 (unaudited)	9

	Notes to the Consolidated Financial Statements Three and Nine Months Ended September 30, 2018 and 2017 (unaudited)	10

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	25

Item 3.	Quantitative and Qualitative Disclosures About Market Risk	33

Item 4.	Controls and Procedures	33

PART II – OTHER INFORMATION

Item 1.	Legal Proceedings	35

Item 1A.	Risk Factors	35

Item 6.	Exhibits	36

Signatures		38

Glossary of Terms and Abbreviations

Form 10-Q	HMS Holdings Corp. Quarterly Report on Form 10-Q For the Quarterly Period Ended September 30, 2018
2017 Form 10-K	HMS Holdings Corp. Annual Report on Form 10-K for the year ended December 31, 2017
ACA	Patient Protections and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act
ACO	Accountable Care Organization
ADR	Additional Documentation Request
ASC	Accounting Standards Codification
ASO	Administrative Service Only
ASU	Accounting Standards Update
CHIP	Children's Health Insurance Program
CMS	Centers for Medicare & Medicaid Services
CMS NHE	CMS National Health Expenditures
COSO	Committee of Sponsoring Organizations of the Treadway Commission
Credit Agreement	The Amended and Restated Credit Agreement dated as of May 3, 2013, as amended by Amendment No. 1 to Amended and Restated Credit Agreement dated as of March 8, 2017, and as further amended by Amendment No. 2 to Amended and Restated Credit Agreement, dated as of December 19, 2017, by and among HMS Holdings Corp. the Guarantors party thereto, the Lenders party thereto and Citibank, N.A. as Administrative Agent
DRA	Deficit Reduction Act of 2005
DSO	Days Sales Outstanding
ERISA	Employment Retirement Income Security Act of 1974
Exchange Act	Securities Exchange Act of 1934, as amended
FASB	Financial Accounting Standards Board
HIPAA	Health Insurance Portability and Accountability Act of 1996
HITECH	Health Information Technology for Economic and Clinical Health Act
IRC	Internal Revenue Code
IRS	U.S Internal Revenue Service
LIBO Rate	Intercontinental Exchange London Interbank Offered Rate
MCO	Managed care organization
MMIS	Medicaid Management Information Systems
PBM	Pharmacy Benefit Manager
PHI	Protected health information
PI	Payment Integrity
PMPM	Per Member Per Month
PMPY	Per Member Per Year
R&D Credit	U.S. Research and Experimentation Tax Credit pursuant to IRC Section 41
RAC	Recovery Audit Contractor
RFP	Request for proposal
SEC	U.S. Securities and Exchange Commission
Securities Act	Securities Act of 1933, as amended
Section 199 Deduction	U.S. Production Activities Deduction pursuant to IRC Section 199
SG&A	Selling, general and administrative
TPL	Third-party liability
U.S. GAAP	United States Generally Accepted Accounting Principles
VHA	Veterans Health Administration
2006 Stock Plan	HMS Holdings Corp. Fourth Amended and Restated 2006 Stock Plan, as amended by Amendment No. 1 to the HMS Holdings Corp. Fourth Amended and Restated 2006 Stock Plan dated as of February 16, 2017
2016 Omnibus Plan	HMS Holdings Corp. 2016 Omnibus Incentive Plan
2017 Tax Act	Tax Cuts and Jobs Act of 2017
401(k) Plan	HMS Holdings Corp. 401(k) Plan

Cautionary Note Regarding Forward-Looking Statements

For purposes of this Form 10-Q, the terms “HMS,” “Company,” “we,” “us,” and “our” refer to HMS Holdings Corp. and its consolidated subsidiaries unless the context clearly indicates otherwise. Included in this Form 10-Q are “forward-looking statements” within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. From time to time, we also provide forward-looking statements in other materials we release to the public, as well as oral forward-looking statements. Such statements relate to our current expectations, projections and assumptions about our business, the economy and future events or conditions. They do not relate strictly to historical or current facts.

We have tried to identify forward-looking statements by using words such as “aim,” “anticipate,” “believe,” “estimate,” “expect,” “forecast,” “future,” “intend,” “likely,” “may,” “plan,” “project,” “seek,” “strategy,” “target,” “will,” “would,” “could,” “should,” and similar expressions and references to guidance, although some forward-looking statements may be expressed differently. These statements include, among other things, information concerning our future growth, business strategy, strategic or operational initiatives, our future operating or financial performance, our ability to invest in and utilize our data and analytics capabilities to expand our solutions and services, the benefits and synergies to be obtained from completed and future acquisitions, the future performance of companies we have acquired, the future effect of different accounting determinations or remediation activities, the sufficiency of our sources of funding for working capital, capital expenditures, acquisitions, stock repurchases, debt repayments and other matters, our future expenses, interest rates, effective tax rates and financial results, the impact of changes to U.S. healthcare legislation or healthcare spending affecting Medicare, Medicaid or other publicly funded or subsidized health programs, and other statements regarding our possible future actions, business plans, objectives and prospects.

Forward-looking statements are not guarantees and involve risks, uncertainties and assumptions that are difficult to predict. Actual results may differ materially from past results and forward-looking statements if known or unknown risks or uncertainties materialize, or if underlying assumptions prove inaccurate. These risks and uncertainties include, among other things:

▪

our ability to execute our business plans or growth strategy;

▪

our ability to innovate, develop or implement new or enhanced solutions or services;

▪

the nature of investment and acquisition opportunities we are pursuing, and the successful execution of such investments and acquisitions;

▪

our ability to successfully integrate acquired businesses and realize synergies;

▪

variations in our results of operations;

▪

our ability to accurately forecast the revenue under our contracts and solutions;

▪

our ability to protect our systems from damage, interruption or breach, and to maintain effective information and technology systems and networks;

▪

our ability to protect our intellectual property rights, proprietary technology, information processes and know-how;

▪

significant competition relating to our solutions and services;

▪

our failure to maintain a high level of customer retention or the unexpected reduction in scope or termination of key contracts with major customers;

▪

customer dissatisfaction or our non-compliance with contractual provisions or regulatory requirements;

▪

our failure to meet performance standards triggering significant costs or liabilities under our contracts;

▪

our inability to manage our relationships with information and data sources and suppliers;

▪

our reliance on subcontractors and other third party providers and parties to perform services;

▪

our ability to continue to secure contracts and favorable contract terms through the competitive bidding process;

▪

pending or threatened litigation;

▪

unfavorable outcomes in legal proceedings;

▪

our success in attracting and retaining qualified employees and members of our management team;

▪

our ability to generate sufficient cash to cover our interest and principal payments under our credit facility, or to borrow or use credit;

▪

unexpected changes in tax laws, regulations or guidance and unexpected changes in our effective tax rate;

▪

unanticipated increases in the number or amount of claims for which we are self-insured;

▪

our ability to develop, implement and maintain effective internal control over financial reporting;

▪

changes in the U.S. healthcare environment or healthcare financing system, including regulatory, budgetary or political actions that affect healthcare spending or the practices and operations of healthcare organizations;

▪

our failure to comply with applicable laws and regulations governing individual privacy and information security or to protect such information from theft and misuse;

▪

our ability to comply with current and future legal and regulatory requirements;

▪

negative results of government or customer reviews, audits or investigations;

▪

state or federal limitations related to outsourcing of certain government programs or functions;

▪

restrictions on bidding or performing certain work due to perceived conflicts of interests;

▪

the market price of our common stock and lack of dividend payments; and

▪

anti-takeover provisions in our corporate governance documents.

These and other risks are discussed under the headings “Part I, Item 1. Business,” “Part I. Item 1A, Risk Factors,” “Part II, Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations,” and “Part II, Item 7A. Quantitative and Qualitative Disclosures About Market Risk,” of our 2017 Form 10-K and in other documents we file with the SEC.

Any forward-looking statements made by us in this Form 10-Q speak only as of the date on which they are made. We undertake no obligation to publicly update forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required by law. We caution readers not to place undue reliance upon any of these forward-looking statements. You are advised, however, to consult any further disclosures we make on related subjects in our Form 10-K, Form 10-Q and Form 8-K reports and our other filings with the SEC.

Market and Industry Data

This Form 10-Q contains market, industry and government data and forecasts that have been obtained from publicly available information, various industry publications and other published industry sources. We have not independently verified the information and cannot make any representation as to the accuracy or completeness of such information. None of the reports and other materials of third party sources referred to in this Form 10-Q were prepared for use in, or in connection with, this report.

Trademarks and Tradenames

We have a number of registered trademarks, including HMS^®, as well as the corresponding HMS + logo design mark, HMS IntegritySource^®, Eliza^®and Essette^®. These and other trademarks of ours appearing in this report are our property. Solely for convenience, trademarks and trade names of ours referred to in this Form 10-Q may appear without the ^® or ™ symbols, but such references are not intended to indicate, in any way, that we will not assert, to the fullest extent under applicable law, our rights or the right of the applicable licensor to these trademarks and trade names. This report contains additional trade names and trademarks of other companies. We do not intend our use or display of other companies' trade names or trademarks to imply an endorsement or sponsorship of us by such companies, or any relationship with any of these companies.

PART I — FINANCIAL INFORMATION

Item 1. Financial Statements

HMS HOLDINGS CORP. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(in thousands, except share and per share amounts)

	September 30, 2018			December 31, 2017
Assets	(unaudited)
Current assets:
Cash and cash equivalents	$	124,297		$	83,313
Accounts receivable, net of allowance of $16,239 and $14,799, at September 30, 2018 and December 31, 2017, respectively		202,498			189,460
Prepaid expenses		16,826			16,589
Income tax receivable		4,597			1,892
Deferred financing costs, net		564			564
Other current assets		314			836
Total current assets		349,096			292,654
Property and equipment, net		93,145			98,581
Goodwill		487,617			487,617
Intangible assets, net		72,593			91,482
Deferred financing costs, net		1,814			2,237
Other assets		2,655			2,589
Total assets	$	1,006,920		$	975,160

Liabilities and Shareholders' Equity
Current liabilities:
Accounts payable, accrued expenses and other liabilities	$	64,295		$	61,900
Estimated liability for appeals		22,184			30,787
Total current liabilities		86,479			92,687
Long-term liabilities:
Revolving credit facility		240,000			240,000
Net deferred tax liabilities		14,407			21,989
Deferred rent		4,329			4,852
Other liabilities		9,925			9,403
Total long-term liabilities		268,661			276,244
Total liabilities		355,140			368,931
Commitments and contingencies
Shareholders' equity:
Preferred stock -- $0.01 par value; 5,000,000 shares authorized; none issued		—			—
Common stock -- $0.01 par value; 175,000,000 shares authorized; 97,588,656 shares issued and 83,925,462 shares outstanding at September 30, 2018; 96,536,251 shares issued and 83,256,858 shares outstanding at December 31, 2017		975			965
Capital in excess of par value		397,192			368,721
Retained earnings		389,189			366,164
Treasury stock, at cost: 13,663,194 shares at September 30, 2018 and 13,279,393 shares at December 31, 2017		(135,576	)		(129,621	)
Total shareholders' equity		651,780			606,229
Total liabilities and shareholders' equity	$	1,006,920		$	975,160

See accompanying notes to the unaudited consolidated financial statements.

HMS HOLDINGS CORP. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF INCOME

(in thousands, except per share amounts)

(unaudited)

	Three Months Ended September 30,						Nine Months Ended September 30,
	2018			2017			2018			2017
Revenue	$	154,246		$	125,673		$	442,462		$	372,719
Cost of services:
Compensation		58,188			49,012			169,455			149,784
Information technology		12,979			12,067			39,482			33,131
Occupancy		3,500			4,332			11,897			12,109
Direct project expenses		10,661			9,548			31,652			30,092
Other operating expenses		8,567			7,446			22,183			21,212
Amortization of acquisition related software and intangible assets		7,942			8,167			25,695			21,825
Total cost of services		101,837			90,572			300,364			268,153
Selling, general and administrative expenses		28,178			22,240			86,708			73,400
Settlement expense		-			-			20,000			-
Total operating expenses		130,015			112,812			407,072			341,553
Operating income		24,231			12,861			35,390			31,166
Interest expense		(2,880	)		(3,109	)		(8,562	)		(7,734	)
Interest income		292			14			600			201
Income before income taxes		21,643			9,766			27,428			23,633
Income taxes		3,069			3,394			5,830			9,302
Net Income	$	18,574		$	6,372		$	21,598		$	14,331

Basic income per common share:
Net income per common share -- basic	$	0.22		$	0.08		$	0.26		$	0.17
Diluted income per common share:
Net income per common share -- diluted	$	0.22		$	0.07		$	0.25		$	0.17
Weighted average shares:
Basic		83,509			83,923			83,373			83,778
Diluted		85,144			85,730			85,241			85,586

See accompanying notes to the unaudited consolidated financial statements.

HMS HOLDINGS CORP. AND SUBSIDIARIES

CONSOLIDATED STATEMENT OF

SHAREHOLDERS’ EQUITY

(in thousands, except share amounts)

(unaudited)

	Common Stock									Treasury Stock
	# of Shares Issued		Par Value		Capital in Excess of Par Value			Retained Earnings		# of Shares		Amount			Total Shareholders' Equity

Balance at December 31, 2017		96,536,251	$	965	$	368,721		$	366,164		13,279,393	$	(129,621	)	$	606,229
Adoption of accounting standard (Note 1 and 3)		-		-		-			1,427		-		-			1,427
Net income		-		-		-			21,598		-		-			21,598
Stock-based compensation expense		-		-		17,645			-		-		-			17,645
Purchase of treasury stock		-		-		-			-		383,801		(5,955	)		(5,955	)
Exercise of stock options		685,812		7		13,626			-		-		-			13,633
Vesting of restricted stock units, net of shares withheld for employee tax		366,593		3		(2,800	)		-		-		-			(2,797	)

Balance at September 30, 2018		97,588,656	$	975	$	397,192		$	389,189		13,663,194	$	(135,576	)	$	651,780

See accompanying notes to the unaudited consolidated financial statements.

HMS HOLDINGS CORP. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)

(unaudited)

	Nine Months Ended September 30,
	2018			2017
Operating activities:
Net income	$	21,598		$	14,331
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization of property, equipment and software		24,331			20,599
Amortization of intangible assets		18,889			15,947
Amortization of deferred financing costs		423			1,563
Stock-based compensation expense		17,645			16,761
Deferred income taxes		(7,582	)		(726	)
Change in fair value of contingent consideration		(35	)		(2,450	)
Release of estimated liability for appeals		(8,436	)		-
Changes in operating assets and liabilities:
Accounts receivable		(13,038	)		5,630
Prepaid expenses		(237	)		757
Other current assets		522			712
Other assets		(66	)		163
Income taxes receivable / (payable)		(2,705	)		(2,731	)
Accounts payable, accrued expenses and other liabilities		4,394			(15,457	)
Estimated liability for appeals		(167	)		(1	)
Net cash provided by operating activities		55,536			55,098
Investing activities:
Acquisition of a business, net of cash acquired		-			(171,174	)
Purchases of property and equipment		(4,333	)		(11,656	)
Investment in capitalized software		(15,100	)		(10,664	)
Net cash used in investing activities		(19,433	)		(193,494	)
Financing activities:
Proceeds from exercise of stock options		13,633			2,580
Payments of tax withholdings on behalf of employees for net-share settlement for stock-based compensation		(2,797	)		(2,898	)
Payments on capital lease obligations		-			(5	)
Proceeds from credit facility		-			42,204
Purchases of treasury stock		(5,955	)		-
Net cash provided by financing activities		4,881			41,881
Net increase (decrease) in cash and cash equivalents		40,984			(96,515	)
Cash and Cash Equivalents
Cash and cash equivalents at beginning of year		83,313			175,999
Cash and cash equivalents at end of period	$	124,297		$	79,484

Supplemental disclosure of cash flow information:
Cash paid for income taxes, net of refunds	$	15,501		$	12,317
Cash paid for interest	$	7,769		$	5,819

Supplemental disclosure of non-cash activities:
Change in balance of accrued property and equipment purchases	$	538		$	(414	)

See accompanying notes to the unaudited consolidated financial statements.

HMS HOLDINGS CORP. AND SUBSIDIARIES

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2018 and 2017

(unaudited)

Business and Summary of Significant Accounting Policies

(a) Business

HMS is a leading provider of cost containment solutions in the U.S. healthcare marketplace. We use innovative technology, extensive data services and powerful analytics to deliver coordination of benefits, payment integrity and care management and consumer engagement solutions to help healthcare payers improve financial performance and clinical outcomes. We provide coordination of benefits services to government and commercial healthcare payers and sponsors to ensure that the responsible party pays healthcare claims. Our payment integrity services ensure healthcare claims billed are accurate and appropriate, and our care management and consumer engagement technology helps risk-bearing organizations to better engage with and manage the care delivered to their members. Together these various services help customers recover erroneously paid amounts from liable third parties; prevent future improper payments; reduce fraud, waste and abuse; better manage the care their members receive; engage healthcare consumers to improve clinical outcomes while increasing member satisfaction and retention; and achieve regulatory compliance. We currently operate as one business segment with a single management team that reports to our Chief Executive Officer.

The accompanying consolidated financial statements and notes are unaudited. Accordingly, they do not include all of the information and notes required by U.S. GAAP for complete financial statements. These statements include all adjustments (which include only normal recurring adjustments, except as disclosed) that management considers necessary to present a fair statement of the Company’s results of operations, financial position and cash flows. The results reported in these unaudited consolidated financial statements should not be regarded as necessarily indicative of results that may be expected for the entire year. It is suggested that these unaudited consolidated financial statements be read in conjunction with the Company’s consolidated financial statements as of and for the year ended December 31, 2017 which were filed with the SEC as part of the 2017 Form 10-K. The consolidated balance sheet as of December 31, 2017 included herein was derived from audited financial statements, but does not include all disclosures required by U.S. GAAP.

The preparation of the Company’s unaudited consolidated financial statements requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities, primarily accounts receivable, intangible assets, fixed assets, accrued expenses, estimated liability for appeals, the disclosure of contingent liabilities at the date of the unaudited consolidated financial statements and the reported amounts of revenue and expenses during the reporting periods. The Company’s actual results could differ from those estimates.

These unaudited consolidated financial statements include HMS accounts and transactions and those of the Company’s wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.

(b) Summary of Significant Accounting Policies

There have been no material changes to the Company’s significant accounting policies that are referenced in the 2017 Form 10-K other than as described below with respect to revenue recognition.

Recently Adopted Accounting Pronouncements

In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers (Topic 606) (“ASU 2014-09”), which is the new comprehensive revenue recognition standard that supersedes all existing revenue recognition guidance under U.S. GAAP. The Company adopted ASU 2014-09 on January 1, 2018 using the modified retrospective method and the Company recognized the cumulative effect of initially applying the new revenue standard as an adjustment to the opening balance of retained earnings. The financial information for comparative prior periods has not been restated and continues to be reported under the accounting standards in effect for those periods. The effect of adopting ASU 2014-09 in the current annual reporting period as compared with the guidance that was in effect before the change is immaterial. The Company’s internal control framework did not materially change, but existing internal controls were modified due to certain changes to business processes and systems to support the new revenue recognition standard as necessary. The Company continues to expect the impact of the adoption of the new standard to be immaterial to its net income and its internal control framework on an ongoing basis.

In August 2016, the FASB issued ASU No. 2016-15, Statements of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments (“ASU 2016-15”). ASU 2016-15 clarifies where certain cash receipts and cash payments are presented and classified in the statement of cash flows. The amendments are effective for annual reporting periods beginning after December 15, 2017, and for interim reporting periods within such annual periods. The Company adopted this guidance on January 1, 2018. The adoption of this guidance did not have an effect on the Company’s consolidated financial statements.

In January 2017, the FASB issued ASU No. 2017-01, Business Combinations (Topic 805) – Clarifying the Definition of a Business (“ASU 2017-01”). ASU 2017-01 finalizes previous proposals regarding shareholder concerns that the definition of a business is applied too broadly. The guidance assists entities with evaluating whether transactions should be accounted for as acquisitions of assets or of businesses. The amendments are effective for annual periods beginning after December 15, 2017, including interim periods within those periods. The Company adopted this guidance on January 1, 2018. The adoption of this guidance did not have a material effect on the Company’s consolidated financial statements.

In May 2017, the FASB issued ASU No. 2017-09, Compensation – Stock Compensation (Topic 718) – Scope of Modification Accounting, (“ASU 2017-09”). ASU 2017-09 requires entities to apply modification accounting to changes made to a share-based payment award. The new guidance specifies that entities will apply modification accounting to changes to a share-based payment award only if any of the following are not the same immediately before and after the change: 1) The award’s fair value (or calculated value or intrinsic value, if those measurement methods are used), 2) the award’s vesting conditions, and 3) the award’s classification as an equity or liability instrument. ASU 2017-09 is effective for annual reporting periods beginning after December 15, 2017, including interim periods within such annual periods, with early adoption permitted. The Company adopted this guidance on January 1, 2018. The adoption of this guidance did not have a material effect on the Company’s consolidated financial statements.

Recently Issued Accounting Pronouncements

In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842) (“ASU 2016-02”). ASU 2016-02 will require most lessees to recognize a majority of the company’s leases on the balance sheet, which will increase reported assets and liabilities. ASU 2016-02 is effective for annual reporting periods beginning after December 15, 2018 including interim periods within such annual reporting periods with early adoption permitted. The Company has not early adopted this guidance. The Company developed a preliminary implementation plan and has reviewed historical lease agreements in order to quantify the impact of adoption. Based upon the Company’s on-going analysis to date, the Company currently expects that there will be a material increase to total assets and total liabilities on the Company’s consolidated balance sheet upon adoption; however, the Company continues to perform the necessary additional reviews and other implementation considerations in order to appropriately quantify the changes. The Company has elected to use the FASB’s optional transition method.The Company expects to complete the on-going analysis and quantification by the end of the fourth quarter of 2018.

In January 2017, the FASB issued ASU No. 2017-04, Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment (“ASU 2017-04”). This amendment simplifies the manner in which an entity is required to test for goodwill impairment by eliminating Step 2 from the goodwill impairment test. Step 2 measures goodwill impairment loss by comparing the implied fair value of a reporting unit’s goodwill with the carrying amount of that goodwill. The amendment simplifies this approach by having the entity (1) perform its annual or interim goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount, and (2) recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value, with the understanding that the loss recognized should not exceed the total amount of goodwill allocated to that reporting unit. The amendment is effective for public entities that are SEC filers prospectively for their annual, or any interim, goodwill impairment tests in fiscal years beginning after December 15, 2019. Early adoption is permitted for all entities for interim or annual goodwill impairment tests performed on testing dates after January 1, 2017. The Company is currently evaluating the impact on the Company’s financial statements of adopting this guidance but this guidance is not expected to have a material impact on the Company’s financial position, results of operations or internal control framework.

In June 2018, the FASB issued ASU No. 2018-07, Compensation – Stock Compensation (Topic 718) – Improvements to Nonemployee Share-Based Payment Accounting, (“ASU 2018-07”). ASU 2018-07 requires entities to apply similar accounting for share-based payment transactions with non-employees as with share-based payment transactions with employees. ASU 2018-07 is effective for public entities for fiscal year beginning after December 15, 2018, including interim periods within that fiscal year. Early adoption is permitted. The Company is currently evaluating the impact on the Company’s financial statements of adopting this guidance but this guidance is not expected to have a material impact on the Company’s financial position, results of operations or internal control framework.

On August 17, 2018 the SEC issued SEC Final Rule Release No. 33-10532, Disclosure Update and Simplification (“Final Rule”). The final rule amends certain disclosure requirements to facilitate the disclosure of information to investors and simplify compliance without significantly altering the total mix of information provided to investors. The final rule is effective for public entities that are SEC filers on November 5, 2018. The Company is currently evaluating the impact of adopting this guidance but this guidance is not expected to have a material impact on the Company’s disclosures.

Fair Value of Financial Instruments

Financial instruments (principally cash and cash equivalents, accounts receivable, accounts payable and accrued expenses) are carried at cost, which approximates fair value due to the short-term maturity of these instruments. The Company’s long-term credit facility is carried at cost, which, due to the variable interest rate associated with the revolving credit facility, approximates its fair value. The Company has no Level 1 or Level 2 financial instruments and there were no transfers between Level 1 or Level 2 financial instruments. The Company’s contingent consideration liability of $35,000 at June 30, 2018 was reduced to zero at September 30, 2018 and is included in Other liabilities on the unaudited Consolidated Balance Sheets. The liability is valued using a Monte Carlo simulation and includes unobservable inputs such as expected levels of revenues and discount rates. Changes in the unobservable inputs of this instrument could result in a significant change in the fair value measurement.

Revenue Recognition

The Company’s revenue disaggregated by product for the three and nine months ended September 30 is as follows (in thousands):

	Three Months Ended September 30				Nine Months Ended September 30
	2018		2017		2018		2017
Coordination of benefits	$	105,694	$	90,073	$	298,201	$	277,018
Analytical services		48,552		35,600		144,261		95,701
Total	$	154,246	$	125,673	$	442,462	$	372,719

Coordination of benefits

Coordination of benefits revenue is derived from contracts with state governments and Medicaid managed care plans that typically span 3 to 5 years with the option to renew. Types of service contracts could include: (a) the identification of erroneously paid claims; (b) the delivery of verified commercial insurance coverage information; (c) the identification of paid claims where another third party is liable; and (d) the identification and enrollment of Medicaid members who have access to affordable employer insurance. Most of these types of service contracts contain multiple promises, all of which are not distinct within the context of the contract. Therefore, the promises represent a single, distinct performance obligation for the types of services we offer. Revenue derived from these performance obligations is largely based on variable consideration where, based on the number of claims or amount of findings the Company identified, a contingent or fixed transaction price/recovery percentage is allocated to each distinct performance obligation. The Company utilizes the expected value method to estimate the variable consideration related to the transaction price for its service contracts. Key inputs and assumptions in determining variable consideration includes identified pricing and expected recoveries and/or savings. The expected recoveries and/or savings are based on historical experience of information received from our customers. Revenue is recognized at a point in time when our customers realize economic benefits from our services when our services are completed. Generally, coordination of benefit contract payment terms are not standardized within the respective contract; however, payment is typically due on demand and there is a clear and distinct history of customers making consistent payments.

Analytical services

The Company’s analytical services revenue consists mostly of payment integrity services but also care management and consumer engagement services.

Payment integrity services revenue is derived from contracts with federal and state governments, commercial health plans and other at-risk entities that can span several years with the option to renew. Types of service contracts could include: (a) services designed to ensure that healthcare payments are accurate and appropriate; and (b) the identification of over/(under)payments or inaccurate charges based on a review of medical records. Most of these types of service contracts contain multiple promises, all of which are not distinct within the context of the contract. Therefore, the promises represent a single, distinct performance obligation for the types of services we offer. Revenue derived from these performance obligations is largely based on variable consideration where, based on the number of claims or amount of findings the Company identified, a contingent or fixed transaction price/recovery percentage is allocated to each distinct performance obligation. The Company utilizes the expected value method to estimate the variable consideration related to the transaction price for its service contracts. Key inputs and assumptions in determining variable consideration includes identified pricing and expected recoveries and/or savings. The expected recoveries and/or savings are based on historical experience of information received from our customers. Revenue is recognized at a point in time when our customers realize economic benefits from our services when our services are completed. Generally, payment integrity contract payment terms are not standardized within the respective contract; however, payment is typically due on demand and there is a clear and distinct history of customers making consistent payments.

Care management and consumer engagement services revenue is derived from contracts with health plans and other risk-bearing entities that can span several years with the option to renew. Types of service contracts could include: (a) programs designed to improve member engagement; and (b) outreach services designed to improve clinical outcomes. Most of these types of service contracts contain multiple promises, all of which are not distinct within the context of the contract. Therefore, the promises represent a single, distinct performance obligation for the types of services we offer. Revenue derived from these services is largely based on consideration associated with prices per order/transfer and PMPM/PMPY fees. The Company believes the output method is a reasonable measure of progress for the satisfaction of our performance obligations, which are satisfied over time, as it provides a faithful depiction of (1) our performance toward complete satisfaction of the performance obligation under the contract and (2) the value transferred to the customer of the services performed under the contract. The Company has elected the right to invoice practical expedient for recognition of revenue related to its performance obligations. Additionally, certain care management and consumer engagement services contracts have distinct performance obligations related to software license and implementation fees which have historically been recognized as revenue ratably over the life of the contract. However, upon adoption of ASC 606, revenue for software licenses is recognized at the beginning of the license period when control is transferred as the license is installed and revenue for implementation fees is recognized when control is transferred over time as the implementation is being performed. As the performance obligation is deemed to have been satisfied and control transferred to our customers for software licenses and implementation fees on or before December 31, 2017, the Company recorded a decrease to deferred revenue and an increase to opening retained earnings of $1.4 million as of January 1, 2018 for the cumulative impact of adopting ASC 606. A portion of the Company’s care management and consumer engagement services are deferred and revenue is recognized over time. Deferred revenue of this nature was approximately $5.2 million and $6.4 million as of September 30, 2018 and December 31, 2017, respectively, and is included in Accounts payable, accrued expenses and other liabilities in the Consolidated Balance Sheets. Generally, care management and consumer engagement contract payment terms are stated within the contract and are due within an explicitly stated time period (e.g., 30, 45, 60 days) from the date of invoice.

Contract modifications are routine in nature and often done to account for changes in the contract specifications or requirements. In most instances, contract modifications are for services that are not distinct, and, therefore, modifications are accounted for as part of the existing contract.

Accounts Receivable and Accounts Receivable Allowance

The Company’s accounts receivable, net, consisted of the following (in thousands):

	September 30, 2018			December 31, 2017
Accounts receivable	$	218,737		$	204,259
Allowance		(16,239	)		(14,799	)
Accounts receivable, net	$	202,498		$	189,460

We record an accounts receivable allowance based on historical patterns of billing adjustments, length of operating and collection cycle and customer negotiations, behaviors and payment patterns. Changes in these estimates are recorded to revenue in the period of change. A summary of the activity in the accounts receivable allowance was as follows (in thousands):

	September 30, 2018			December 31, 2017
Balance--beginning of period	$	14,799		$	10,772
Provision		16,107			20,233
Charge-offs		(14,667	)		(16,206	)
Balance--end of period	$	16,239		$	14,799

Acquisition

On April 17, 2017, the Company completed the acquisition of 100% of the outstanding capital stock of Eliza Holding Corp. (“Eliza”), for a preliminary purchase price of $171.6 million funded with available liquidity of approximately 75% cash on hand and 25% from the Company’s existing credit line.

The allocation of the purchase price to the fair value of the assets acquired and the liabilities assumed as of April 17, 2017, the effective date of the acquisition, is as follows (in thousands):

Cash and cash equivalents	$	435
Accounts receivable		8,902
Prepaid expenses		1,427
Property and equipment		1,146
Intangible assets		76,240
Goodwill		107,754
Other assets		63
Accounts payable		(2,620	)
Deferred tax liability		(19,681	)
Other liabilities		(2,057	)
Total purchase price	$	171,609

The purchase price allocated to the intangibles acquired was as follows (in thousands):

	Useful Life (in years)
Customer relationships	15	$	56,200
Intellectual property	6		19,600
Trade name	1.5		310
Restrictive covenants	1		130
Fair value of intangibles acquired		$	76,240

Acquisition costs recorded in the second quarter 2017 to selling, general and administrative expenses were as follows (in thousands):

Other operating expenses - consulting fees	$	3,515
Other operating expenses - legal fees		832
Other operating expenses - transaction costs		185
Acquisition-related costs	$	4,532

The financial results of Eliza have been included in the Company’s consolidated financial statements since the date of acquisition. Eliza contributed approximately $37.4 million in revenue to HMS results of operations for the nine months ended September 30, 2018. Eliza contributed approximately $17.5 million in revenue to HMS results of operations from the date of acquisition through September 30, 2017.

Intangible Assets and Goodwill

Intangible assets consisted of the following (in thousands, except for weighted average amortization period):

	Gross Carrying Amount		Accumulated Amortization			Net Carrying Amount		Weighted Average Amortization Period (in years)
September 30, 2018
Customer relationships	$	156,790	$	(100,758	)	$	56,032	12.4
Trade names		16,246		(15,724	)		522	0.3
Intellectual property		21,700		(5,701	)		15,999	4.3
Restrictive covenants		263		(223	)		40	0.9
Total	$	194,999	$	(122,406	)	$	72,593

	Gross Carrying Amount		Accumulated Amortization			Net Carrying Amount		Weighted Average Amortization Period (in years)
December 31, 2017
Customer relationships	$	159,290	$	(89,106	)	$	70,184	11.3
Trade names		16,246		(13,916	)		2,330	1
Intellectual property		21,700		(2,874	)		18,826	5.2
Restrictive covenants		263		(121	)		142	1.3
Total	$	197,499	$	(106,017	)	$	91,482

Amortization expense of intangible assets is expected to approximate the following (in thousands):

Year ending December 31,
2018	$	5,452
2019		9,195
2020		7,664
2021		7,197
2022		7,197
Thereafter		35,888
Total	$	72,593

For the three months ended September 30, 2018 and 2017, amortization expense related to intangible assets was $6.1 million and $6.2 million, respectively. For the nine months ended September 30, 2018 and 2017, amortization expense related to intangible assets was $18.9 million and $15.9 million, respectively.

The Company assesses goodwill for impairment on an annual basis as of June 30th of each year or more frequently if an event occurs or changes in circumstances would more likely than not reduce the fair value of a reporting unit below its carrying amount. Assessment of goodwill impairment is at the HMS Holdings Corp. entity level as the Company operates as a single reporting unit. The Company completed the annual impairment test as of June 30, 2018 electing to perform the first step of the goodwill impairment test by comparing the fair value of the reporting unit with its carrying value, including goodwill. In calculating the fair value of the reporting unit, the Company utilized a weighting across three commonly accepted valuation approaches: an income approach, a guideline public company approach and a merger and acquisition approach. The income approach to determining fair value computes projections of the cash flows that the reporting unit is expected to generate converted into a present value equivalent through discounting. Significant assumptions in the income approach include income projections, a discount rate and a terminal growth value which are all level 3 inputs. The income projections include assumptions for revenue and expense growth which are based on internally developed business plans and largely reflect recent historical revenue and expense trends. The discount rate was based on a risk free rate plus a beta adjusted equity risk premium and specific company risk premium. The terminal growth value is Company specific and was determined analyzing inputs such as historical inflation and the GDP growth rate. The guideline public company approach and merger and acquisition approach are based on pricing multiples observed for similar publicly traded companies or similar market companies that were sold. The results of the annual impairment assessment provide that the fair value of the reporting unit was significantly in excess of the Company’s carrying value; therefore, no impairment was indicated and step two was not performed. If actual results are not consistent with our estimates or assumptions, the Company may be exposed to an impairment charge that could materially adversely impact our consolidated financial position and results of operations.

There were no impairment charges related to goodwill during the years ended December 31, 2017, 2016 or 2015. There were no changes in the carrying amount of goodwill for the nine-months ended September 30, 2018.

Accounts Payable, Accrued Expenses and Other Liabilities

Accounts payable, accrued expenses and other liabilities consisted of the following (in thousands):

	September 30, 2018		December 31, 2017
Accounts payable, trade	$	13,850	$	19,330
Accrued compensation and other		32,372		24,072
Accrued operating expenses		18,073		18,498
Total accounts payable, accrued expenses and other liabilities	$	64,295	$	61,900

Income Taxes

The Company’s effective tax rate decreased to 21.3% for the nine months ended September 30, 2018 from 39.4% for the nine months ended September 30, 2017. The nine months ended September 30, 2018 effective tax rate includes discrete tax expense items related to a previously disclosed legal settlement, interest on uncertain tax benefits, state tax refunds and net stock compensation in addition to a net federal tax reform benefit comprised of a federal tax rate decrease, net of state impact, offset by tax increases for officer compensation deduction limits and loss of the domestic manufacturing deduction. For the nine months ended September 30, 2018, the differences between the federal statutory rate and our effective tax rate are discrete tax expense items related to the previously disclosed legal settlement, state taxes, equity compensation impacts, unrecognized tax benefits, including interest, officer compensation deduction limits, research and development tax credits, and other permanent differences.

The effective tax rate for the nine months ended September 30, 2018 represents the Company’s best estimate using information available to the Company as of November 5, 2018. The Company anticipates U.S. regulatory agencies will issue further regulations over the next three months which may alter this estimate. The Company is still evaluating, among other things, the application of limitations for executive compensation related to contracts existing prior to November 2, 2017. The Company will refine its estimates to incorporate new or better information as it becomes available through the filing date of its 2017 U.S. income tax returns in the fourth quarter of 2018.

Included in Other Liabilities on the Consolidated Balance Sheets, are the total amount of unrecognized tax benefits of approximately $8.9 million and $8.2 million, as of September 30, 2018 and December 31, 2017, respectively, (net of the federal benefit for state issues) that, if recognized, would favorably affect the Company’s future effective tax rate. Also included in Other Liabilities on the Consolidated Balance Sheets, are accrued liabilities for interest expense and penalties related to unrecognized tax benefits of $1.0 million and $0.6 million as of September 30, 2018 and December 31, 2017, respectively. HMS includes interest expense and penalties in the provision for income taxes in the unaudited Consolidated Statements of Income. The amount of interest expense (net of federal and state income tax benefits) and penalties in the unaudited Consolidated Statements of Income for the nine months ended September 30, 2018 and 2017 was $0.4 million and an immaterial amount, respectively. The Company believes it is reasonably possible that the amount of unrecognized tax benefits may decrease by $3.5 million over the next twelve months, due to the expiration of the statute of limitations in federal and various state jurisdictions.

HMS files income tax returns with the U.S. Federal government and various state, territory, and local jurisdictions. HMS is no longer subject to U.S. Federal income tax examinations for years before 2012. The Company is currently under audit by the Internal Revenue Service for years 2013 and 2014 and no adjustments have been received to date. HMS operates in a number of state and local jurisdictions. Accordingly, HMS is subject to state and local income tax examinations based on the various statutes of limitations in each jurisdiction. Previously recognized state apportionment benefits were adjusted by the state resulting in additional benefits, net of federal tax, of $0.5 million relating to the current period and $2.4 million relating to prior periods.

Estimated Liability For Appeals

Under the Company’s contracts with certain commercial health plan customers and its Medicare RAC contracts with CMS (included within the Company’s analytical services product revenue), providers have the right to appeal HMS claim findings and to pursue additional appeals if the initial appeal is found in favor of HMS’s customer. The appeal process established under the Medicare RAC contract with CMS includes five levels of appeals, and resolution of appeals can take substantial time to resolve. HMS records a) a return obligation liability for findings which have been adjudicated in favor of providers and b) an estimated return obligation liability based on the amount of revenue that is subject to appeals and which are probable of being adjudicated in favor of providers following their successful appeal. The Company’s estimate is based on the Company’s historical experience. To the extent the amount to be returned to providers following a successful appeal exceeds or is less than the amount recorded, revenue in the applicable period would be reduced or increased by such amount. Any future changes to any of the Company’s customer contracts, including modifications to the Medicare RAC contract, may require the Company to apply different assumptions that could materially affect both the Company’s revenue and estimated liability for appeals in future periods.

The Company’s original Medicare RAC contract with CMS expired on January 31, 2018. As a result of the contract expiration, the Company’s contractual obligation with respect to any appeals resolved in favor of providers subsequent to the expiration date have ceased and therefore the Company released its estimated liability and increased revenue by $8.4 million during the first quarter of 2018. The Company continues to assess the remaining Medicare RAC liability to determine management’s best estimate of liability for any findings which have been previously adjudicated prior to the expiration of the contract.

The total estimated liability for appeals balance of $22.2 million and $30.8 million as of September 30, 2018 and December 31, 2017, respectively, includes $19.4 million and $19.3 million, respectively, of Medicare RAC claim findings which have been adjudicated in favor of providers, and $0.0 million and $8.5 million, respectively, of the Company’s estimate of the potential amount of Medicare RAC repayments that are probable of being adjudicated in favor of providers following a successful appeal. Additionally, the total estimated liability for appeals balance includes $2.8 million and $3.2 million related to commercial customers claim appeals. The provision included in the estimated liability for appeals is an offset to revenue in the Company’s Consolidated Statements of Income.

A summary of the activity in the estimated liability for appeals related to the Company’s original Medicare RAC contract was as follows (in thousands):

	September 30, 2018
Balance--beginning of period	$	8,544
Provision		-
Appeals found in providers favor		(108	)
Release of liability		(8,436	)
Balance--end of period	$	-

10.

Credit Agreement

In December 2017, the Company entered into an amendment to its Credit Agreement, which, among other things, extended the maturity of its then existing $500 million revolving credit facility by five years to December 2022 (the “Amended Revolving Facility”). The availability of funds under the Amended Revolving Facility includes sublimits for (a) up to $50 million for the issuance of letters of credit and (b) up to $25 million for swingline loans. In addition, the Company may increase the commitments under the Amended Revolving Facility and/or add one or more incremental term loan facilities, provided that such incremental facilities do not exceed in the aggregate the sum of (i) the greater of $120 million and 100% of Consolidated EBITDA (as defined in the Credit Agreement) and (ii) an additional amount so long as our first lien leverage ratio (as defined in the Credit Agreement) on a pro forma basis is not greater than 3.00:1.00, subject to obtaining commitments from lenders therefor and meeting certain other conditions.

As of September 30, 2018 and December 31, 2017, the outstanding principal balance due on the Amended Revolving Facility was $240.0 million. No principal payments were made against the Company’s Amended Revolving Facility during the nine months ended September 30, 2018.

Borrowings under the Amended Revolving Facility bear interest at a rate equal to, at the Company’s election (except with respect to swingline borrowings, which will accrue interest based only at the base rate), either:

▪

a base rate determined by reference to the greatest of (a) the prime or base commercial lending rate of the administrative agent as in effect on the relevant date, (b) the federal funds effective rate plus 0.50% and (c) the one-month LIBO Rate plus 1.00%, plus an interest margin ranging from 0.50% to 1.00% based on the Company’s consolidated leverage ratio for the applicable period; or

▪

an adjusted LIBO Rate, equal to the LIBO Rate for the applicable interest period multiplied by the statutory reserve rate (equal to (x) one divided by (y) one minus the aggregate of the maximum reserve percentage (including any marginal, special, emergency or supplemental reserves) established by the Board of Governors of the Federal Reserve System of the United States), plus an interest margin ranging from 1.50% to 2.00% based on the Company’s consolidated leverage ratio for the applicable period.

In addition to paying interest on the outstanding principal, the Company is required to pay unused commitment fees on the Amended Revolving Facility during the term of the Credit Agreement ranging from 0.375% to 0.250% per annum based on the Company’s consolidated leverage ratio and letter of credit fees equal to 0.125% per annum on the aggregate face amount of each letter of credit, as well as customary agency fees.

The Amended Revolving Facility is secured, subject to certain customary carve-outs and exceptions, by a first priority lien and security interest in substantially all tangible and intangible assets of the Company and certain subsidiaries of the Company. The Amended Revolving Facility contains certain restrictive covenants, which affect, among other things, the ability of the Company and its subsidiaries to incur indebtedness, create liens, make investments, sell or otherwise dispose of assets, engage in mergers or consolidations with other entities, and pay dividends or repurchase stock. The Company is also required to comply, on a quarterly basis, with two financial covenants: (i) a minimum interest coverage ratio of 3:00:1:00, and (ii) a maximum consolidated leverage ratio of 4.75:1.00 through December 2019 and 4.25:1.00 from and after January 2020. The consolidated leverage ratio is subject to a step-up to 5.25:1.00 for four full consecutive fiscal quarters following a permitted acquisition or similar investment. As of September 30, 2018, the Company was in compliance with all terms of the Credit Agreement.

Interest expense and the commitment fees on the unused portion of the Company’s revolving credit facility were as follows (in thousands):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2018		2017		2018		2017
Interest expense	$	2,527	$	2,230	$	7,224	$	5,072
Commitment fees		211		325		688		1,036

As of September 30, 2018 and December 31, 2017, the unamortized balance of deferred origination fees and debt issuance costs was $2.4 million and $2.8 million, respectively. For the nine month periods ended September 30, 2018 and 2017, HMS amortized $0.4 million and $1.0 million, respectively, of interest expense related to the Company’s deferred origination fees and debt issue costs.

Although HMS expects that operating cash flows will continue to be a primary source of liquidity for the Company’s operating needs, the Amended Revolving Facility may be used for general corporate purposes, including, but not limited to acquisitions, if necessary.

11.

Earnings Per Share

The following table reconciles the basic to diluted weighted average common shares outstanding using the treasury stock method (in thousands, except per share amounts):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2018		2017		2018		2017
Net income	$	18,574	$	6,372	$	21,598	$	14,331

Weighted average common shares outstanding-basic		83,509		83,923		83,373		83,778
Plus: net effect of dilutive stock options and restricted stock units		1,635		1,807		1,868		1,808
Weighted average common shares outstanding-diluted		85,144		85,730		85,241		85,586
Net income per common share-basic	$	0.22	$	0.08	$	0.26	$	0.17
Net income per common share-diluted	$	0.22	$	0.07	$	0.25	$	0.17

For the three months ended September 30, 2018 and 2017, 21,105 and 2,642,548 stock options, respectively, were not included in the diluted earnings per share calculation because the effect would have been anti-dilutive. For the three months ended September 30, 2018 and 2017, restricted stock units representing 202 and 84,360 shares of common stock, respectively, were not included in the diluted earnings per share calculation because the effect would have been anti-dilutive.

For the nine months ended September 30, 2018 and 2017, 531,378 and 2,132,017 stock options, respectively, were not included in the diluted earnings per share calculation because the effect would have been anti-dilutive. For the nine months ended September 30, 2018 and 2017, restricted stock units representing 595 and 63,452 shares of common stock, respectively, were not included in the diluted earnings per share calculation because the effect would have been anti-dilutive.

12.

Stock-Based Compensation

(a)

Stock-Based Compensation Expense

Total stock-based compensation expense in the Company’s unaudited Consolidated Statements of Income related to the Company’s long-term incentive award plans was as follows (in thousands):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2018		2017		2018		2017
Cost of services-compensation	$	1,537	$	1,851	$	5,802	$	5,353
Selling, general and administrative		1,900		5,531		11,843		11,408
Total	$	3,437	$	7,382	$	17,645	$	16,761

(b)

Stock Options

Stock-based compensation expense related to stock options was approximately $1.6 million and $3.2 million for the three months ended September 30, 2018 and 2017, respectively. Stock-based compensation expense related to stock options was approximately $7.6 million and $7.1 million for the nine months ended September 30, 2018 and 2017, respectively.

Presented below is a summary of stock option activity for the nine months ended September 30, 2018 (in thousands except for weighted average exercise price and weighted average remaining contractual terms):

	Number of Options			Weighted Average Exercise Price		Weighted Average Remaining Contractual Terms		Aggregate Intrinsic Value
Outstanding balance at December 31, 2017		5,554		$	17.35
Granted		1,010			19.58
Exercised		(686	)		21.13
Forfeitures		(100	)		17.64
Expired		(30	)		22.21
Outstanding balance at September 30, 2018		5,748			17.33		5.41	$	88,909

Expected to vest at September 30, 2018		1,561			17.65		7.79	$	23,669
Exercisable at September 30, 2018		3,373		$	17.13		3.76	$	52,900

During the three months ended September 30, 2018 and 2017, the Company issued 535,077 and 40,734 shares, respectively, of the Company’s common stock upon the exercise of outstanding stock options and received proceeds of $12.1 million and $0.8 million, respectively. The total intrinsic value of stock options exercised during the three months ended September 30, 2018 and 2017 was $4.0 million and $0.3 million, respectively. During the nine months ended September 30, 2018 and 2017, the Company issued 686,111 and 173,539 shares, respectively, of the Company’s common stock upon the exercise of outstanding stock options and received proceeds of $13.7 million and $2.7 million, respectively. The total intrinsic value of stock options exercised during the nine months ended September 30, 2018 and 2017 was $4.7 million and $0.6 million, respectively.

As of September 30, 2018, there was approximately $7.6 million of total unrecognized compensation cost related to stock options outstanding, which is expected to be recognized over a weighted average period of 2.1 years.

The weighted-average grant date fair value per share of the stock options granted during the nine months ended September 30, 2018 and 2017 was $7.52 and $7.68, respectively. HMS estimated the fair value of each stock option grant on the date of grant using a Black-Scholes option pricing model and weighted–average assumptions set forth in the following table:

	Nine Months Ended September 30,
	2018			2017
Expected dividend yield		0	%		0	%
Risk-free interest rate		2.68	%		1.74	%
Expected volatility		42.43	%		44.23	%
Expected life (years)		6.00			5.00

The total tax benefits recognized on stock-based compensation for the three and nine months ended September 30, 2018 was $1.0 million and $3.5 million, respectively. The total tax benefits recognized on stock-based compensation for the three and nine months ended September 30, 2017 was $0.0 and $3.6 million, respectively.

(c)

Restricted Stock Units

Stock-based compensation expense related to restricted stock units was approximately $1.9 million and $4.2 million for the three months ended September 30, 2018 and 2017, respectively. Stock-based compensation expense related to restricted stock units was approximately $10.0 million and $9.7 million for the nine months ended September 30, 2018 and 2017, respectively.

Presented below is a summary of restricted stock units activity for the nine months ended September 30, 2018 (in thousands, except for weighted average grant date fair value per unit):

	Number of Units			Weighted Average Grant Date Fair Value per Unit
Outstanding balance at December 31, 2017		1,346		$	17.65
Granted		763			16.76
Vesting of restricted stock units, net of units withheld for taxes		(367	)		17.00
Units withheld for taxes		(163	)		17.00
Forfeitures		(70	)		17.26
Outstanding balance at September 30, 2018		1,509		$	19.98

For the three months ended September 30, 2018 and 2017, HMS granted 1,794 and 59,784 restricted stock units, respectively, with an aggregate fair market value of $58,861 and $1.0 million, respectively. For the nine months ended September 30, 2018 and 2017, HMS granted 762,877 and 599,441 restricted stock units, respectively, with an aggregate fair market value of $12.8 million and $11.3 million, respectively.

As of September 30, 2018, 1,281,206 restricted stock units remained unvested and there was approximately $11.3 million of unrecognized compensation cost related to restricted stock units, which is expected to be recognized over a weighted average vesting period of 1.13 years.

13.

Commitments and Contingencies

In July 2012, Dennis Demetre and Lori Lewis (the “Plaintiffs”), filed an action in the Supreme Court of the State of New York against HMS Holdings Corp., claiming an undetermined amount of damages alleging that various actions by HMS unlawfully deprived the Plaintiffs of the acquisition earn-out portion of the purchase price for Allied Management Group Special Investigation Unit (“AMG”) under the applicable Stock Purchase Agreement (the “SPA”) and that HMS had breached certain contractual provisions under the SPA. The Plaintiffs filed a second amended complaint with two causes of action for breach of contract and one cause of action for breach of implied covenant of good faith and fair dealing. HMS asserted a counterclaim against Plaintiffs for breach of contract based on contractual indemnification costs, including attorneys’ fees arising out of the Company’s defense of AMG in Kern Health Systems v. AMG, Dennis Demetre and Lori Lewis (the “California Action”), which are recoverable under the SPA. In June 2016, Kern Health Systems and AMG entered into a settlement agreement that resolved all claims in the California Action. In July 2017, the Court issued a decision on the Company’s motion for partial summary judgment and granted the motion in part, dismissing one of Plaintiffs’ breach of contract causes of action against HMS. On November 3, 2017, following a jury trial, a verdict was returned in favor of the Plaintiffs on a breach of contract claim, and the jury awarded $60 million in damages to the Plaintiffs. On March 14, 2018, the Court held a hearing on the Company’s post-trial motion for an order granting it judgment notwithstanding the verdict or, alternatively, setting aside the jury’s award of damages. On June 27, 2018, prior to the Court issuing a decision on the motion, the Company entered into a Settlement Agreement (the “Settlement Agreement”) with the Plaintiffs, John Alfred Lewis and Christopher Brandon Lewis. Pursuant to the terms of the Settlement Agreement, the Company paid $20 million to resolve all matters in controversy pertaining to the lawsuit. On July 5, 2018, the Court entered an order to discontinue the lawsuit pursuant to the Stipulation of Discontinuance with Prejudice filed by the parties.

In February 2018, the Company received a Civil Investigative Demand (“CID”) from the Texas Attorney General, purporting to investigate possible unspecified violations of the Texas Medicaid Fraud Prevention Act. The Company has provided certain documents and information in March 2018 in response to the CID and continues to cooperate with the government. HMS has not received any further requests for information in connection with this CID.

On September 11, 2018, a former employee filed an action in the New York County Supreme Court entitled Christopher Frey v. Health Management Systems, Inc. alleging retaliation under New York law. The complaint seeks recovery of an unspecified amount of monetary damages, including back pay and other compensatory and equitable relief. The Company believes this claim is without merit and intends to vigorously defend this matter.

From time to time, HMS may be subject to investigations, legal proceedings and other disputes arising in the ordinary course of the Company’s business, including but not limited to regulatory audits, billing and contractual disputes, employment-related matters and post-closing disputes related to acquisitions. Due to the Company’s contractual relationships, including those with federal and state government entities, HMS’s operations, billing and business practices are subject to scrutiny and audit by those entities and other multiple agencies and levels of government, as well as to frequent transitions and changes in the personnel responsible for oversight of the Company’s contractual performance. HMS may have contractual disputes with its customers arising from differing interpretations of contractual provisions that define the Company’s rights, obligations, scope of work or terms of payment, and with associated claims of liability for inaccurate or improper billing for reimbursement of contract fees, or for sanctions or damages for alleged performance deficiencies. Resolution of such disputes may involve litigation or may require that HMS accept some amount of loss or liability in order to avoid customer abrasion, negative marketplace perceptions and other disadvantageous results that could affect the Company’s business, financial condition, results of operations and cash flows.

HMS records accruals for outstanding legal matters when it believes it is probable that a loss will be incurred and the amount can be reasonably estimated. The Company evaluates, on a quarterly basis, developments in legal matters that could affect the amount of any accrual and developments that would make a loss contingency both probable and reasonably estimable. If a loss contingency is not both probable and estimable, HMS does not establish an accrued liability.

14.

Subsequent Events

In connection with the preparation of these unaudited Consolidated Financial Statements, an evaluation of subsequent events was performed through the date of filing and there were no events that have occurred that would require adjustments to the financial statements or disclosures.

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following Management’s Discussion and Analysis is intended to help the reader understand the results of operations and financial condition of HMS. You should read this discussion and analysis in conjunction with the other sections of this Form 10-Q, including the Cautionary Note Regarding Forward-Looking Statements appearing prior to Part I and the unaudited Consolidated Financial Statements and Notes thereto in Part I, Item 1. The historical results set forth in Part I, Item 1 and Item 2 of this Form 10-Q should not be taken as necessarily indicative of our future operations or financial results.

Business Overview

HMS is a leading provider of cost containment solutions in the U.S. healthcare marketplace. Using innovative technology as well as extensive data services and powerful analytics, we deliver coordination of benefits, payment integrity, and care management and consumer engagement solutions through our operating subsidiaries to help healthcare payers improve financial performance and clinical outcomes. Together our various services help our customers recover improper payments; prevent future improper payments; reduce fraud, waste and abuse; better manage the care that their members receive; engage healthcare consumers to improve clinical outcomes and increase retention; and achieve regulatory compliance.

We serve state Medicaid programs, commercial health plans, federal government health agencies, government and private employers, CHIP and other healthcare payers and sponsors. We also serve as a subcontractor for certain business outsourcing and technology firms. As of September 30, 2018, our customer base included the following:

▪	over 40 state Medicaid programs;

▪	approximately 325 health plans, including 23 of the top 25 health plans nationally (based on membership) in support of their multiple lines of business, including Medicaid managed care, Medicare Advantage and group and individual health;

▪	over 225 private employers;

▪	CMS, the Centers for Disease Control and Prevention, and the Department of Veterans Affairs; and

▪	PBMs, third-party administrators and other risk-bearing entities, including independent practice associations, hospital systems, ACOs and specialty care organizations.

Critical Accounting Policies and Estimates

Since the date of our 2017 Form 10-K, there have been no material changes to our critical accounting policies other than with respect to revenue recognition as described in Notes 1 and 3 to the unaudited Consolidated Financial Statements in Part I, Item 1 of this Form 10-Q. With respect to our accounting policies other than revenue recognition, refer to the discussion in our 2017 Form 10-K under “Critical Accounting Policies and Estimates” in Part II, Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations and “Business and Summary of Significant Accounting Policies” in Note 1 to the Consolidated Financial Statements under Part II, Item 8.

RESULTS

As of and for the three months ended September 30, 2018 and September 30, 2017

▪

Revenue of $154.2 million increased $28.5 million, or 22.7% over the same quarter in 2017; and

▪

Operating income of $24.2 million increased by $11.3 million as compared to operating income of $12.9 million in the same quarter prior year.

Comparison of Three Months Ended September 30, 2018 to September 30, 2017

	Three Months Ended
dollars in millions	September 30,						$ Change			% Change
	2018			2017			2018 vs 2017
Revenue	$	154.2		$	125.7		$	28.5			22.7	%
Cost of Services :
Compensation		58.2			49.0			9.2			18.8
Information technology		13.0			12.1			0.9			7.4
Occupancy		3.5			4.3			(0.8	)		(18.6	)
Direct project costs		10.7			9.5			1.2			12.6
Other operating costs		8.5			7.5			1.0			13.3
Amortization of acquisition related software and intangible assets		8.0			8.2			(0.2	)		(2.4	)
Total Cost of Services		101.9			90.6			11.3			12.5
Selling, general and administrative expenses		28.1			22.2			5.9			26.6
Settlement expense		-			-			-			-
Total Operating Expenses		130.0			112.8			17.2			15.2
Operating income		24.2			12.9			11.3			87.6
Interest expense		(2.9	)		(3.1	)		0.2			(6.8	)
Interest income		0.3			-			0.3			-
Income before income taxes		21.6			9.8			11.8			120.5
Income taxes		3.1			3.4			(0.3	)		(8.8	)
Net Income		18.5			6.4			12.1			189.2	%

Revenue (in millions)

Three Months Ended September 30 – 2018 vs. 2017

During the three months ended September 30, 2018, revenue was $154.2 million, an increase of $28.5 million or 22.7% compared to revenue of $125.7 million for the prior year quarter.

▪

By product:

Coordination of benefits revenue increased $15.6 million or 17.3% which was attributable to incremental services and yield increases provided to existing customers in our cost avoidance and direct bill business.

Analytical services revenue, which consists of Care Management and Consumer Engagement, Payment integrity, and Medicare RAC, increased $13.0 million or 36.5%. Care management and consumer engagement revenue increased by $4.4 million or 40.4% which was mostly driven by growth in the Eliza business. Payment integrity revenue increased $6.3 million or 26.4% primarily due to increased demand from existing clients, yield enhancements and improvements in provider processes. Medicare RAC revenue also increased by $2.3 million period over period.

▪

By market:

Commercial health plan market revenue increased $19.1 million or 28.3% which was attributable to growth in the Eliza business and incremental services and yield increases provided to existing customers in our cost avoidance business.

Federal government market revenue increased $1.8 million or 27.7%.

State government market revenue grew by $7.7 million or 14.9%.

Total Cost of Services (in millions)

Three Months Ended September 30 – 2018 vs. 2017

During the three months ended September 30, 2018, total cost of services was $101.9 million, an increase of $11.3 million or 12.5% compared to $90.6 million for the prior year quarter.

	▪	Compensation expense increased by $9.2 million due to increases in variable compensation and fringe benefits expenses. The increase in variable compensation relates to improved results of operations in the current period compared to prior year. The increase in fringe benefits is the result of higher insurance claims cost and an increase in employer 401(k) match during 2018.
	▪	Direct project costs increased by $1.2 million due to increased revenue.
	▪	Other operating expenses increased by $1.0 million due to legal and consulting expenses.
	▪	Information technology expenses increased by $0.9 million due to increases in amortization of internally developed software and software maintenance.

Selling, General and Administrative expenses (in millions)

Three Months Ended September – 2018 vs. 2017

During the three months ended September 30, 2018, SG&A expense was $28.1 million, an increase of $5.9 million or 26.6% compared to $22.2 million for the prior year quarter.

▪

In the third quarter of 2017, the Company had decreases in legal expense and other operating expenses which reduced SG&A expenses by $4.6 million. The Company had no such reductions in 2018.

▪

Compensation expense in 2018 increased by $0.9 million due to an increase in variable compensation in the current period related to improved results of operations. The increase was partially offset by a decrease in fringe benefits expenses primarily related to stock compensation expense.

Income Taxes

Three Months Ended September 30 – 2018 vs. 2017

The Company’s effective tax rate decreased to 14.2% for the three months ended September 30, 2018 compared to 34.8% for the three months ended September 30, 2017. The three months ended September 30, 2018 effective tax rate includes discrete tax expenses related to the settlement of previously disclosed litigation, interest on uncertain tax benefits, state tax refunds and net stock compensation in addition to a net federal tax reform benefit comprised of a federal tax rate decrease, net of state impact, offset by tax increases for officer compensation deduction limits and loss of the domestic manufacturing deduction. Excluding the above mentioned discrete tax items and net federal tax reform benefit, our effective tax rate would approximate 35.9% for the three months ended September 30, 2018. For the three months ended September 30, 2018, the differences between the federal statutory rate and our effective tax rate are discrete tax expenses related to the settlement of previously disclosed litigation, state taxes, equity compensation impacts, unrecognized tax benefits, including interest, officer compensation deduction limits, research and development tax credits, and other permanent differences.

As of and for the nine months ended September 30, 2018 and September 30, 2017

▪

Revenue of $442.5 million increased $69.8 million, or 18.7% over the same period in 2017;

▪

Operating income of $35.4 million increased $4.1 million over the same period in 2017; and

▪

Net income of $21.6 million increased $7.3 million over the same period in 2017.

Comparison of Nine months ended September 30, 2018 to September 30, 2017

	Nine Months Ended
dollars in millions	September 30,						$ Change			% Change
	2018			2017			2018 vs 2017
Revenue	$	442.5		$	372.7		$	69.8			18.7	%
Cost of Services :
Compensation		169.5			149.8			19.7			13.2
Information technology		39.5			33.1			6.4			19.3
Occupancy		11.9			12.1			(0.2	)		(1.7	)
Direct project costs		31.7			30.1			1.6			5.3
Other operating costs		22.1			21.2			0.9			4.2
Amortization of acquisition related software and intangible assets		25.7			21.7			4.0			18.4
Total Cost of Services		300.4			268.0			32.4			12.1
Selling, general and administrative expenses		86.7			73.4			13.3			18.1
Settlement expense		20.0			-			20.0			-
Total Operating Expenses		407.1			341.4			65.7			19.2
Operating Income		35.4			31.3			4.1			13.1
Interest expense		(8.6	)		(7.7	)		(0.9	)		11.7
Interest income		0.6			0.2			0.4			200.0
Income before income taxes		27.4			23.8			3.6			15.1
Income taxes		5.8			9.3			(3.5	)		(37.6	)
Net Income	$	21.6		$	14.5		$	7.1			49.0	%

Revenue (in millions)

Nine Months Ended September 30 – 2018 vs. 2017

During the nine months ended September 30, 2018, revenue was $442.5 million, an increase of $69.8 million or 18.7% compared to revenue of $372.7 million for the prior year period.

▪

By product:

Coordination of benefits revenue increased $21.1 million or 7.6% which was attributable to incremental services and yield increases provided to existing customers in our cost avoidance business.

Analytical services revenue which consists of Care Management and Consumer Engagement, Payment integrity, and Medicare RAC, increased $48.7 million or 50.9%. The increase was primarily due to our Eliza subsidiary (acquired in April 2017) increasing revenue by $19.9 million as compared to prior year. Also, Medicare RAC revenue increased by $14.5 million as compared to prior year primarily due to an $8.4 million release of our Medicare RAC appeals liability due to contract expiration in the first quarter of the current year. Payment integrity revenue increased $13.2 million as compared to prior year primarily due to increased demand from existing clients, yield enhancements and improvements in provider processes.

▪

By market:

Commercial health plan market revenue increased $46.9 million or 24.4% which was attributable to growth in the Eliza subsidiary (acquired in April 2017) of $19.9 million and incremental services and yield increases provided to existing customers in our cost avoidance and direct bill business.

Federal government market revenue increased $13.0 million or 73.0%, primarily due to an $8.4 million release of our Medicare RAC appeals liability due to contract expiration in the first quarter of the current year.

State government market revenue grew by $9.9 million or 6.1%.

Total Cost of Services (in millions)

Nine Months Ended September 30– 2018 vs. 2017

During the nine months ended September 30, 2018, total cost of services was $300.4 million, an increase of $32.4 million or 12.1% compared to $268.0 million for the prior year period.

▪

Our Eliza subsidiary (acquired in April 2017) and its related compensation, information technology, occupancy and amortization of intangibles expenses represented $12.5 million of the increase.

▪

Excluding Eliza, compensation expense increased by $14.8 million, including variable compensation, salaries, fringe benefits expenses, and stock compensation. The increase in variable compensation relates to improved results of operations in the current period compared to prior year. The increase in fringe benefits is the result of higher insurance claims cost and an increase in employer 401(k) match during 2018.

▪

Information technology expense increased by $3.5 million relating to amortization of internally developed software and software maintenance.

Selling, General and Administrative expenses (in millions)

Nine Months Ended September 30 – 2018 vs. 2017

During the nine months ended September 30, 2018, SG&A expense was $86.7 million, an increase of $13.3 million or 18.1% compared to $73.4 million for the prior year period.

▪

Our Eliza subsidiary (acquired in April 2017) represented $2.8 million of the increase.

▪

Excluding Eliza, compensation expense increased by $8.3 million including variable compensation, salaries, fringe benefits, and stock compensation expenses. The increase in variable compensation relates to improved results of operations in the current period compared to prior year. The increase in fringe benefits is the result of higher insurance claims cost and an increase in employer 401(k) match during 2018.

▪

Other expenses decreased by $2.5 million primarily relating to acquisition costs incurred in the prior period.

Income Taxes

Nine Months Ended September 30 – 2018 vs. 2017

The Company’s effective tax rate decreased to 21.3% for the nine months ended September 30, 2018 compared to 39.4% for the nine months ended September 30, 2017. The nine months ended September 30, 2018 effective tax rate includes discrete tax expenses related to the settlement of previously disclosed litigation, interest on uncertain tax benefits, state tax refunds and net stock compensation in addition to a net federal tax reform benefit comprised of a federal tax rate decrease, net of state impact, offset by tax increases for officer compensation deduction limits and loss of the domestic manufacturing deduction. Excluding the above mentioned discrete tax items and net federal tax reform benefit, our effective tax rate would approximate 37.2% for the nine months ended September 30, 2018. For the nine months ended September 30, 2018, the differences between the federal statutory rate and our effective tax rate are discrete tax expenses related to the settlement of previously disclosed litigation, state taxes, equity compensation impacts, unrecognized tax benefits, including interest, officer compensation deduction limits, research and development tax credits, and other permanent differences.

Off-Balance Sheet Arrangements

We do not have any off-balance sheet arrangements.

Liquidity and Capital Resources

The following tables should be read in conjunction with the unaudited Consolidated Financial Statements and Notes thereto in Part I, Item 1 of this Form 10-Q.

Our cash and cash equivalents, working capital and available borrowings under our credit facility (based upon the borrowing base and financial covenants in our Credit Agreement) were as follows (in thousands):

	September 30, 2018		December 31, 2017
Cash and cash equivalents	$	124,297	$	83,313
Working capital	$	262,617	$	199,967
Available borrowings under credit facility	$	260,000	$	254,600

A summary of our cash flows is as follows (in thousands):

	Nine Months Ended September 30,
	2018			2017
Net cash provided by operating activities	$	55,536		$	55,098
Net cash used in investing activities		(19,433	)		(193,494	)
Net cash provided by financing activities		4,881			41,881
Net increase (decrease) in cash and cash equivalents	$	40,984		$	(96,515	)

Cash and cash equivalents at September 30, 2018 and net cash provided by operating activities for the nine months ended September 30, 2018, included a non-recurring cash outflow of $20 million for the settlement expense.

Our principal source of cash has been our cash flow from operations and our $500 million five-year revolving credit facility. Other sources of cash include proceeds from the exercise of stock options and tax benefits associated with stock option exercises. The primary uses of cash are capital investments, acquisitions, compensation expenses, information technology, direct project costs, SG&A expenses, other expense and repurchases of our common stock.

We believe that expected cash flows from operations, available cash and cash equivalents, and funds available under our revolving credit facility will be sufficient to meet our liquidity requirements for the following year, which include:

▪

the working capital requirements of our operations;

▪

investments in our business;

▪

business development activities; and

▪

repurchases of common stock

Any projections of future earnings and cash flows are subject to substantial uncertainty. We may need to access debt and equity markets in the future if unforeseen costs or opportunities arise, to meet working capital requirements, fund acquisitions or repay our indebtedness under the Credit Agreement. If we need to obtain new debt or equity financing in the future, the terms and availability of such financing may be impacted by economic and financial market conditions as well as our financial condition and results of operations at the time we seek additional financing.

Cash Flows from Operating Activities

Net cash provided by operating activities for the nine months ended September 30, 2018 was $55.5 million, an increase of $0.4 million as compared to net cash provided by operating activities of $55.1 million for the nine months ended September 30, 2017. Net cash provided by operating activities for the nine months ended September 30, 2018 includes a non-recurring cash outflow of $20 million for the settlement expense.

Cash Flows from Investing Activities

Net cash used in investing activities for the nine months ended September 30, 2018 was $19.4 million, a $174.1 million decrease compared to net cash used in investing activities of $193.5 million for the nine months ended September 30, 2017. The decrease primarily related to the $171.1 million acquisition of Eliza in the prior year period.

Cash Flows from Financing Activities

Net cash provided by financing activities for the nine months ended September 30, 2018 was $4.9 million, a $37.0 million decrease compared to net cash provided by financing activities of $41.9 million for the nine months ended September 30, 2017. The decrease is primarily related to proceeds from our revolving credit facility of $42.2 million in the prior year.

Contractual Obligations

There have been no material changes outside the ordinary course of business in our contractual obligations as presented in our 2017 Form 10-K.

Recently Issued Accounting Pronouncements

The information set forth under the caption “Recently Issued Accounting Pronouncements” in Note 1 to the unaudited Consolidated Financial Statements in Part I, Item 1 is incorporated herein by reference.

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

There have been no material changes to the market risks discussed in Item 7A to Part II of our 2017 Form 10-K.

Item 4.

Controls and Procedures

We are responsible for maintaining disclosure controls and procedures (as defined in Rule 13a-15(e) under the Exchange Act) that are designed to ensure that information required to be disclosed in our reports filed under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and that such information is accumulated and communicated to our management, including our Chief Executive Officer and our Chief Financial Officer, as appropriate, to allow for timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

As required by Rule 13a-15(b) under the Exchange Act, management, with the participation of our Chief Executive Officer and Chief Financial Officer, performed an evaluation of the effectiveness of our disclosure controls and procedures as of September 30, 2018. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective to provide reasonable assurance that their objectives were met as of the end of the period covered by this Form 10-Q.

There have been no changes in the Company's internal control over financial reporting identified in connection with the evaluation of our controls performed during the three months ended September 30, 2018, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II — OTHER INFORMATION

Item 1.

Legal Proceedings

The information set forth under the caption “Commitments and Contingencies” in Note 13 to the unaudited Consolidated Financial Statements of this Form 10-Q is incorporated herein by reference.

Item 1A.

Risk Factors

In addition to the information set forth in this Form 10-Q, the risks that are discussed in the 2017 Form 10-K, under the headings “Part I, Item 1. Business,” “Part I, Item 1A. Risk Factors” and “Part II, Item 7A. Quantitative and Qualitative Disclosures About Market Risk,” should be carefully considered as such risks could materially affect the Company’s business, financial condition or future results. There has been no material change in the Company’s risk factors from those described in the 2017 Form 10-K.

These risks are not the only risks facing the Company. Additional risks and uncertainties not currently known to the Company or that it currently deems to be immaterial also may have a material adverse effect on the Company’s business, financial condition or future results.

Item 6.

Exhibits

The Exhibits may include agreements to which the Company is a party or has a beneficial interest. The agreements have been filed to provide investors with information regarding their respective terms. The agreements are not intended to provide any other actual information about the Company or its business or operations. In particular, the assertions embodied in any representations, warranties, and covenants contained in the agreements may be subject to qualifications with respect to knowledge and materiality different from those applicable to investors and may be qualified by information in confidential disclosure schedules not included with the exhibits. These disclosure schedules may contain information that modifies, qualifies and creates exceptions to the representations, warranties and covenants set forth in the agreements. Moreover, certain representations, warranties, and covenants in the agreements may have been used for the purpose of allocating risk between parties, rather than establishing matters as facts. In addition, information concerning the subject matter of the representations, warranties and covenants may have changed after the date of the respective agreement, which subsequent information may or may not be fully reflected in the Company’s public disclosures. Accordingly, investors should not rely on the representations, warranties and covenants in the agreements as characterizations of the actual state of facts about the Company or its business or operations on the date hereof.

Where an exhibit is filed by incorporation by reference to a previously filed registration statement or report, such registration statement or report is identified after the description of the exhibit.

Exhibit Number		Description

3.1		Conformed copy of Certificate of Incorporation of the Company, as amended through May 23, 2018 (incorporated by reference to Exhibit 3.1 to the Company's Quarterly Report on Form 10-Q (File No. 000-50194) as filed with the SEC on August 6, 2018)

3.2		Second Amended and Restated Bylaws of HMS Holdings Corp. dated May 23, 2018 (incorporated) by reference to Exhibit 3.2 to the Company’s Current Report on Form 8-K (File No. 000-50194) as filed with the SEC on May 25, 2018)

31.1		Rule 13a-14(a)/15d-14(a) Certification of the Principal Executive Officer of HMS Holdings Corp., as adopted pursuant to Section 302 of the Sarbanes- Oxley Act of 2002

31.2		Rule 13a-14(a)/15d-14(a) Certification of the Principal Financial Officer of HMS Holdings Corp., as adopted pursuant to Section 302 of the Sarbanes- Oxley Act of 2002

32.1		Section 1350 Certification of the Principal Executive Officer of HMS Holdings Corp., as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002*

32.2		Section 1350 Certification of the Principal Financial Officer of HMS Holdings Corp., as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002*

101.INS		XBRL Instance Document
101.SCH		XBRL Taxonomy Extension Schema Document
101.CAL		XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF		XBRL Taxonomy Extension Definition Linkbase Document
101.LAB		XBRL Taxonomy Extension Label Linkbase Document
101.PRE		XBRL Taxonomy Extension Presentation Linkbase Document

_________________________

The certifications attached hereto as Exhibit 32.1 and Exhibit 32.2 are furnished with this Form 10-Q and shall not be deemed “filed” by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Date:	November 5, 2018	HMS HOLDINGS CORP.


		By:
			William C. Lucia
			President and Chief Executive Officer
			(Principal Executive Officer)


		By:
			Jeffrey S. Sherman
			Executive Vice President, Chief Financial Officer and Treasurer
			(Principal Financial Officer)

EX-31.1 2 exh_311.htm EXHIBIT 31.1

Exhibit 31.1

Certification

I, William C. Lucia, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of HMS Holdings Corp.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 5, 2018
	William C. Lucia
	Chief Executive Officer
	(Principal Executive Officer)

EX-31.2 3 exh_312.htm EXHIBIT 31.2

Exhibit 31.2

Certification

I, Jeffrey S. Sherman, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of HMS Holdings Corp.;

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 5, 2018
	Jeffrey S. Sherman
	Chief Financial Officer
	(Principal Financial Officer)

EX-32.1 4 exh_321.htm EXHIBIT 32.1

Exhibit 32.1

Certification Pursuant To 18 U.S.C. Section 1350 As Adopted Pursuant To Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the Quarterly Report of HMS Holdings Corp. (the “Company”) on Form 10-Q for the period ended September 30, 2018 as filed with the Securities and Exchange Commission (the “Report”), I, William C. Lucia, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


	William C. Lucia
	Chief Executive Officer
	(Principal Executive Officer)


	November 5, 2018

EX-32.2 5 exh_322.htm EXHIBIT 32.2

Exhibit 32.2

Certification Pursuant To 18 U.S.C. Section 1350 As Adopted Pursuant To Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the Quarterly Report of HMS Holdings Corp. (the “Company”) on Form 10-Q for the period ended September 30, 2018 as filed with the Securities and Exchange Commission (the “Report”), I, Jeffrey S. Sherman, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


	Jeffrey S. Sherman
	Chief Financial Officer
	(Principal Financial Officer)


	November 5, 2018

EX-101.INS 6 hmsy-20180930.xml XBRL INSTANCE FILE false --12-31 Q3 2018 2018-09-30 10-Q 0001196501 83907132 Yes false Large Accelerated Filer HMS HOLDINGS CORP false hmsy <div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="font-size: 10pt; color: #00A9E0; margin-top: 0pt; margin-bottom: 0pt; min-width: 700px;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: top; text-align: justify"> <td style="width: 35pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4.</div></div></div></td> <td style="width: 5pt"></td> <td style="text-align: justify"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"><div style="display: inline; font-weight: bold;">Accounts Receivable and Accounts Receivable Allowance</div></div></td> </tr> </table> <div style=" font-size: 10pt; margin: 0pt 0; color: #00A9E0"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"><div style="display: inline; font-weight: bold;"> </div></div></div> <div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">The Company’s accounts receivable, net, consisted of the following <div style="display: inline; font-style: italic;">(in thousands)</div>:</div></div> <div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></div> <div style=" font-size: 10pt; margin: 0pt 0; color: Red"></div> <div> <table style="border-collapse: collapse; font: 12pt Arial Narrow; min-width: 700px;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; font-weight: bold; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">September 30,</div><div style="display: inline; font-size: 12pt"><br /> <div style="display: inline; font-family: Arial Narrow">2018</div></div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; font-weight: bold; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">December 31, </div><div style="display: inline; font-size: 12pt"><br /> <div style="display: inline; font-family: Arial Narrow">2017</div></div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 74%; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Accounts receivable</div></td> <td style="width: 1%; font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="width: 1%; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">$</div></td> <td style="width: 10%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">218,737</div></div></td> <td style="width: 1%; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="width: 1%; font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">$</div></td> <td style="width: 0; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">204,259</div></div></td> <td style="width: 1%; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Allowance</div></td> <td style="font-size: 10pt; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">(16,239</div></div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">)</div></td> <td style="font-size: 10pt; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">(14,799</div></div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">)</div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; border-bottom: Black 2.25pt double"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Accounts receivable, net</div></td> <td style="font-size: 10pt; border-bottom: Black 2.25pt double"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">$</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">202,498</div></div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; border-bottom: Black 2.25pt double"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">$</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">189,460</div></div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> </tr> </table> </div> <div style=" font-size: 10pt; margin: 0pt 0; color: Red"></div> <div style=" font-size: 10pt; margin: 0pt 0; color: Red"></div> <div style=" font-size: 10pt; margin: 0pt 0"></div> <div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></div> <div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font: 12pt Arial Narrow"> </div></div> <div style=" font-size: 10pt; margin: 0pt 0"></div>   <div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font: 12pt Arial Narrow">We record an accounts receivable allowance based on historical patterns of billing adjustments, length of operating and collection cycle and customer negotiations, behaviors and payment patterns. Changes in these estimates are recorded to revenue in the period of change. A summary of the activity in the accounts receivable allowance was as follows <div style="display: inline; font-style: italic;">(in thousands)</div>:</div></div> <div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font: 12pt Arial Narrow"> </div></div> <div style=" font-size: 10pt; margin: 0pt 0; color: Red"></div> <div> <table style="border-collapse: collapse; font: 12pt Arial Narrow; min-width: 700px;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; border-bottom: Black 1pt solid"><div style="display: inline; font: 12pt Arial Narrow"> </div></td> <td style="font-size: 10pt; font-weight: bold; border-bottom: Black 1pt solid"><div style="display: inline; font: 12pt Arial Narrow"> </div></td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"><div style="display: inline; font-weight: bold;">September 30,<br /> 2018</div></div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"><div style="display: inline; font: 12pt Arial Narrow"> </div></td> <td style="font-size: 10pt; font-weight: bold; border-bottom: Black 1pt solid"><div style="display: inline; font: 12pt Arial Narrow"> </div></td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"><div style="display: inline; font-weight: bold;">December 31, <br /> 2017</div></div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"><div style="display: inline; font: 12pt Arial Narrow"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 74%; font-size: 10pt"><div style="display: inline; font: 12pt Arial Narrow">Balance--beginning of period</div></td> <td style="width: 1%; font-size: 10pt"><div style="display: inline; font: 12pt Arial Narrow"> </div></td> <td style="width: 1%; font-size: 10pt; text-align: left"><div style="display: inline; font: 12pt Arial Narrow">$</div></td> <td style="width: 10%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font: 12pt Arial Narrow">14,799</div></div></td> <td style="width: 1%; font-size: 10pt; text-align: left"><div style="display: inline; font: 12pt Arial Narrow"> </div></td> <td style="width: 1%; font-size: 10pt"><div style="display: inline; font: 12pt Arial Narrow"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font: 12pt Arial Narrow">$</div></td> <td style="width: 0; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font: 12pt Arial Narrow">10,772</div></div></td> <td style="width: 1%; font-size: 10pt; text-align: left"><div style="display: inline; font: 12pt Arial Narrow"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt"><div style="display: inline; font: 12pt Arial Narrow">Provision</div></td> <td style="font-size: 10pt"><div style="display: inline; font: 12pt Arial Narrow"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font: 12pt Arial Narrow"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font: 12pt Arial Narrow">16,107</div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font: 12pt Arial Narrow"> </div></td> <td style="font-size: 10pt"><div style="display: inline; font: 12pt Arial Narrow"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font: 12pt Arial Narrow"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font: 12pt Arial Narrow">20,233</div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font: 12pt Arial Narrow"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; border-bottom: Black 1pt solid"><div style="display: inline; font: 12pt Arial Narrow">Charge-offs</div></td> <td style="font-size: 10pt; border-bottom: Black 1pt solid"><div style="display: inline; font: 12pt Arial Narrow"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font: 12pt Arial Narrow"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font: 12pt Arial Narrow">(14,667</div></div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font: 12pt Arial Narrow">)</div></td> <td style="font-size: 10pt; border-bottom: Black 1pt solid"><div style="display: inline; font: 12pt Arial Narrow"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font: 12pt Arial Narrow"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font: 12pt Arial Narrow">(16,206</div></div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font: 12pt Arial Narrow">)</div></td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; border-bottom: Black 2.25pt double"><div style="display: inline; font: 12pt Arial Narrow">Balance--end of period</div></td> <td style="font-size: 10pt; border-bottom: Black 2.25pt double"><div style="display: inline; font: 12pt Arial Narrow"> </div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"><div style="display: inline; font: 12pt Arial Narrow">$</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font: 12pt Arial Narrow">16,239</div></div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"><div style="display: inline; font: 12pt Arial Narrow"> </div></td> <td style="font-size: 10pt; border-bottom: Black 2.25pt double"><div style="display: inline; font: 12pt Arial Narrow"> </div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"><div style="display: inline; font: 12pt Arial Narrow">$</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font: 12pt Arial Narrow">14,799</div></div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"><div style="display: inline; font: 12pt Arial Narrow"> </div></td> </tr> </table> </div></div> 18073000 18498000 0.75 0.25 P3Y P5Y 120000000 1 3 3 4.75 4.25 5.25 32372000 24072000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" style="font-size: 10pt; color: #00A9E0; margin-top: 0pt; margin-bottom: 0pt; min-width: 700px;"> <tr style="vertical-align: top; text-align: justify"> <td style="width: 35pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">9.</div></div></div></td> <td style="width: 5pt"></td> <td style="text-align: justify"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"><div style="display: inline; font-weight: bold;">Estimated Liability For Appeals</div></div></td> </tr> </table> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Under the Company’s contracts with certain commercial health plan customers and its Medicare RAC contracts with CMS (included within the Company’s analytical services product revenue), providers have the right to appeal HMS claim findings and to pursue additional appeals if the initial appeal is found in favor of HMS’s customer. The appeal process established under the Medicare RAC contract with CMS includes <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">five</div> levels of appeals, and resolution of appeals can take substantial time to resolve. HMS records a) a return obligation liability for findings which have been adjudicated in favor of providers and b) an estimated return obligation liability based on the amount of revenue that is subject to appeals and which are probable of being adjudicated in favor of providers following their successful appeal. The Company’s estimate is based on the Company’s historical experience. To the extent the amount to be returned to providers following a successful appeal exceeds or is less than the amount recorded, revenue in the applicable period would be reduced or increased by such amount. Any future changes to any of the Company’s customer contracts, including modifications to the Medicare RAC contract, <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>require the Company to apply different assumptions that could materially affect both the Company’s revenue and estimated liability for appeals in future periods.</div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">The Company’s original Medicare RAC contract with CMS expired on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 31, 2018. </div>As a result of the contract expiration, the Company’s contractual obligation with respect to any appeals resolved in favor of providers subsequent to the expiration date have ceased and therefore the Company released its estimated liability and increased revenue by <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$8.4</div> million during the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> quarter of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018.</div> The Company continues to assess the remaining Medicare RAC liability to determine management’s best estimate of liability for any findings which have been previously adjudicated prior to the expiration of the contract.</div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">The total estimated liability for appeals balance of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$22.2</div> million and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$30.8</div> million as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2018 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017, </div>respectively, includes <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$19.4</div> million and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$19.3</div> million, respectively, of Medicare RAC claim findings which have been adjudicated in favor of providers, and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.0</div> million and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$8.5</div> million, respectively, of the Company’s estimate of the potential amount of Medicare RAC repayments that are probable of being adjudicated in favor of providers following a successful appeal. Additionally, the total estimated liability for appeals balance includes <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$2.8</div> million and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$3.2</div> million related to commercial customers claim appeals. The provision included in the estimated liability for appeals is an offset to revenue in the Company’s Consolidated Statements of Income.</div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"></div>   <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">A summary of the activity in the estimated liability for appeals related to the Company’s original Medicare RAC contract was as follows <div style="display: inline; font-style: italic;">(in thousands)</div>:</div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0; color: Red"></div> <div> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font: 12pt Arial Narrow; min-width: 700px;"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; font-weight: bold; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">September 30, </div><div style="display: inline; font-size: 12pt"><br /> <div style="display: inline; font-family: Arial Narrow">2018</div></div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 87%; font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Balance--beginning of period</div></td> <td style="width: 1%; font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="width: 1%; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">$</div></td> <td style="width: 10%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">8,544</div></div></td> <td style="width: 1%; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Provision</div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">-</div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Appeals found in providers favor</div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">(108</div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">)</div></td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Release of liability</div></td> <td style="font-size: 10pt; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">(8,436</div></div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">)</div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; border-bottom: Black 1.5pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Balance--end of period</div></td> <td style="font-size: 10pt; border-bottom: Black 1.5pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">$</div></td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">-</div></div></td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> </tr> </table> </div></div> 22184000 30787000 19400000 19300000 0 8500000 2800000 3200000 8400000 8436000 8436000 17 538000 -414000 -167000 -1000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font: 12pt Arial Narrow; min-; min-width: 700px;"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; border-bottom: Black 1pt solid"><div style="display: inline; font: 12pt Arial Narrow"> </div></td> <td style="font-size: 10pt; font-weight: bold; border-bottom: Black 1pt solid"><div style="display: inline; font: 12pt Arial Narrow"> </div></td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"><div style="display: inline; font-weight: bold;">September 30,<br /> 2018</div></div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"><div style="display: inline; font: 12pt Arial Narrow"> </div></td> <td style="font-size: 10pt; font-weight: bold; border-bottom: Black 1pt solid"><div style="display: inline; font: 12pt Arial Narrow"> </div></td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"><div style="display: inline; font-weight: bold;">December 31, <br /> 2017</div></div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"><div style="display: inline; font: 12pt Arial Narrow"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 74%; font-size: 10pt"><div style="display: inline; font: 12pt Arial Narrow">Balance--beginning of period</div></td> <td style="width: 1%; font-size: 10pt"><div style="display: inline; font: 12pt Arial Narrow"> </div></td> <td style="width: 1%; font-size: 10pt; text-align: left"><div style="display: inline; font: 12pt Arial Narrow">$</div></td> <td style="width: 10%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font: 12pt Arial Narrow">14,799</div></div></td> <td style="width: 1%; font-size: 10pt; text-align: left"><div style="display: inline; font: 12pt Arial Narrow"> </div></td> <td style="width: 1%; font-size: 10pt"><div style="display: inline; font: 12pt Arial Narrow"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font: 12pt Arial Narrow">$</div></td> <td style="width: 0; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font: 12pt Arial Narrow">10,772</div></div></td> <td style="width: 1%; font-size: 10pt; text-align: left"><div style="display: inline; font: 12pt Arial Narrow"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt"><div style="display: inline; font: 12pt Arial Narrow">Provision</div></td> <td style="font-size: 10pt"><div style="display: inline; font: 12pt Arial Narrow"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font: 12pt Arial Narrow"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font: 12pt Arial Narrow">16,107</div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font: 12pt Arial Narrow"> </div></td> <td style="font-size: 10pt"><div style="display: inline; font: 12pt Arial Narrow"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font: 12pt Arial Narrow"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font: 12pt Arial Narrow">20,233</div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font: 12pt Arial Narrow"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; border-bottom: Black 1pt solid"><div style="display: inline; font: 12pt Arial Narrow">Charge-offs</div></td> <td style="font-size: 10pt; border-bottom: Black 1pt solid"><div style="display: inline; font: 12pt Arial Narrow"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font: 12pt Arial Narrow"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font: 12pt Arial Narrow">(14,667</div></div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font: 12pt Arial Narrow">)</div></td> <td style="font-size: 10pt; border-bottom: Black 1pt solid"><div style="display: inline; font: 12pt Arial Narrow"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font: 12pt Arial Narrow"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font: 12pt Arial Narrow">(16,206</div></div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font: 12pt Arial Narrow">)</div></td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; border-bottom: Black 2.25pt double"><div style="display: inline; font: 12pt Arial Narrow">Balance--end of period</div></td> <td style="font-size: 10pt; border-bottom: Black 2.25pt double"><div style="display: inline; font: 12pt Arial Narrow"> </div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"><div style="display: inline; font: 12pt Arial Narrow">$</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font: 12pt Arial Narrow">16,239</div></div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"><div style="display: inline; font: 12pt Arial Narrow"> </div></td> <td style="font-size: 10pt; border-bottom: Black 2.25pt double"><div style="display: inline; font: 12pt Arial Narrow"> </div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"><div style="display: inline; font: 12pt Arial Narrow">$</div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font: 12pt Arial Narrow">14,799</div></div></td> <td style="border-bottom: Black 2.25pt double; font-size: 10pt; text-align: left"><div style="display: inline; font: 12pt Arial Narrow"> </div></td> </tr> </table></div> 1 <div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font: 12pt Arial Narrow; min-; min-width: 700px;"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; padding-bottom: 1pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; font-weight: bold; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Three Months Ended </div><div style="display: inline; font-size: 12pt"><br /> <div style="display: inline; font-family: Arial Narrow">September 30,</div></div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; font-weight: bold; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Nine Months Ended </div><div style="display: inline; font-size: 12pt"><br /> <div style="display: inline; font-family: Arial Narrow">September 30,</div></div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> </tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; font-weight: bold; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: right; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">2018</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; font-weight: bold; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: right; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">2017</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; font-weight: bold; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: right; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">2018</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; font-weight: bold; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: right; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">2017</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 48%; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Interest expense</div></td> <td style="width: 1%; font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="width: 1%; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">$</div></td> <td style="width: 10%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">2,527</div></div></td> <td style="width: 1%; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="width: 1%; font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="width: 1%; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">$</div></td> <td style="width: 10%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">2,230</div></div></td> <td style="width: 1%; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="width: 1%; font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="width: 1%; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">$</div></td> <td style="width: 10%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">7,224</div></div></td> <td style="width: 1%; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="width: 1%; font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="width: 1%; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">$</div></td> <td style="width: 10%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">5,072</div></div></td> <td style="width: 1%; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Commitment fees</div></td> <td style="font-size: 10pt; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">211</div></div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">325</div></div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">688</div></div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">1,036</div></div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> </tr> </table></div> 108000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font: 12pt Arial Narrow; min-; min-width: 700px;"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; font-weight: bold; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">September 30, </div><div style="display: inline; font-size: 12pt"><br /> <div style="display: inline; font-family: Arial Narrow">2018</div></div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 87%; font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Balance--beginning of period</div></td> <td style="width: 1%; font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="width: 1%; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">$</div></td> <td style="width: 10%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">8,544</div></div></td> <td style="width: 1%; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Provision</div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">-</div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Appeals found in providers favor</div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">(108</div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">)</div></td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Release of liability</div></td> <td style="font-size: 10pt; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">(8,436</div></div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">)</div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; border-bottom: Black 1.5pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Balance--end of period</div></td> <td style="font-size: 10pt; border-bottom: Black 1.5pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">$</div></td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">-</div></div></td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> </tr> </table></div>

64295000

61900000

64295000

61900000

13850000

19330000

218737000

204259000

202498000

189460000

P15Y

P6Y

P1Y182D

P1Y

397192000

368721000

17645000

1600000

3200000

7600000

7100000

1900000

4200000

10000000

9700000

1537000

1851000

5802000

5353000

1900000

5531000

11843000

11408000

3437000

7382000

17645000

16761000

16239000

14799000

10772000

14667000

16206000

400000

1000000

423000

1563000

6100000

6200000

18889000

15947000

21105

2642548

202

84360

531378

2132017

595

63452

1006920000

975160000

349096000

292654000

37400000

17500000

35000

2450000

35000

<div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" style="font-size: 10pt; color: #00A9E0; margin-top: 0pt; margin-bottom: 0pt; min-width: 700px;"> <tr style="vertical-align: top; text-align: justify"> <td style="width: 35pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5.</div></div></div></td> <td style="width: 5pt"></td> <td style="text-align: justify"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"><div style="display: inline; font-weight: bold;">Acquisition</div></div></td> </tr> </table> <div style=" font-size: 10pt; margin: 0pt 0; color: #00A9E0"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"><div style="display: inline; font-weight: bold;"> </div></div></div> <div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> April 17, 2017, </div>the Company completed the acquisition of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">100%</div> of the outstanding capital stock of Eliza Holding Corp. (“Eliza”), for a preliminary purchase price of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$171.6</div> million funded with available liquidity of approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">75%</div> cash on hand and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">25%</div> from the Company’s existing credit line.</div></div> <div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">The allocation of the purchase price to the fair value of the assets acquired and the liabilities assumed as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> April </div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">17,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> the effective date of the acquisition, is as follows (<div style="display: inline; font-style: italic;">in thousands</div>):</div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0; color: Red"></div> <div> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font: 12pt Arial Narrow; min-width: 700px;"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 87%; font-size: 10pt; text-align: left; border-top: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Cash and cash equivalents</div></td> <td style="width: 1%; font-size: 10pt; border-top: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="width: 1%; font-size: 10pt; text-align: left; border-top: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">$</div></td> <td style="width: 10%; font-size: 10pt; text-align: right; border-top: Black 1pt solid"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">435</div></div></td> <td style="width: 1%; font-size: 10pt; text-align: left; border-top: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Accounts receivable</div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">8,902</div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Prepaid expenses</div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">1,427</div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Property and equipment</div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">1,146</div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Intangible assets</div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">76,240</div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Goodwill</div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">107,754</div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Other assets</div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">63</div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Accounts payable</div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">(2,620</div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">)</div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Deferred tax liability</div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">(19,681</div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">)</div></td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Other liabilities</div></td> <td style="font-size: 10pt; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right; border-bottom: Black 1pt solid"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">(2,057</div></div></td> <td style="font-size: 10pt; text-align: left; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">)</div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; font-weight: bold; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Total purchase price</div></td> <td style="font-size: 10pt; font-weight: bold; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">$</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">171,609</div></div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> </tr> </table> </div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0; color: Red"></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0; color: Red"></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">The purchase price allocated to the intangibles acquired was as follows (<div style="display: inline; font-style: italic;">in thousands</div>):</div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"></div> <div> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font: 12pt Arial Narrow; min-width: 700px;"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; font-style: italic; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; font-weight: bold; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Useful Life <br /> (in years)</div></td> <td style="font-size: 10pt; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td colspan="2" style="font-size: 10pt; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 74%; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Customer relationships</div></td> <td style="width: 1%; font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="width: 12%; font-size: 10pt; text-align: left"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">15</div></div></td> <td style="width: 1%; font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="width: 1%; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">$</div></td> <td style="width: 10%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">56,200</div></div></td> <td style="width: 1%; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Intellectual property</div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">6</div></div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">19,600</div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Trade name</div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">1.5</div></div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">310</div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Restrictive covenants</div></td> <td style="font-size: 10pt; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">1</div></div></td> <td style="font-size: 10pt; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">130</div></div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; font-weight: bold; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Fair value of intangibles acquired</div></td> <td style="font-size: 10pt; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></div></td> <td style="font-size: 10pt; font-weight: bold; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">$</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">76,240</div></div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> </tr> </table> </div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Acquisition costs recorded in the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">second</div> quarter <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div> to selling, general and administrative expenses were as follows (<div style="display: inline; font-style: italic;">in thousands):</div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"><div style="display: inline; font-style: italic;"> </div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"></div> <div> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; min-width: 700px;"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 87%; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Other operating expenses - consulting fees</div></td> <td style="width: 1%; font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="width: 1%; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">$</div></td> <td style="width: 10%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">3,515</div></div></td> <td style="width: 1%; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Other operating expenses - legal fees</div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">832</div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Other operating expenses - transaction costs</div></td> <td style="font-size: 10pt; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">185</div></div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; font-weight: bold; text-align: left; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Acquisition-related costs</div></td> <td style="font-size: 10pt; font-weight: bold; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">$</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">4,532</div></div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> </tr> </table> </div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">The financial results of Eliza have been included in the Company’s consolidated financial statements since the date of acquisition. Eliza contributed approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$37.4</div> million in revenue to HMS results of operations for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2018. </div>Eliza contributed approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$17.5</div> million in revenue to HMS results of operations from the date of acquisition through <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2017.</div></div></div></div>

435000

1427000

8902000

2620000

19681000

76240000

2057000

63000

1146000

171609000

3515000

832000

185000

4532000

<div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; min-; min-width: 700px;"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 87%; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Other operating expenses - consulting fees</div></td> <td style="width: 1%; font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="width: 1%; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">$</div></td> <td style="width: 10%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">3,515</div></div></td> <td style="width: 1%; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Other operating expenses - legal fees</div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">832</div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Other operating expenses - transaction costs</div></td> <td style="font-size: 10pt; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">185</div></div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; font-weight: bold; text-align: left; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Acquisition-related costs</div></td> <td style="font-size: 10pt; font-weight: bold; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">$</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">4,532</div></div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> </tr> </table></div>

124297000

83313000

175999000

79484000

40984000

-96515000

0.01

175000000

97588656

96536251

83925462

83256858

975000

965000

7942000

8167000

25695000

21825000

101837000

90572000

300364000

268153000

130015000

112812000

407072000

341553000

1427000

0.005

0.01

0.005

0.01

0.015

0.02

3500000

564000

2400000

2800000

1814000

2237000

-7582000

-726000

4329000

4852000

14407000

21989000

24331000

20599000

10661000

9548000

31652000

30092000

<div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="font-size: 10pt; color: #00A9E0; margin-top: 0pt; margin-bottom: 0pt; min-width: 700px;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: top; text-align: justify"> <td style="width: 35pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12.</div></div></div></td> <td style="width: 5pt"></td> <td style="text-align: justify"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"><div style="display: inline; font-weight: bold;">Stock-Based Compensation</div></div></td> </tr> </table> <div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"><div style="display: inline; font-weight: bold;"> </div></div></div> <table style="font-size: 10pt; color: #FF6633; margin-top: 0pt; margin-bottom: 0pt; min-width: 700px;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"><div style="display: inline; font-style: italic;">(a)</div></div></td> <td style="width: 5pt"></td> <td style="text-align: justify"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"><div style="display: inline; font-style: italic;">Stock-Based Compensation Expense</div></div></td> </tr> </table> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0; color: #FF6633"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"><div style="display: inline; font-style: italic;"> </div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Total stock-based compensation expense in the Company’s unaudited Consolidated Statements of Income related to the Company’s long-term incentive award plans was as follows <div style="display: inline; font-style: italic;">(in thousands)</div>:</div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0; color: Red"></div> <div> <table style="border-collapse: collapse; font: 12pt Arial Narrow; min-width: 700px;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; padding-bottom: 1pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; font-weight: bold; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Three Months Ended </div><div style="display: inline; font-size: 12pt"><br /> <div style="display: inline; font-family: Arial Narrow">September 30,</div></div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Nine Months Ended </div><div style="display: inline; font-size: 12pt"><br /> <div style="display: inline; font-family: Arial Narrow">September 30,</div></div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> </tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; font-weight: bold; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: right; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">2018</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; font-weight: bold; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: right; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">2017</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: right; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">2018</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; font-weight: bold; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: right; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">2017</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 48%; font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Cost of services-compensation</div></td> <td style="width: 1%; font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="width: 1%; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">$</div></td> <td style="width: 10%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">1,537</div></div></td> <td style="width: 1%; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="width: 1%; font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="width: 1%; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">$</div></td> <td style="width: 10%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">1,851</div></div></td> <td style="width: 1%; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="width: 1%; font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="width: 1%; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">$</div></td> <td style="width: 10%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">5,802</div></div></td> <td style="width: 1%; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="width: 1%; font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="width: 1%; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">$</div></td> <td style="width: 10%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">5,353</div></div></td> <td style="width: 1%; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Selling, general and administrative</div></td> <td style="font-size: 10pt; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">1,900</div></div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">5,531</div></div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; padding-bottom: 1pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">11,843</div></div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">11,408</div></div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; border-bottom: Black 1.5pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Total</div></td> <td style="font-size: 10pt; border-bottom: Black 1.5pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">$</div></td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">3,437</div></div></td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; border-bottom: Black 1.5pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">$</div></td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">7,382</div></div></td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; padding-bottom: 1.5pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">$</div></td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">17,645</div></div></td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; border-bottom: Black 1.5pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">$</div></td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">16,761</div></div></td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> </tr> </table> </div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0; color: Red"></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0; color: Red"></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0 0pt 0.25in; color: #FF6633"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"><div style="display: inline; font-style: italic;"> </div></div></div> <table style="font-size: 10pt; color: #FF6633; margin-top: 0pt; margin-bottom: 0pt; min-width: 700px;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"><div style="display: inline; font-style: italic;">(b)</div></div></td> <td style="width: 5pt"></td> <td style="text-align: justify"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"><div style="display: inline; font-style: italic;">Stock Options</div></div></td> </tr> </table> <div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"><div style="display: inline; font-style: italic;"> </div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Stock-based compensation expense related to stock options was approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1.6</div> million and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$3.2</div> million for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2018 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> respectively. Stock-based compensation expense related to stock options was approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$7.6</div> million and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$7.1</div> million for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2018 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> respectively.</div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></div> <div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Presented below is a summary of stock option activity for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2018 (</div><div style="display: inline; font-style: italic;">in thousands except for weighted average exercise price and weighted average remaining contractual terms</div>):</div></div> <div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></div> <div style=" font-size: 10pt; margin: 0pt 0; color: Red"></div> <div> <table style="border-collapse: collapse; font: 12pt Arial Narrow; min-width: 700px;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; border-bottom: Black 1pt solid; white-space: nowrap"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; font-weight: bold; border-bottom: Black 1pt solid; white-space: nowrap"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid; white-space: nowrap"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Number </div><div style="display: inline; font-size: 12pt"><br /> <div style="display: inline; font-family: Arial Narrow">of </div><br /> <div style="display: inline; font-family: Arial Narrow">Options</div></div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; white-space: nowrap"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; font-weight: bold; border-bottom: Black 1pt solid; white-space: nowrap"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid; white-space: nowrap"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Weighted</div><div style="display: inline; font-size: 12pt"><br /> <div style="display: inline; font-family: Arial Narrow">Average</div><br /> <div style="display: inline; font-family: Arial Narrow">Exercise</div><br /> <div style="display: inline; font-family: Arial Narrow">Price</div></div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; white-space: nowrap"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; font-weight: bold; border-bottom: Black 1pt solid; white-space: nowrap"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid; white-space: nowrap"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Weighted</div><div style="display: inline; font-size: 12pt"><br /> <div style="display: inline; font-family: Arial Narrow">Average</div><br /> <div style="display: inline; font-family: Arial Narrow">Remaining</div><br /> <div style="display: inline; font-family: Arial Narrow">Contractual</div><br /> <div style="display: inline; font-family: Arial Narrow">Terms</div></div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; white-space: nowrap"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; font-weight: bold; border-bottom: Black 1pt solid; white-space: nowrap"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid; white-space: nowrap"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Aggregate</div><div style="display: inline; font-size: 12pt"><br /> <div style="display: inline; font-family: Arial Narrow">Intrinsic</div><br /> <div style="display: inline; font-family: Arial Narrow">Value</div></div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; white-space: nowrap"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 48%; font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Outstanding balance at December 31, 2017</div></td> <td style="width: 1%; font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="width: 1%; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="width: 10%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">5,554</div></div></td> <td style="width: 1%; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="width: 1%; font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="width: 1%; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">$</div></td> <td style="width: 10%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">17.35</div></div></td> <td style="width: 1%; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="width: 1%; font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="width: 1%; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="width: 10%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></div></td> <td style="width: 1%; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="width: 1%; font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="width: 1%; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="width: 10%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></div></td> <td style="width: 1%; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; text-indent: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Granted</div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">1,010</div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">19.58</div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; text-indent: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Exercised</div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">(686</div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">)</div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">21.13</div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; text-indent: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Forfeitures</div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">(100</div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">)</div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">17.64</div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; border-bottom: Black 1pt solid; text-indent: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Expired</div></td> <td style="font-size: 10pt; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">(30</div></div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">)</div></td> <td style="font-size: 10pt; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">22.21</div></div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; border-bottom: Black 1.5pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Outstanding balance at September 30, 2018</div></td> <td style="font-size: 10pt; border-bottom: Black 1.5pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">5,748</div></div></td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; border-bottom: Black 1.5pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">17.33</div></div></td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; border-bottom: Black 1.5pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">5.41</div></div></td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; border-bottom: Black 1.5pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">$</div></td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">88,909</div></div></td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Expected to vest at September 30, 2018</div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">1,561</div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">17.65</div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">7.79</div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">$</div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">23,669</div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Exercisable at September 30, 2018</div></td> <td style="font-size: 10pt; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">3,373</div></div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">$</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">17.13</div></div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">3.76</div></div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">$</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">52,900</div></div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> </tr> </table> </div> <div style=" font-size: 10pt; margin: 0pt 0; color: Red"></div> <div style=" font-size: 10pt; margin: 0pt 0; color: Red"></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">During the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2018 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> the Company issued <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">535,077</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">40,734</div> shares, respectively, of the Company’s common stock upon the exercise of outstanding stock options and received proceeds of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$12.1</div> million and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.8</div> million, respectively. The total intrinsic value of stock options exercised during the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2018 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div> was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$4.0</div> million and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.3</div> million, respectively. During the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2018 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> the Company issued <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">686,111</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">173,539</div> shares, respectively, of the Company’s common stock upon the exercise of outstanding stock options and received proceeds of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$13.7</div> million and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$2.7</div> million, respectively. The total intrinsic value of stock options exercised during the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2018 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div> was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$4.7</div> million and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.6</div> million, respectively.</div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2018, </div>there was approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$7.6</div> million of total unrecognized compensation cost related to stock options outstanding, which is expected to be recognized over a weighted average period of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.1</div> years.</div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"></div>   <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">The weighted-average grant date fair value per share of the stock options granted during the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2018 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div> was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$7.52</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$7.68,</div> respectively. HMS estimated the fair value of each stock option grant on the date of grant using a Black-Scholes option pricing model and weighted–average assumptions set forth in the following table:</div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></div> <div style=" font-size: 10pt; margin: 0pt 0; color: Red"></div> <div> <table style="border-collapse: collapse; font: 12pt Arial Narrow; min-width: 700px;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; padding-bottom: 1pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; font-weight: bold; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Nine Months </div><div style="display: inline; font-size: 12pt"><br /> <div style="display: inline; font-family: Arial Narrow">Ended September 30,</div></div></td> <td style="border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> </tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; font-weight: bold; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">2018</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; font-weight: bold; border-bottom: Black 1pt solid; text-align: center"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">2017</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 74%; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Expected dividend yield</div></td> <td style="width: 1%; font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="width: 1%; font-size: 10pt; text-align: center"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="width: 10%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">0</div></div></td> <td style="width: 1%; font-size: 10pt; text-align: center"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">%</div></td> <td style="width: 1%; font-size: 10pt; text-align: center"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="width: 1%; font-size: 10pt; text-align: center"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="width: 10%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">0</div></div></td> <td style="width: 1%; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">%</div></td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Risk-free interest rate</div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: center"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">2.68</div></div></td> <td style="font-size: 10pt; text-align: center"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">%</div></td> <td style="font-size: 10pt; text-align: center"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: center"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">1.74</div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">%</div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Expected volatility</div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: center"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">42.43</div></div></td> <td style="font-size: 10pt; text-align: center"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">%</div></td> <td style="font-size: 10pt; text-align: center"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: center"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">44.23</div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">%</div></td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Expected life (years)</div></td> <td style="font-size: 10pt; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">6.00</div></div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; border-bottom: Black 1pt solid; text-align: center"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">5.00</div></div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> </tr> </table> </div> <div style=" font-size: 10pt; margin: 0pt 0; color: Red"></div> <div style=" font-size: 10pt; margin: 0pt 0; color: Red"></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0; color: red"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"><div style="display: inline; font-weight: bold;"> </div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">The total tax benefits recognized on stock-based compensation for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2018 </div>was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1.0</div> million and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$3.5</div> million, respectively.  The total tax benefits recognized on stock-based compensation for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2017 </div>was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.0</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$3.6</div> million, respectively.</div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></div> <table style="font-size: 10pt; color: #FF6633; margin-top: 0pt; margin-bottom: 0pt; min-width: 700px;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"><div style="display: inline; font-style: italic;">(c)</div></div></td> <td style="width: 5pt"></td> <td style="text-align: justify"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"><div style="display: inline; font-style: italic;">Restricted Stock Units</div></div></td> </tr> </table> <div style=" font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Stock-based compensation expense related to restricted stock units was approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1.9</div> million and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$4.2</div> million for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2018 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> respectively. Stock-based compensation expense related to restricted stock units was approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$10.0</div> million and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$9.7</div> million for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2018 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> respectively.</div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></div> <div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Presented below is a summary of restricted stock units activity for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2018 </div><div style="display: inline; font-style: italic;">(in thousands, except for weighted average grant date fair value per unit):</div></div></div> <div style=" font-size: 10pt; margin: 0pt 0; color: red"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;"> </div></div></div></div> <div style=" font-size: 10pt; margin: 0pt 0; color: Red"></div> <div> <table style="border-collapse: collapse; font: 12pt Arial Narrow; min-width: 700px;" cellspacing="0" cellpadding="0"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; border-bottom: Black 1pt solid; white-space: nowrap"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; font-weight: bold; border-bottom: Black 1pt solid; white-space: nowrap"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid; white-space: nowrap"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Number of </div><div style="display: inline; font-size: 12pt"><br /> <div style="display: inline; font-family: Arial Narrow">Units</div></div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; white-space: nowrap"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; font-weight: bold; border-bottom: Black 1pt solid; white-space: nowrap"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid; white-space: nowrap"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Weighted <br /> Average</div><div style="display: inline; font-size: 12pt"><br /> <div style="display: inline; font-family: Arial Narrow">Grant Date Fair</div><br /> <div style="display: inline; font-family: Arial Narrow">Value per Unit</div></div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; white-space: nowrap"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 74%; font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Outstanding balance at December 31, 2017</div></td> <td style="width: 1%; font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="width: 1%; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="width: 10%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">1,346</div></div></td> <td style="width: 1%; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="width: 1%; font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="width: 1%; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">$</div></td> <td style="width: 10%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">17.65</div></div></td> <td style="width: 1%; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Granted</div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">763</div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">16.76</div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Vesting of restricted stock units, net of units withheld for taxes</div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">(367</div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">)</div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">17.00</div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Units withheld for taxes</div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">(163</div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">)</div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">17.00</div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Forfeitures</div></td> <td style="font-size: 10pt; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">(70</div></div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">)</div></td> <td style="font-size: 10pt; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">17.26</div></div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; border-bottom: Black 1.5pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Outstanding balance at September 30, 2018</div></td> <td style="font-size: 10pt; border-bottom: Black 1.5pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">1,509</div></div></td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; border-bottom: Black 1.5pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">$</div></td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">19.98</div></div></td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> </tr> </table> </div> <div style=" font-size: 10pt; margin: 0pt 0; color: Red"></div> <div style=" font-size: 10pt; margin: 0pt 0; color: Red"></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">For the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2018 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> HMS granted <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,794</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">59,784</div> restricted stock units, respectively, with an aggregate fair market value of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$58,861</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1.0</div> million, respectively. For the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2018 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> HMS granted <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">762,877</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">599,441</div> restricted stock units, respectively, with an aggregate fair market value of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$12.8</div> million and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$11.3</div> million, respectively.</div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0; color: red"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"><div style="display: inline; font-weight: bold;"> </div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2018, </div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,281,206</div> restricted stock units remained unvested and there was approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$11.3</div> million of unrecognized compensation cost related to restricted stock units, which is expected to be recognized over a weighted average vesting period of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.13</div> years.</div></div></div>

0.22

0.08

0.26

0.17

0.22

0.07

0.25

0.17

<div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; min-width: 700px;"> <tr style="vertical-align: top; text-align: justify"> <td style="width: 35pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt; color: #00A9E0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11.</div></div></div></td> <td style="width: 5pt"></td> <td style="text-align: justify"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt; color: #00A9E0"><div style="display: inline; font-weight: bold;">Earnings Per Share</div></div></td> </tr> </table> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0; color: #00A9E0"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"><div style="display: inline; font-weight: bold;"> </div></div></div> <div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">The following table reconciles the basic to diluted weighted average common shares outstanding using the treasury stock method <div style="display: inline; font-style: italic;">(in thousands, except per share amounts)</div>:</div></div> <div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></div> <div style=" font-size: 10pt; margin: 0pt 0; color: Red"></div> <div> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font: 12pt Arial Narrow; min-width: 700px;"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; padding-bottom: 1pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; font-weight: bold; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Three Months Ended </div><div style="display: inline; font-size: 12pt"><br /> <div style="display: inline; font-family: Arial Narrow">September 30,</div></div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td colspan="6" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Nine Months Ended </div><div style="display: inline; font-size: 12pt"><br /> <div style="display: inline; font-family: Arial Narrow">September 30,</div></div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> </tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; font-weight: bold; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: right; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">2018</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; font-weight: bold; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: right; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">2017</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: right; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">2018</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; font-weight: bold; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: right; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">2017</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 48%; font-size: 10pt; font-weight: bold; text-align: left; border-bottom: Black 1.5pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Net income</div></td> <td style="width: 1%; font-size: 10pt; border-bottom: Black 1.5pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="width: 1%; border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">$</div></td> <td style="width: 10%; border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">18,574</div></div></td> <td style="width: 1%; border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="width: 1%; font-size: 10pt; border-bottom: Black 1.5pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="width: 1%; border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">$</div></td> <td style="width: 10%; border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">6,372</div></div></td> <td style="width: 1%; border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="width: 1%; font-size: 10pt; padding-bottom: 1.5pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="width: 1%; border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">$</div></td> <td style="width: 10%; border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">21,598</div></div></td> <td style="width: 1%; border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="width: 1%; font-size: 10pt; border-bottom: Black 1.5pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="width: 1%; border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">$</div></td> <td style="width: 10%; border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">14,331</div></div></td> <td style="width: 1%; border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Weighted average common shares outstanding-basic</div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">83,509</div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">83,923</div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">83,373</div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">83,778</div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Plus: net effect of dilutive stock options and restricted stock units</div></td> <td style="font-size: 10pt; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">1,635</div></div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">1,807</div></div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; padding-bottom: 1pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">1,868</div></div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">1,808</div></div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Weighted average common shares outstanding-diluted</div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">85,144</div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">85,730</div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">85,241</div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">85,586</div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; border-bottom: Black 1.5pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Net income per common share-basic</div></td> <td style="font-size: 10pt; border-bottom: Black 1.5pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">$</div></td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">0.22</div></div></td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; border-bottom: Black 1.5pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">$</div></td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">0.08</div></div></td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; padding-bottom: 1.5pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">$</div></td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">0.26</div></div></td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; border-bottom: Black 1.5pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">$</div></td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">0.17</div></div></td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; border-bottom: Black 1.5pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Net income per common share-diluted</div></td> <td style="font-size: 10pt; border-bottom: Black 1.5pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">$</div></td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">0.22</div></div></td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; border-bottom: Black 1.5pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">$</div></td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">0.07</div></div></td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; padding-bottom: 1.5pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">$</div></td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">0.25</div></div></td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; border-bottom: Black 1.5pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">$</div></td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">0.17</div></div></td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> </tr> </table> </div> <div style=" font-size: 10pt; margin: 0pt 0; color: Red"></div> <div style=" font-size: 10pt; margin: 0pt 0; color: Red"></div> <div style=" font-size: 10pt; margin: 0pt 0; color: Red"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">For the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2018 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">21,105</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,642,548</div> stock options, respectively, were <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> included in the diluted earnings per share calculation because the effect would have been anti-dilutive. For the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2018 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> restricted stock units representing <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">202</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">84,360</div> shares of common stock, respectively, were <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> included in the diluted earnings per share calculation because the effect would have been anti-dilutive.</div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">For the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2018 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">531,378</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,132,017</div> stock options, respectively, were <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> included in the diluted earnings per share calculation because the effect would have been anti-dilutive. For the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2018 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> restricted stock units representing <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">595</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">63,452</div> shares of common stock, respectively, were <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> included in the diluted earnings per share calculation because the effect would have been anti-dilutive.</div></div></div>

0.213

0.394

P2Y36D

P1Y47D

11300000

7600000

P12Y146D

P109D

P4Y109D

P328D

P11Y109D

P1Y

P5Y73D

P1Y109D

100758000

15724000

5701000

223000

122406000

89106000

13916000

2874000

121000

106017000

35888000

5452000

7197000

7664000

9195000

156790000

16246000

21700000

263000

194999000

159290000

16246000

21700000

263000

197499000

72593000

56032000

522000

15999000

40000

70184000

2330000

18826000

142000

91482000

56200000

19600000

310000

130000

76240000

-20000000

107754000

487617000

21643000

9766000

27428000

23633000

2013

2014

1000000

3500000

3600000

3069000

3394000

5830000

9302000

4597000

1892000

15501000

12317000

4394000

-15457000

13038000

-5630000

-2705000

-2731000

-522000

-712000

66000

-163000

237000

-757000

1635000

1807000

1868000

1808000

12979000

12067000

39482000

33131000

72593000

91482000

2880000

3109000

8562000

7734000

2527000

2230000

7224000

5072000

7769000

5819000

292000

14000

600000

201000

58188000

49012000

169455000

149784000

3500000

4332000

11897000

12109000

355140000

368931000

1006920000

975160000

86479000

92687000

268661000

276244000

240000000

211000

325000

688000

1036000

P5Y

500000000

50000000

25000000

0.00375

0.0025

0.00125

20000000

240000000

60000000

4881000

41881000

-19433000

-193494000

55536000

55098000

21598000

14331000

18574000

6372000

21598000

<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; margin: 0pt 0; color: #FF6633"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"><div style="display: inline; font-style: italic;"><div style="display: inline; text-decoration: underline;">Recently Adopted Accounting Pronouncements </div></div></div></div> <div style=" font-size: 10pt; margin: 0pt 0; color: #FF6633"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May 2014, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09,</div> <div style="display: inline; font-style: italic;">Revenue from Contracts with Customers</div> (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606</div>) (“ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09”</div>), which is the new comprehensive revenue recognition standard that supersedes all existing revenue recognition guidance under U.S. GAAP. The Company adopted ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09</div> on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 1, 2018 </div>using the modified retrospective method and the Company recognized the cumulative effect of initially applying the new revenue standard as an adjustment to the opening balance of retained earnings. The financial information for comparative prior periods has <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> been restated and continues to be reported under the accounting standards in effect for those periods. The effect of adopting ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09</div> in the current annual reporting period as compared with the guidance that was in effect before the change is immaterial. The Company’s internal control framework did <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> materially change, but existing internal controls were modified due to certain changes to business processes and systems to support the new revenue recognition standard as necessary. The Company continues to expect the impact of the adoption of the new standard to be immaterial to its net income and its internal control framework on an ongoing basis.</div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August 2016, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,</div> <div style="display: inline; font-style: italic;">Statements of Cash Flows (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">230</div>): Classification of Certain Cash Receipts and Cash Payments </div>(“ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15”</div>)<div style="display: inline; font-style: italic;">.</div> ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15</div> clarifies where certain cash receipts and cash payments are presented and classified in the statement of cash flows. The amendments are effective for annual reporting periods beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 15, 2017, </div>and for interim reporting periods within such annual periods. The Company adopted this guidance on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 1, 2018. </div>The adoption of this guidance did <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> have an effect on the Company’s consolidated financial statements.</div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 2017, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">01,</div> <div style="display: inline; font-style: italic;">Business Combinations (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">805</div>) – Clarifying the Definition of a Business</div> (“ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">01”</div>). ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">01</div> finalizes previous proposals regarding shareholder concerns that the definition of a business is applied too broadly. The guidance assists entities with evaluating whether transactions should be accounted for as acquisitions of assets or of businesses. The amendments are effective for annual periods beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 15, 2017, </div>including interim periods within those periods. The Company adopted this guidance on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 1, 2018. </div>The adoption of this guidance did <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> have a material effect on the Company’s consolidated financial statements.</div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May 2017, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09,</div> <div style="display: inline; font-style: italic;">Compensation – Stock Compensation (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">718</div>) – Scope of Modification Accounting, </div>(“ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09”</div>). ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09</div> requires entities to apply modification accounting to changes made to a share-based payment award. The new guidance specifies that entities will apply modification accounting to changes to a share-based payment award only if any of the following are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> the same immediately before and after the change: <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1</div>) The award’s fair value (or calculated value or intrinsic value, if those measurement methods are used), <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2</div>) the award’s vesting conditions, and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3</div>) the award’s classification as an equity or liability instrument. ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09</div> is effective for annual reporting periods beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 15, 2017, </div>including interim periods within such annual periods, with early adoption permitted. The Company adopted this guidance on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 1, 2018. </div>The adoption of this guidance did <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> have a material effect on the Company’s consolidated financial statements.</div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0; color: #FF6633"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"><div style="display: inline; font-style: italic;"><div style="display: inline; text-decoration: underline;">Recently Issued Accounting Pronouncements</div></div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> February 2016, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02,</div> <div style="display: inline; font-style: italic;">Leases (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">842</div>)</div> (“ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02”</div>). ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02</div> will require most lessees to recognize a majority of the company’s leases on the balance sheet, which will increase reported assets and liabilities. ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02</div> is effective for annual reporting periods beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 15, 2018 </div>including interim periods within such annual reporting periods with early adoption permitted. The Company has <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> early adopted this guidance. The Company developed a preliminary implementation plan and has reviewed historical lease agreements in order to quantify the impact of adoption. Based upon the Company’s on-going analysis to date, the Company currently expects that there will be a material increase to total assets and total liabilities on the Company’s consolidated balance sheet upon adoption; however, the Company continues to perform the necessary additional reviews and other implementation considerations in order to appropriately quantify the changes. The Company has elected to use the FASB’s optional transition method.The Company expects to complete the on-going analysis and quantification by the end of the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">fourth</div> quarter of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018.</div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"></div>   <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 2017, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">04,</div> <div style="display: inline; font-style: italic;">Goodwill and Other (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">350</div>): Simplifying the Test for Goodwill Impairment </div>(“ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">04”</div>). This amendment simplifies the manner in which an entity is required to test for goodwill impairment by eliminating Step <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2</div> from the goodwill impairment test. Step <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2</div> measures goodwill impairment loss by comparing the implied fair value of a reporting unit’s goodwill with the carrying amount of that goodwill. The amendment simplifies this approach by having the entity (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1</div>) perform its annual or interim goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount, and (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2</div>) recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value, with the understanding that the loss recognized should <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> exceed the total amount of goodwill allocated to that reporting unit. The amendment is effective for public entities that are SEC filers prospectively for their annual, or any interim, goodwill impairment tests in fiscal years beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 15, 2019. </div>Early adoption is permitted for all entities for interim or annual goodwill impairment tests performed on testing dates after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 1, 2017. </div>The Company is currently evaluating the impact on the Company’s financial statements of adopting this guidance but this guidance is <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> expected to have a material impact on the Company’s financial position, results of operations or internal control framework.</div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 2018, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">07,</div> <div style="display: inline; font-style: italic;">Compensation – Stock Compensation (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">718</div>) – Improvements to Nonemployee Share-Based Payment Accounting, </div>(“ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">07”</div>). ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">07</div> requires entities to apply similar accounting for share-based payment transactions with non-employees as with share-based payment transactions with employees. ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">07</div> is effective for public entities for fiscal year beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 15, 2018, </div>including interim periods within that fiscal year. Early adoption is permitted. The Company is currently evaluating the impact on the Company’s financial statements of adopting this guidance but this guidance is <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> expected to have a material impact on the Company’s financial position, results of operations or internal control framework.</div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August 17, 2018 </div>the SEC issued SEC Final Rule Release <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">33</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10532,</div> <div style="display: inline; font-style: italic;">Disclosure Update and Simplification</div> (“Final Rule”). The final rule amends certain disclosure requirements to facilitate the disclosure of information to investors and simplify compliance without significantly altering the total mix of information provided to investors. The final rule is effective for public entities that are SEC filers on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> November 5, 2018. </div>The Company is currently evaluating the impact of adopting this guidance but this guidance is <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> expected to have a material impact on the Company’s disclosures.</div></div></div></div>

24231000

12861000

35390000

31166000

314000

836000

2655000

2589000

8567000

7446000

22183000

21212000

9925000

9403000

5955000

15100000

10664000

2797000

2898000

171600000

171174000

4333000

11656000

0.01

5000000

16826000

16589000

42204000

12100000

800000

13633000

2580000

93145000

98581000

16107000

20233000

5000

1400000

389189000

366164000

154246000

125673000

442462000

372719000

105694000

90073000

298201000

277018000

48552000

35600000

144261000

95701000

5200000

6400000

<div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font: 12pt Arial Narrow; min-; min-width: 700px;"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 87%; font-size: 10pt; text-align: left; border-top: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Cash and cash equivalents</div></td> <td style="width: 1%; font-size: 10pt; border-top: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="width: 1%; font-size: 10pt; text-align: left; border-top: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">$</div></td> <td style="width: 10%; font-size: 10pt; text-align: right; border-top: Black 1pt solid"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">435</div></div></td> <td style="width: 1%; font-size: 10pt; text-align: left; border-top: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Accounts receivable</div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">8,902</div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Prepaid expenses</div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">1,427</div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Property and equipment</div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">1,146</div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Intangible assets</div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">76,240</div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Goodwill</div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">107,754</div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Other assets</div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">63</div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Accounts payable</div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">(2,620</div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">)</div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Deferred tax liability</div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">(19,681</div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">)</div></td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Other liabilities</div></td> <td style="font-size: 10pt; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right; border-bottom: Black 1pt solid"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">(2,057</div></div></td> <td style="font-size: 10pt; text-align: left; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">)</div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; font-weight: bold; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Total purchase price</div></td> <td style="font-size: 10pt; font-weight: bold; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">$</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">171,609</div></div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> </tr> </table></div>

<div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font: 12pt Arial Narrow; min-; min-width: 700px;"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; border-bottom: Black 1pt solid; white-space: nowrap"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; font-weight: bold; border-bottom: Black 1pt solid; white-space: nowrap"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid; white-space: nowrap"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Gross </div><div style="display: inline; font-size: 12pt"><br /> <div style="display: inline; font-family: Arial Narrow">Carrying </div><br /> <div style="display: inline; font-family: Arial Narrow">Amount</div></div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; white-space: nowrap"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; font-weight: bold; border-bottom: Black 1pt solid; white-space: nowrap"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid; white-space: nowrap"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Accumulated </div><div style="display: inline; font-size: 12pt"><br /> <div style="display: inline; font-family: Arial Narrow">Amortization</div></div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; white-space: nowrap"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; font-weight: bold; border-bottom: Black 1pt solid; white-space: nowrap"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid; white-space: nowrap"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Net Carrying </div><div style="display: inline; font-size: 12pt"><br /> <div style="display: inline; font-family: Arial Narrow">Amount</div></div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; white-space: nowrap"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; font-weight: bold; border-bottom: Black 1pt solid; white-space: nowrap"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center; white-space: nowrap"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Weighted </div><div style="display: inline; font-size: 12pt"><br /> <div style="display: inline; font-family: Arial Narrow">Average </div><br /> <div style="display: inline; font-family: Arial Narrow">Amortization </div><br /> <div style="display: inline; font-family: Arial Narrow">Period (in years)</div></div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; font-weight: bold"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">September 30, 2018</div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 48%; font-size: 10pt; text-align: left; text-indent: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Customer relationships</div></td> <td style="width: 1%; font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="width: 1%; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">$</div></td> <td style="width: 10%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">156,790</div></div></td> <td style="width: 1%; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="width: 1%; font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="width: 1%; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">$</div></td> <td style="width: 10%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">(100,758</div></div></td> <td style="width: 1%; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">)</div></td> <td style="width: 1%; font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="width: 1%; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">$</div></td> <td style="width: 10%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">56,032</div></div></td> <td style="width: 1%; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="width: 1%; font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="width: 12%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> 12.4 </div></div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; text-indent: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Trade names</div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">16,246</div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">(15,724</div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">)</div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">522</div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> 0.3 </div></div></td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; text-indent: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Intellectual property</div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">21,700</div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">(5,701</div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">)</div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">15,999</div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> 4.3 </div></div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; border-bottom: Black 1pt solid; text-indent: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Restrictive covenants</div></td> <td style="font-size: 10pt; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">263</div></div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">(223</div></div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">)</div></td> <td style="font-size: 10pt; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">40</div></div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> 0.9 </div></div></td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; border-bottom: Black 1.5pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Total</div></td> <td style="font-size: 10pt; border-bottom: Black 1.5pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">$</div></td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">194,999</div></div></td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; border-bottom: Black 1.5pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">$</div></td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">(122,406</div></div></td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">)</div></td> <td style="font-size: 10pt; border-bottom: Black 1.5pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">$</div></td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">72,593</div></div></td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; border-bottom: Black 1.5pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></div></td> </tr> </table></div><div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font: 12pt Arial Narrow; min-; min-width: 700px;"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; border-bottom: Black 1pt solid; white-space: nowrap"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; font-weight: bold; border-bottom: Black 1pt solid; white-space: nowrap"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid; white-space: nowrap"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Gross </div><div style="display: inline; font-size: 12pt"><br /> <div style="display: inline; font-family: Arial Narrow">Carrying </div><br /> <div style="display: inline; font-family: Arial Narrow">Amount</div></div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; white-space: nowrap"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; font-weight: bold; border-bottom: Black 1pt solid; white-space: nowrap"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid; white-space: nowrap"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Accumulated </div><div style="display: inline; font-size: 12pt"><br /> <div style="display: inline; font-family: Arial Narrow">Amortization</div></div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; white-space: nowrap"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; font-weight: bold; border-bottom: Black 1pt solid; white-space: nowrap"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid; white-space: nowrap"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Net Carrying </div><div style="display: inline; font-size: 12pt"><br /> <div style="display: inline; font-family: Arial Narrow">Amount</div></div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; white-space: nowrap"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; font-weight: bold; border-bottom: Black 1pt solid; white-space: nowrap"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center; white-space: nowrap"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Weighted </div><div style="display: inline; font-size: 12pt"><br /> <div style="display: inline; font-family: Arial Narrow">Average </div><br /> <div style="display: inline; font-family: Arial Narrow">Amortization </div><br /> <div style="display: inline; font-family: Arial Narrow">Period (in years)</div></div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; font-weight: bold"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">December 31, 2017</div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 48%; font-size: 10pt; text-align: left; text-indent: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Customer relationships</div></td> <td style="width: 1%; font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="width: 1%; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">$</div></td> <td style="width: 10%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">159,290</div></div></td> <td style="width: 1%; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="width: 1%; font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="width: 1%; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">$</div></td> <td style="width: 10%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">(89,106</div></div></td> <td style="width: 1%; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">)</div></td> <td style="width: 1%; font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="width: 1%; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">$</div></td> <td style="width: 10%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">70,184</div></div></td> <td style="width: 1%; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="width: 1%; font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="width: 12%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> 11.3 </div></div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; text-indent: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Trade names</div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">16,246</div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">(13,916</div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">)</div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">2,330</div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> 1 </div></div></td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; text-indent: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Intellectual property</div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">21,700</div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">(2,874</div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">)</div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">18,826</div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> 5.2 </div></div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; border-bottom: Black 1pt solid; text-indent: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Restrictive covenants</div></td> <td style="font-size: 10pt; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">263</div></div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">(121</div></div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">)</div></td> <td style="font-size: 10pt; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">142</div></div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> 1.3 </div></div></td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; border-bottom: Black 1.5pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Total</div></td> <td style="font-size: 10pt; border-bottom: Black 1.5pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">$</div></td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">197,499</div></div></td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; border-bottom: Black 1.5pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">$</div></td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">(106,017</div></div></td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">)</div></td> <td style="font-size: 10pt; border-bottom: Black 1.5pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">$</div></td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">91,482</div></div></td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; border-bottom: Black 1.5pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></div></td> </tr> </table></div>

<div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font: 12pt Arial Narrow; min-; min-width: 700px;"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; border-bottom: Black 1pt solid; white-space: nowrap"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; font-weight: bold; border-bottom: Black 1pt solid; white-space: nowrap"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid; white-space: nowrap"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Number </div><div style="display: inline; font-size: 12pt"><br /> <div style="display: inline; font-family: Arial Narrow">of </div><br /> <div style="display: inline; font-family: Arial Narrow">Options</div></div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; white-space: nowrap"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; font-weight: bold; border-bottom: Black 1pt solid; white-space: nowrap"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid; white-space: nowrap"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Weighted</div><div style="display: inline; font-size: 12pt"><br /> <div style="display: inline; font-family: Arial Narrow">Average</div><br /> <div style="display: inline; font-family: Arial Narrow">Exercise</div><br /> <div style="display: inline; font-family: Arial Narrow">Price</div></div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; white-space: nowrap"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; font-weight: bold; border-bottom: Black 1pt solid; white-space: nowrap"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid; white-space: nowrap"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Weighted</div><div style="display: inline; font-size: 12pt"><br /> <div style="display: inline; font-family: Arial Narrow">Average</div><br /> <div style="display: inline; font-family: Arial Narrow">Remaining</div><br /> <div style="display: inline; font-family: Arial Narrow">Contractual</div><br /> <div style="display: inline; font-family: Arial Narrow">Terms</div></div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; white-space: nowrap"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; font-weight: bold; border-bottom: Black 1pt solid; white-space: nowrap"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td colspan="2" style="font-size: 10pt; font-weight: bold; text-align: center; border-bottom: Black 1pt solid; white-space: nowrap"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Aggregate</div><div style="display: inline; font-size: 12pt"><br /> <div style="display: inline; font-family: Arial Narrow">Intrinsic</div><br /> <div style="display: inline; font-family: Arial Narrow">Value</div></div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; white-space: nowrap"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 48%; font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Outstanding balance at December 31, 2017</div></td> <td style="width: 1%; font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="width: 1%; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="width: 10%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">5,554</div></div></td> <td style="width: 1%; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="width: 1%; font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="width: 1%; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">$</div></td> <td style="width: 10%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">17.35</div></div></td> <td style="width: 1%; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="width: 1%; font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="width: 1%; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="width: 10%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></div></td> <td style="width: 1%; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="width: 1%; font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="width: 1%; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="width: 10%; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></div></td> <td style="width: 1%; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; text-indent: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Granted</div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">1,010</div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">19.58</div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; text-indent: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Exercised</div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">(686</div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">)</div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">21.13</div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left; text-indent: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Forfeitures</div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">(100</div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">)</div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">17.64</div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; text-align: left; border-bottom: Black 1pt solid; text-indent: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Expired</div></td> <td style="font-size: 10pt; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">(30</div></div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">)</div></td> <td style="font-size: 10pt; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">22.21</div></div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; border-bottom: Black 1.5pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Outstanding balance at September 30, 2018</div></td> <td style="font-size: 10pt; border-bottom: Black 1.5pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">5,748</div></div></td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; border-bottom: Black 1.5pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">17.33</div></div></td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; border-bottom: Black 1.5pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">5.41</div></div></td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; border-bottom: Black 1.5pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">$</div></td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">88,909</div></div></td> <td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Expected to vest at September 30, 2018</div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">1,561</div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">17.65</div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">7.79</div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">$</div></td> <td style="font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">23,669</div></div></td> <td style="font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-size: 10pt; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">Exercisable at September 30, 2018</div></td> <td style="font-size: 10pt; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">3,373</div></div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">$</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">17.13</div></div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">3.76</div></div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="font-size: 10pt; border-bottom: Black 1pt solid"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">$</div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt">52,900</div></div></td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"><div style="display: inline; font-family: Arial Narrow; font-size: 12pt"> </div></td> </tr> </table></div>

28178000

22240000

86708000

73400000

17645000

16761000

70000

17.26

1794

59784

762877

599441

16.76

1281206

17.65

19.98

367000

0.4243

0.4423

0.0268

0.0174

1346000

1509000

3373000

17.13

4000000

300000

4700000

600000

30000

100000

1010000

7.52

7.68

88909000

5554000

5748000

17.35

17.33

23669000

1561000

17.65

21.13

22.21

17.64

19.58

P6Y

P5Y

52900000

P3Y277D

P5Y149D

P7Y288D

96536251

13279393

97588656

13663194

163000

-2400000

58861

1000000

12800000

11300000

366593

535077

40734

686111

173539

685812

3000

-2800000

-2797000

7000

13626000

13633000

651780000

606229000

965000

368721000

366164000

-129621000

975000

397192000

389189000

-135576000

13663194

13279393

383801

135576000

129621000

5955000

1000000

600000

400000

8900000

8200000

8544000

85144000

85730000

85241000

85586000

83509000

83923000

83373000

83778000

xbrli:shares xbrli:pure iso4217:USD iso4217:USD xbrli:shares 0001196501 2015-01-01 2015-12-31 0001196501 2016-01-01 2016-12-31 0001196501 2017-01-01 2017-09-30 0001196501 us-gaap:EmployeeStockOptionMember 2017-01-01 2017-09-30 0001196501 us-gaap:EmployeeStockOptionMember hmsy:BlackScholesModelMember 2017-01-01 2017-09-30 0001196501 us-gaap:RestrictedStockMember 2017-01-01 2017-09-30 0001196501 us-gaap:RestrictedStockUnitsRSUMember 2017-01-01 2017-09-30 0001196501 hmsy:ElizaHoldingCorpMember 2017-01-01 2017-09-30 0001196501 us-gaap:RevolvingCreditFacilityMember 2017-01-01 2017-09-30 0001196501 us-gaap:RevolvingCreditFacilityMember hmsy:CreditAgreementMember 2017-01-01 2017-09-30 0001196501 us-gaap:CostOfSalesMember 2017-01-01 2017-09-30 0001196501 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2017-01-01 2017-09-30 0001196501 hmsy:AnalyticalServicesMember 2017-01-01 2017-09-30 0001196501 hmsy:CoordinationOfBenefitsMember 2017-01-01 2017-09-30 0001196501 2017-01-01 2017-12-31 0001196501 us-gaap:CustomerRelationshipsMember 2017-01-01 2017-12-31 0001196501 us-gaap:IntellectualPropertyMember 2017-01-01 2017-12-31 0001196501 hmsy:RestrictiveCovenantMember 2017-01-01 2017-12-31 0001196501 us-gaap:TradeNamesMember 2017-01-01 2017-12-31 0001196501 hmsy:ElizaHoldingCorpMember 2017-04-17 2017-04-17 0001196501 hmsy:ElizaHoldingCorpMember us-gaap:CustomerRelationshipsMember 2017-04-17 2017-04-17 0001196501 hmsy:ElizaHoldingCorpMember us-gaap:IntellectualPropertyMember 2017-04-17 2017-04-17 0001196501 hmsy:ElizaHoldingCorpMember hmsy:RestrictiveCovenantMember 2017-04-17 2017-04-17 0001196501 hmsy:ElizaHoldingCorpMember us-gaap:TradeNamesMember 2017-04-17 2017-04-17 0001196501 2017-07-01 2017-09-30 0001196501 us-gaap:EmployeeStockOptionMember 2017-07-01 2017-09-30 0001196501 us-gaap:RestrictedStockMember 2017-07-01 2017-09-30 0001196501 us-gaap:RestrictedStockUnitsRSUMember 2017-07-01 2017-09-30 0001196501 us-gaap:RevolvingCreditFacilityMember 2017-07-01 2017-09-30 0001196501 us-gaap:CostOfSalesMember 2017-07-01 2017-09-30 0001196501 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2017-07-01 2017-09-30 0001196501 hmsy:AnalyticalServicesMember 2017-07-01 2017-09-30 0001196501 hmsy:CoordinationOfBenefitsMember 2017-07-01 2017-09-30 0001196501 hmsy:SuitAgainstHMSHoldingsRelatedToTheAcquisitionOfAlliedManagementGroupMember 2017-11-03 2017-11-03 0001196501 us-gaap:LetterOfCreditMember hmsy:CreditAgreementMember 2017-12-19 2017-12-19 0001196501 us-gaap:RevolvingCreditFacilityMember hmsy:CreditAgreementMember 2017-12-19 2017-12-19 0001196501 us-gaap:RevolvingCreditFacilityMember hmsy:CreditAgreementMember srt:MaximumMember 2017-12-19 2017-12-19 0001196501 us-gaap:RevolvingCreditFacilityMember hmsy:CreditAgreementMember srt:MaximumMember hmsy:FromAndAfterJanuary2020Member 2017-12-19 2017-12-19 0001196501 us-gaap:RevolvingCreditFacilityMember hmsy:CreditAgreementMember srt:MaximumMember hmsy:ThroughDecember2019Member 2017-12-19 2017-12-19 0001196501 us-gaap:RevolvingCreditFacilityMember hmsy:CreditAgreementMember srt:MaximumMember us-gaap:LondonInterbankOfferedRateLIBORMember 2017-12-19 2017-12-19 0001196501 us-gaap:RevolvingCreditFacilityMember hmsy:CreditAgreementMember srt:MaximumMember hmsy:OneMonthLIBORRateMember 2017-12-19 2017-12-19 0001196501 us-gaap:RevolvingCreditFacilityMember hmsy:CreditAgreementMember srt:MinimumMember 2017-12-19 2017-12-19 0001196501 us-gaap:RevolvingCreditFacilityMember hmsy:CreditAgreementMember srt:MinimumMember us-gaap:LondonInterbankOfferedRateLIBORMember 2017-12-19 2017-12-19 0001196501 us-gaap:RevolvingCreditFacilityMember hmsy:CreditAgreementMember srt:MinimumMember hmsy:OneMonthLIBORRateMember 2017-12-19 2017-12-19 0001196501 us-gaap:RevolvingCreditFacilityMember hmsy:CreditAgreementMember us-gaap:FederalFundsEffectiveSwapRateMember 2017-12-19 2017-12-19 0001196501 us-gaap:RevolvingCreditFacilityMember hmsy:CreditAgreementMember us-gaap:LondonInterbankOfferedRateLIBORMember 2017-12-19 2017-12-19 0001196501 hmsy:CreditAgreementMember 2017-12-19 2017-12-19 0001196501 2018-01-01 2018-03-31 0001196501 2018-01-01 2018-09-30 0001196501 us-gaap:EmployeeStockOptionMember 2018-01-01 2018-09-30 0001196501 us-gaap:EmployeeStockOptionMember hmsy:BlackScholesModelMember 2018-01-01 2018-09-30 0001196501 us-gaap:RestrictedStockMember 2018-01-01 2018-09-30 0001196501 us-gaap:RestrictedStockUnitsRSUMember 2018-01-01 2018-09-30 0001196501 hmsy:ElizaHoldingCorpMember 2018-01-01 2018-09-30 0001196501 us-gaap:RevolvingCreditFacilityMember 2018-01-01 2018-09-30 0001196501 us-gaap:RevolvingCreditFacilityMember hmsy:CreditAgreementMember 2018-01-01 2018-09-30 0001196501 us-gaap:CustomerRelationshipsMember 2018-01-01 2018-09-30 0001196501 us-gaap:IntellectualPropertyMember 2018-01-01 2018-09-30 0001196501 hmsy:RestrictiveCovenantMember 2018-01-01 2018-09-30 0001196501 us-gaap:TradeNamesMember 2018-01-01 2018-09-30 0001196501 us-gaap:CostOfSalesMember 2018-01-01 2018-09-30 0001196501 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2018-01-01 2018-09-30 0001196501 us-gaap:DomesticCountryMember us-gaap:InternalRevenueServiceIRSMember us-gaap:EarliestTaxYearMember 2018-01-01 2018-09-30 0001196501 us-gaap:DomesticCountryMember us-gaap:InternalRevenueServiceIRSMember us-gaap:LatestTaxYearMember 2018-01-01 2018-09-30 0001196501 hmsy:AnalyticalServicesMember 2018-01-01 2018-09-30 0001196501 hmsy:CoordinationOfBenefitsMember 2018-01-01 2018-09-30 0001196501 srt:MaximumMember 2018-01-01 2018-09-30 0001196501 srt:MinimumMember 2018-01-01 2018-09-30 0001196501 us-gaap:AdditionalPaidInCapitalMember 2018-01-01 2018-09-30 0001196501 us-gaap:CommonStockMember 2018-01-01 2018-09-30 0001196501 us-gaap:RetainedEarningsMember 2018-01-01 2018-09-30 0001196501 us-gaap:TreasuryStockMember 2018-01-01 2018-09-30 0001196501 hmsy:EstimatedLiabilityForAppealsAndEstimatedAllowanceForAppealsMember 2018-01-01 2018-09-30 0001196501 hmsy:SuitAgainstHMSHoldingsRelatedToTheAcquisitionOfAlliedManagementGroupMember 2018-06-27 2018-06-27 0001196501 2018-07-01 2018-09-30 0001196501 us-gaap:EmployeeStockOptionMember 2018-07-01 2018-09-30 0001196501 us-gaap:RestrictedStockMember 2018-07-01 2018-09-30 0001196501 us-gaap:RestrictedStockUnitsRSUMember 2018-07-01 2018-09-30 0001196501 us-gaap:RevolvingCreditFacilityMember 2018-07-01 2018-09-30 0001196501 us-gaap:CostOfSalesMember 2018-07-01 2018-09-30 0001196501 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2018-07-01 2018-09-30 0001196501 hmsy:AnalyticalServicesMember 2018-07-01 2018-09-30 0001196501 hmsy:CoordinationOfBenefitsMember 2018-07-01 2018-09-30 0001196501 2016-12-31 0001196501 hmsy:ElizaHoldingCorpMember 2017-04-17 0001196501 hmsy:ElizaHoldingCorpMember hmsy:OtherOperatingExpensesConsultingFeesMember hmsy:CostOfServicesMember 2017-04-17 0001196501 hmsy:ElizaHoldingCorpMember hmsy:OtherOperatingExpensesLegalFeesMember hmsy:CostOfServicesMember 2017-04-17 0001196501 hmsy:ElizaHoldingCorpMember hmsy:OtherOperatingExpensesTransactionCostsMember hmsy:CostOfServicesMember 2017-04-17 0001196501 hmsy:ElizaHoldingCorpMember hmsy:CostOfServicesMember 2017-04-17 0001196501 2017-09-30 0001196501 hmsy:CreditAgreementMember 2017-12-18 0001196501 us-gaap:LetterOfCreditMember hmsy:CreditAgreementMember 2017-12-19 0001196501 hmsy:SwinglineLoansMember hmsy:CreditAgreementMember 2017-12-19 0001196501 hmsy:CreditAgreementMember 2017-12-19 0001196501 2017-12-31 0001196501 us-gaap:AccountingStandardsUpdate201409Member 2017-12-31 0001196501 us-gaap:AccountingStandardsUpdate201409Member us-gaap:AdditionalPaidInCapitalMember 2017-12-31 0001196501 us-gaap:AccountingStandardsUpdate201409Member us-gaap:CommonStockMember 2017-12-31 0001196501 us-gaap:AccountingStandardsUpdate201409Member us-gaap:RetainedEarningsMember 2017-12-31 0001196501 us-gaap:AccountingStandardsUpdate201409Member us-gaap:TreasuryStockMember 2017-12-31 0001196501 us-gaap:RestrictedStockUnitsRSUMember 2017-12-31 0001196501 hmsy:AccountsPayableAccruedExpensesAndOtherLiabilitiesMember hmsy:CareManagementAndConsumerEngagementServicesMember us-gaap:TransferredOverTimeMember 2017-12-31 0001196501 us-gaap:RevolvingCreditFacilityMember hmsy:CreditAgreementMember 2017-12-31 0001196501 us-gaap:CustomerRelationshipsMember 2017-12-31 0001196501 us-gaap:IntellectualPropertyMember 2017-12-31 0001196501 hmsy:RestrictiveCovenantMember 2017-12-31 0001196501 us-gaap:TradeNamesMember 2017-12-31 0001196501 us-gaap:AdditionalPaidInCapitalMember 2017-12-31 0001196501 us-gaap:CommonStockMember 2017-12-31 0001196501 us-gaap:RetainedEarningsMember 2017-12-31 0001196501 us-gaap:TreasuryStockMember 2017-12-31 0001196501 hmsy:EstimatedLiabilityForAppealsAndEstimatedAllowanceForAppealsMember 2017-12-31 0001196501 us-gaap:AccountingStandardsUpdate201409Member 2018-01-01 0001196501 us-gaap:OtherLiabilitiesMember us-gaap:FairValueInputsLevel3Member 2018-06-30 0001196501 2018-09-30 0001196501 us-gaap:RestrictedStockUnitsRSUMember 2018-09-30 0001196501 hmsy:AccountsPayableAccruedExpensesAndOtherLiabilitiesMember hmsy:CareManagementAndConsumerEngagementServicesMember us-gaap:TransferredOverTimeMember 2018-09-30 0001196501 us-gaap:OtherLiabilitiesMember us-gaap:FairValueInputsLevel3Member 2018-09-30 0001196501 us-gaap:RevolvingCreditFacilityMember hmsy:CreditAgreementMember 2018-09-30 0001196501 us-gaap:CustomerRelationshipsMember 2018-09-30 0001196501 us-gaap:IntellectualPropertyMember 2018-09-30 0001196501 hmsy:RestrictiveCovenantMember 2018-09-30 0001196501 us-gaap:TradeNamesMember 2018-09-30 0001196501 us-gaap:AdditionalPaidInCapitalMember 2018-09-30 0001196501 us-gaap:CommonStockMember 2018-09-30 0001196501 us-gaap:RetainedEarningsMember 2018-09-30 0001196501 us-gaap:TreasuryStockMember 2018-09-30 0001196501 hmsy:EstimatedLiabilityForAppealsAndEstimatedAllowanceForAppealsMember 2018-09-30 0001196501 2018-11-02

EX-101.SCH 7 hmsy-20180930.xsd XBRL SCHEMA FILE 000 - Document - Document And Entity Information link:calculationLink link:definitionLink link:presentationLink 001 - Statement - Consolidated Balance Sheets (Current Period Unaudited) link:calculationLink link:definitionLink link:presentationLink 002 - Statement - Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) link:calculationLink link:definitionLink link:presentationLink 003 - Statement - Consolidated Statements of Income (Unaudited) link:calculationLink link:definitionLink link:presentationLink 004 - Statement - Consolidated Statement of Shareholders' Equity (Unaudited) link:calculationLink link:definitionLink link:presentationLink 005 - Statement - Consolidated Statements of Cash Flows (Unaudited) link:calculationLink link:definitionLink link:presentationLink 006 - Disclosure - Note 1 - Business and Summary of Significant Accounting Policies link:calculationLink link:definitionLink link:presentationLink 007 - Disclosure - Note 2 - Fair Value of Financial Instruments link:calculationLink link:definitionLink link:presentationLink 008 - Disclosure - Note 3 - Revenue Recognition link:calculationLink link:definitionLink link:presentationLink 009 - Disclosure - Note 4 - Accounts Receivable and Accounts Receivable Allowance link:calculationLink link:definitionLink link:presentationLink 010 - Disclosure - Note 5 - Acquisition link:calculationLink link:definitionLink link:presentationLink 011 - Disclosure - Note 6 - Intangible Assets and Goodwill link:calculationLink link:definitionLink link:presentationLink 012 - Disclosure - Note 7 - Accounts Payable, Accrued Expenses and Other Liabilities link:calculationLink link:definitionLink link:presentationLink 013 - Disclosure - Note 8 - Income Taxes link:calculationLink link:definitionLink link:presentationLink 014 - Disclosure - Note 9 - Estimated Liability for Appeals link:calculationLink link:definitionLink link:presentationLink 015 - Disclosure - Note 10 - Credit Agreement link:calculationLink link:definitionLink link:presentationLink 017 - Disclosure - Note 12 - Stock-based Compensation link:calculationLink link:definitionLink link:presentationLink 018 - Disclosure - Note 13 - Commitments and Contingencies link:calculationLink link:definitionLink link:presentationLink 019 - Disclosure - Note 14 - Subsequent Events link:calculationLink link:definitionLink link:presentationLink 020 - Disclosure - Significant Accounting Policies (Policies) link:calculationLink link:definitionLink link:presentationLink 021 - Disclosure - Note 3 - Revenue Recognition (Tables) link:calculationLink link:definitionLink link:presentationLink 022 - Disclosure - Note 4 - Accounts Receivable and Accounts Receivable Allowance (Tables) link:calculationLink link:definitionLink link:presentationLink 023 - Disclosure - Note 5 - Acquisition (Tables) link:calculationLink link:definitionLink link:presentationLink 024 - Disclosure - Note 6 - Intangible Assets and Goodwill (Tables) link:calculationLink link:definitionLink link:presentationLink 025 - Disclosure - Note 7 - Accounts Payable, Accrued Expenses and Other Liabilities (Tables) link:calculationLink link:definitionLink link:presentationLink 026 - Disclosure - Note 9 - Estimated Liability for Appeals (Tables) link:calculationLink link:definitionLink link:presentationLink 027 - Disclosure - Note 10 - Credit Agreement (Tables) link:calculationLink link:definitionLink link:presentationLink 029 - Disclosure - Note 12 - Stock-based Compensation (Tables) link:calculationLink link:definitionLink link:presentationLink 030 - Disclosure - Note 1 - Business and Summary of Significant Accounting Policies (Details Textual) link:calculationLink link:definitionLink link:presentationLink 031 - Disclosure - Note 2 - Fair Value of Financial Instruments (Details Textual) link:calculationLink link:definitionLink link:presentationLink 032 - Disclosure - Note 3 - Revenue Recognition (Details Textual) link:calculationLink link:definitionLink link:presentationLink 033 - Disclosure - Note 3 - Revenue Recognition - Revenues Disaggregated by Revenue Source (Details) link:calculationLink link:definitionLink link:presentationLink 034 - Disclosure - Note 4 - Accounts Receivable and Accounts Receivable Allowance - Accounts Receivable, Net (Details) link:calculationLink link:definitionLink link:presentationLink 035 - Disclosure - Note 4 - Accounts Receivable and Accounts Receivable Allowance - Activity in Allowance for Doubtful Accounts (Details) link:calculationLink link:definitionLink link:presentationLink 036 - Disclosure - Note 5 - Acquisition (Details Textual) link:calculationLink link:definitionLink link:presentationLink 037 - Disclosure - Note 5 - Acquisition - Preliminary Allocation of the Purchase Price (Details) link:calculationLink link:definitionLink link:presentationLink 038 - Disclosure - Note 5 - Acquisition - Preliminary Purchase Price Allocated to the Intangibles Acquired (Details) link:calculationLink link:definitionLink link:presentationLink 039 - Disclosure - Note 5 - Acquisition - Acquisition Costs (Details) link:calculationLink link:definitionLink link:presentationLink 040 - Disclosure - Note 6 - Intangible Assets and Goodwill (Details Textual) link:calculationLink link:definitionLink link:presentationLink 041 - Disclosure - Note 6 - Intangible Assets and Goodwill - Summary of Intangible Assets (Details) link:calculationLink link:definitionLink link:presentationLink 042 - Disclosure - Note 6 - Intangible Assets and Goodwill - Estimated Amortization Expense of Intangible Assets (Details) link:calculationLink link:definitionLink link:presentationLink 043 - Disclosure - Note 7 - Accounts Payable, Accrued Expenses and Other Liabilities - Summary of Accounts Payable, Accrued Expenses and Other Liabilities (Details) link:calculationLink link:definitionLink link:presentationLink 044 - Disclosure - Note 8 - Income Taxes (Details Textual) link:calculationLink link:definitionLink link:presentationLink 045 - Disclosure - Note 9 - Estimated Liability for Appeals (Details Textual) link:calculationLink link:definitionLink link:presentationLink 046 - Disclosure - Note 9 - Estimated Liability for Appeals - Activity in Estimated Liability for Appeals (Details) link:calculationLink link:definitionLink link:presentationLink 047 - Disclosure - Note 10 - Credit Agreement (Details Textual) link:calculationLink link:definitionLink link:presentationLink 048 - Disclosure - Note 10 - Credit Agreement - Summary of Interest Expense and Commitment Fees on Unused Portion of Revolving Credit Facility (Details) link:calculationLink link:definitionLink link:presentationLink 051 - Disclosure - Note 12 - Stock-based Compensation (Details Textual) link:calculationLink link:definitionLink link:presentationLink 052 - Disclosure - Note 12 - Stock-based Compensation - Summary of Stock-based Compensation Expense (Details) link:calculationLink link:definitionLink link:presentationLink 053 - Disclosure - Note 12 - Stock-based Compensation - Stock Option Activity (Details) link:calculationLink link:definitionLink link:presentationLink 054 - Disclosure - Note 12 - Stock-based Compensation - Weighted Average Assumptions Used in Valuation of Stock Options (Details) link:calculationLink link:definitionLink link:presentationLink 055 - Disclosure - Note 12 - Stock-based Compensation - Summary of Restricted Stock Units (Details) link:calculationLink link:definitionLink link:presentationLink 056 - Disclosure - Note 13 - Commitments and Contingencies (Details Textual) link:calculationLink link:definitionLink link:presentationLink EX-101.CAL 8 hmsy-20180930_cal.xml XBRL CALCULATION FILE EX-101.DEF 9 hmsy-20180930_def.xml XBRL DEFINITION FILE EX-101.LAB 10 hmsy-20180930_lab.xml XBRL LABEL FILE Document And Entity Information Expected dividend yield hmsy_NumberOfBusinesses Number of Businesses Represents number of businesses. Note To Financial Statement Details Textual Intangible assets Significant Accounting Policies Note 3 - Revenue Recognition Note 4 - Accounts Receivable and Accounts Receivable Allowance Risk-free interest rate Note 5 - Acquisition Note 6 - Intangible Assets and Goodwill Note 7 - Accounts Payable, Accrued Expenses and Other Liabilities Note 9 - Estimated Liability for Appeals Long-term liabilities: Note 10 - Credit Agreement us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets Prepaid expenses Note 11 - Earnings Per Share us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables Accounts receivable Income Tax Disclosure [Text Block] Note 12 - Stock-based Compensation Revolving credit facility Note 3 - Revenue Recognition - Revenues Disaggregated by Revenue Source (Details) us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents Cash and cash equivalents Note 4 - Accounts Receivable and Accounts Receivable Allowance - Accounts Receivable, Net (Details) Note 4 - Accounts Receivable and Accounts Receivable Allowance - Activity in Allowance for Doubtful Accounts (Details) Expected volatility Note 5 - Acquisition - Preliminary Allocation of the Purchase Price (Details) us-gaap_LiabilitiesCurrent Total current liabilities Note 5 - Acquisition - Preliminary Purchase Price Allocated to the Intangibles Acquired (Details) Note 5 - Acquisition - Acquisition Costs (Details) Note 6 - Intangible Assets and Goodwill - Summary of Intangible Assets (Details) Note 6 - Intangible Assets and Goodwill - Estimated Amortization Expense of Intangible Assets (Details) Expected life (Year) Note 7 - Accounts Payable, Accrued Expenses and Other Liabilities - Summary of Accounts Payable, Accrued Expenses and Other Liabilities (Details) Note 9 - Estimated Liability for Appeals - Activity in Estimated Liability for Appeals (Details) Note 10 - Credit Agreement - Summary of Interest Expense and Commitment Fees on Unused Portion of Revolving Credit Facility (Details) Note 11 - Earnings Per Share - Summary of Basic and Diluted Earnings Per Share (Details) Fair value of intangibles acquired Note 12 - Stock-based Compensation - Summary of Stock-based Compensation Expense (Details) Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Intangibles acquired, useful life (Year) Note 12 - Stock-based Compensation - Stock Option Activity (Details) Note 12 - Stock-based Compensation - Weighted Average Assumptions Used in Valuation of Stock Options (Details) Note 12 - Stock-based Compensation - Summary of Restricted Stock Units (Details) Notes To Financial Statements us-gaap_LitigationSettlementAmountAwardedToOtherParty Litigation Settlement, Amount Awarded to Other Party Notes To Financial Statements [Abstract] Share-based Compensation, Stock Options, Activity [Table Text Block] Granted, weighted average grant date fair value per unit (in dollars per share) us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired Business Acquisition, Percentage of Voting Interests Acquired Vesting of restricted stock units, net of units withheld for taxes, weighted average grant date fair value per unit (in dollars per share) Schedule of Share-based Compensation, Restricted Stock Units Award Activity [Table Text Block] Forfeitures, weighted average grant date fair value per unit (in dollars per share) us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue Beginning balance, weighted average grant date fair value per unit (in dollars per share) Ending balance, weighted average grant date fair value per unit (in dollars per share) us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod Forfeitures, shares (in shares) us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number, Ending Balance Granted, shares (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod Vesting of restricted stock units, net of units withheld for taxes (in shares) Schedule of Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs by Plan [Table Text Block] us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1 Expected to Vest, Weighted Average Remaining Contractual Terms (Year) us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Expected to Vest, Shares (in shares) us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Expected to Vest, Weighted Average Exercise Price (in dollars per share) us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Expected to Vest, Aggregate Intrinsic Value us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Exercisable, Weighted Average Exercise Price (in dollars per share) Black Scholes Model [Member] Represents information about Black Scholes simulation model. us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 Exercisable, Weighted Average Remaining Contractual Terms (Year) us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Exercisable, Aggregate Intrinsic Value us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value us-gaap_BusinessAcquisitionsProFormaRevenue Business Acquisition, Pro Forma Revenue us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Exercisable, Shares (in shares) us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 Ending Balance, Weighted Average Remaining Contractual Terms (Year) Outstanding, Aggregate intrinsic value us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Beginning Balance, Weighted Average Exercise Price (in dollars per share) Ending Balance, Weighted Average Exercise Price (in dollars per share) Accounts payable, accrued expenses and other liabilities us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Forfeitures, Weighted Average Exercise Price (in dollars per share) us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice Expired, Weighted Average Exercise Price (in dollars per share) us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber Beginning balance, shares (in shares) Ending balance, shares (in shares) Goodwill and Intangible Assets Disclosure [Text Block] us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Granted, Weighted Average Exercise Price (in dollars per share) us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Exercised, Weighted Average Exercise Price (in dollars per share) Revolving Credit Facility [Member] us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Beginning Balance, Shares (in shares) Ending Balance, Shares (in shares) us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Expired, Shares (in shares) Credit Facility [Axis] Credit Facility [Domain] us-gaap_PolicyTextBlockAbstract Accounting Policies Trade Names [Member] us-gaap_PaymentsForSoftware Investment in capitalized software us-gaap_PaymentsToAcquirePropertyPlantAndEquipment Purchases of property and equipment Plus: net effect of dilutive stock options and restricted stock units (in shares) Weighted average shares: Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block] Cash paid for income taxes, net of refunds Accounts payable, trade Current liabilities: hmsy_BusinessAcquisitionFundingSourceCashOnHandPercentage Business Acquisition, Funding Source, Cash on Hand, Percentage The percentage of the purchase price using cash on hand as the source of funding for a business acquisition. hmsy_BusinessAcquisitionFundingSourceExistingCreditLinePercentage Business Acquisition, Funding Source, Existing Credit Line, Percentage The percentage of the purchase price using an existing credit line as the source of funding for a business acquisition. us-gaap_Assets Total assets Supplemental disclosure of cash flow information: Other Operating Expenses, Consulting Fees [Member] The acquisition costs relating to other operating expenses, consulting fees. us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options Cost of Services [Member] Primary financial statement caption encompassing cost of services. us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Share-based Awards Other than Options Other Operating Expenses, Legal Fees [Member] The acquisition costs relating to other operating expenses, legal fees. us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition Other Operating Expenses, Transaction Costs [Member] The acquisition costs relating to other operating expenses, transaction costs. Intellectual Property [Member] Customer Relationships [Member] us-gaap_LossContingencyDamagesAwardedValue Loss Contingency, Damages Awarded, Value Disclosure of Compensation Related Costs, Share-based Payments [Text Block] Finite-Lived Intangible Assets by Major Class [Axis] Income tax receivable Finite-Lived Intangible Assets, Major Class Name [Domain] Equity Award [Domain] Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block] Acquisition-related costs Award Type [Axis] Net income Net Income us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization Accumulated Amortization Net Carrying Amount Total Intangible assets, net Restricted Stock Units (RSUs) [Member] Gross Carrying Amount Restricted Stock [Member] Business Combination, Separately Recognized Transactions [Table Text Block] Business Combination, Separately Recognized Transactions [Axis] Business Combination, Separately Recognized Transactions [Domain] us-gaap_GoodwillPeriodIncreaseDecrease Goodwill, Period Increase (Decrease), Total Employee Stock Option [Member] Interest expense Business Combination Disclosure [Text Block] Commitments and Contingencies Disclosure [Text Block] Schedule of Business Acquisitions, by Acquisition [Table Text Block] Property and equipment, net Goodwill Accrued operating expenses Carrying value as of the balance sheet date of obligations incurred through that date and payable for operating expenses. Investing activities: Earnings Per Share [Text Block] hmsy_EstimatedLiabilityForAppealsCommercialCustomersClaimFindingsAdjudicatedInFavorOfProviders Estimated Liability for Appeals, Commercial Customers Claim Findings, Adjudicated in Favor of Providers Represents the portion of the estimated liability for appeals attributable to commercial customers claim findings which have been adjudicated in favor of providers and the Company’s estimate of the potential amount of commercial customers repayments that are probable of being adjudicated in favor of providers following a successful appeal. Income taxes receivable / (payable) Accounts payable, accrued expenses and other liabilities us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Letter of Credit [Member] us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments Income before income taxes Income taxes Income Tax Expense (Benefit), Total Change in balance of accrued property and equipment purchases The increase (decrease) in future cash outflow to pay for purchases of fixed assets that have occurred. Credit Agreement [Member] Information pertaining to the credit agreement. From and After January 2020 [Member] Represents the period from January 2020 and after. Occupancy hmsy_DebtAgreementMaximumBorrowingCapacity Debt Agreement, Maximum Borrowing Capacity Maximum borrowing capacity under a debt agreement on the amount that could be borrowed with a combination of, but not limited to, a line of credit and term loan. Swingline Loans [Member] Information pertaining to swingline loans. Cash and cash equivalents Cash and cash equivalents at beginning of year Cash and cash equivalents at end of period hmsy_DebtAgreementMaximumBorrowingCapacityPercentOfConsolidatedEBITDA Debt Agreement, Maximum Borrowing Capacity, Percent of Consolidated EBITDA Maximum borrowing capacity under a debt agreement on the amount that could be borrowed with a combination of, but not limited to, a line of credit and term loan, reflected as a percentage of consolidated EBITDA. Compensation Allocated Share-based Compensation Expense Allocated Share-based Compensation Expense, Total Estimated liability for appeals Estimated Liability for Appeals Liability as of the balance sheet date for the estimated liability for appeals and estimated allowance for appeals related to receivables associated with client contracts that have be received on or before the balance sheet date. hmsy_IncreaseDecreaseInEstimatedLiabilityForAppeals Estimated liability for appeals The increase (decrease) during the reporting period in the estimated liability for appeals and estimated allowance for appeals related to receivables associated with client contracts that have be received. Amendment Flag New Accounting Pronouncements, Policy [Policy Text Block] us-gaap_TreasuryStockSharesAcquired Purchase of treasury stock (in shares) us-gaap_SharesOutstanding Balance (in shares) Balance (in shares) Common stock, shares outstanding (in shares) us-gaap_IncreaseDecreaseInOtherOperatingAssets Other assets Current Fiscal Year End Date us-gaap_DebtInstrumentBasisSpreadOnVariableRate1 Debt Instrument, Basis Spread on Variable Rate Document Fiscal Period Focus Document Fiscal Year Focus Document Period End Date us-gaap_IncreaseDecreaseInPrepaidExpense Prepaid expenses Entity Emerging Growth Company Document Type Entity Small Business us-gaap_GainLossRelatedToLitigationSettlement Settlement expense Document Information [Line Items] Document Information [Table] Entity Filer Category Debt Instrument [Axis] Entity Current Reporting Status Debt Instrument, Name [Domain] London Interbank Offered Rate (LIBOR) [Member] Variable Rate [Domain] Federal Funds Effective Swap Rate [Member] us-gaap_GoodwillImpairmentLoss Goodwill, Impairment Loss Variable Rate [Axis] us-gaap_IncreaseDecreaseInAccountsReceivable Accounts receivable Stock-based compensation expense Entity Central Index Key Entity Registrant Name Entity [Domain] Legal Entity [Axis] us-gaap_TreasuryStockValueAcquiredParValueMethod Purchase of treasury stock EX-101.PRE 11 hmsy-20180930_pre.xml XBRL PRESENTATION FILE GRAPHIC 12 logo.jpg GRAPHIC begin 644 logo.jpg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end GRAPHIC 13 graph1.jpg GRAPHIC begin 644 graph1.jpg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end GRAPHIC 14 graph2.jpg GRAPHIC begin 644 graph2.jpg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end GRAPHIC 15 graph3.jpg GRAPHIC begin 644 graph3.jpg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end GRAPHIC 16 graph4.jpg GRAPHIC begin 644 graph4.jpg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end GRAPHIC 17 graph5.jpg GRAPHIC begin 644 graph5.jpg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end GRAPHIC 18 graph6.jpg GRAPHIC begin 644 graph6.jpg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end GRAPHIC 19 lucia1.jpg GRAPHIC begin 644 lucia1.jpg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end GRAPHIC 20 sherman1.jpg GRAPHIC begin 644 sherman1.jpg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end GRAPHIC 21 lucia2.jpg GRAPHIC begin 644 lucia2.jpg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sherman2.jpg GRAPHIC begin 644 sherman2.jpg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lucia3.jpg GRAPHIC begin 644 lucia3.jpg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sherman3.jpg GRAPHIC begin 644 sherman3.jpg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end XML 25 R1.htm IDEA: XBRL DOCUMENT v3.10.0.1

Document And Entity Information - shares
9 Months Ended

Sep. 30, 2018

Nov. 02, 2018

Document Information [Line Items]

Entity Registrant Name HMS HOLDINGS CORP

Entity Central Index Key 0001196501

Trading Symbol hmsy

Current Fiscal Year End Date --12-31

Entity Filer Category Large Accelerated Filer

Entity Current Reporting Status Yes

Entity Emerging Growth Company false

Entity Small Business false

Entity Common Stock, Shares Outstanding (in shares) 83,907,132

Document Type 10-Q

Document Period End Date Sep. 30, 2018

Document Fiscal Year Focus 2018

Document Fiscal Period Focus Q3

Amendment Flag false

X

- Definition
If the value is true, then the document is an amendment to previously-filed/accepted document.
+ References
No definition available.
+ Details

Name: dei_AmendmentFlag

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition
End date of current fiscal year in the format --MM-DD.
+ References
No definition available.
+ Details

Name: dei_CurrentFiscalYearEndDate

Namespace Prefix: dei_

Data Type: xbrli:gMonthDayItemType

Balance Type: na

Period Type: duration

X

- Definition
This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.
+ References
No definition available.
+ Details

Name: dei_DocumentFiscalPeriodFocus

Namespace Prefix: dei_

Data Type: dei:fiscalPeriodItemType

Balance Type: na

Period Type: duration

X

- Definition
This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.
+ References
No definition available.
+ Details

Name: dei_DocumentFiscalYearFocus

Namespace Prefix: dei_

Data Type: xbrli:gYearItemType

Balance Type: na

Period Type: duration

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: dei_DocumentInformationLineItems

Namespace Prefix: dei_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.
+ References
No definition available.
+ Details

Name: dei_DocumentPeriodEndDate

Namespace Prefix: dei_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition
The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
+ References
No definition available.
+ Details

Name: dei_DocumentType

Namespace Prefix: dei_

Data Type: dei:submissionTypeItemType

Balance Type: na

Period Type: duration

X

- Definition
A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12
-Subsection b-2
+ Details

Name: dei_EntityCentralIndexKey

Namespace Prefix: dei_

Data Type: dei:centralIndexKeyItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
+ References
No definition available.
+ Details

Name: dei_EntityCommonStockSharesOutstanding

Namespace Prefix: dei_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.
+ References
No definition available.
+ Details

Name: dei_EntityCurrentReportingStatus

Namespace Prefix: dei_

Data Type: dei:yesNoItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate if registrant meets the emerging growth company criteria.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12
-Subsection b-2
+ Details

Name: dei_EntityEmergingGrowthCompany

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated), (5) Smaller Reporting Accelerated Filer or (6) Smaller Reporting Company and Large Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12
-Subsection b-2
+ Details

Name: dei_EntityFilerCategory

Namespace Prefix: dei_

Data Type: dei:filerCategoryItemType

Balance Type: na

Period Type: duration

X

- Definition
The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12
-Subsection b-2
+ Details

Name: dei_EntityRegistrantName

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicates that the company is a smaller reporting company with both a public float and revenues of less than $75 million.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12
-Subsection b-2
+ Details

Name: dei_EntitySmallBusiness

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition
Trading symbol of an instrument as listed on an exchange.
+ References
No definition available.
+ Details

Name: dei_TradingSymbol

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

XML 26 R2.htm IDEA: XBRL DOCUMENT v3.10.0.1

Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
$ in Thousands

Sep. 30, 2018

Dec. 31, 2017

Current assets:

Cash and cash equivalents $ 124,297 $ 83,313

Accounts receivable, net of allowance of $16,239 and $14,799, at September 30, 2018 and December 31, 2017, respectively 202,498 189,460

Prepaid expenses 16,826 16,589

Income tax receivable 4,597 1,892

Deferred financing costs, net 564 564

Other current assets 314 836

Total current assets 349,096 292,654

Property and equipment, net 93,145 98,581

Goodwill 487,617 487,617

Intangible assets, net 72,593 91,482

Deferred financing costs, net 1,814 2,237

Other assets 2,655 2,589

Total assets 1,006,920 975,160

Current liabilities:

Accounts payable, accrued expenses and other liabilities 64,295 61,900

Estimated liability for appeals 22,184 30,787

Total current liabilities 86,479 92,687

Long-term liabilities:

Revolving credit facility 240,000 240,000

Net deferred tax liabilities 14,407 21,989

Deferred rent 4,329 4,852

Other liabilities 9,925 9,403

Total long-term liabilities 268,661 276,244

Total liabilities 355,140 368,931

Commitments and contingencies

Shareholders' equity:

Preferred stock -- $0.01 par value; 5,000,000 shares authorized; none issued 0 0

Common stock -- $0.01 par value; 175,000,000 shares authorized; 97,588,656 shares issued and 83,925,462 shares outstanding at September 30, 2018; 96,536,251 shares issued and 83,256,858 shares outstanding at December 31, 2017 975 965

Capital in excess of par value 397,192 368,721

Retained earnings 389,189 366,164

Treasury stock, at cost: 13,663,194 shares at September 30, 2018 and 13,279,393 shares at December 31, 2017 (135,576) (129,621)

Total shareholders' equity 651,780 606,229

Total liabilities and shareholders' equity $ 1,006,920 $ 975,160

X

- Definition
Liability as of the balance sheet date for the estimated liability for appeals and estimated allowance for appeals related to receivables associated with client contracts that have be received on or before the balance sheet date.
+ References
No definition available.
+ Details

Name: hmsy_EstimatedLiabilityForAppeals

Namespace Prefix: hmsy_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer.
+ References
No definition available.
+ Details

Name: us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 8
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109196051&loc=SL49130549-203045

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(3))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_AccountsReceivableNetCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30)(a)(1))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_AdditionalPaidInCapitalCommonStock

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(11))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(12))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910
+ Details

Name: us-gaap_Assets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=82887183&loc=d3e6801-107765

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.9)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=82887183&loc=d3e6676-107765
+ Details

Name: us-gaap_AssetsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_AssetsCurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3044-108585

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=82887183&loc=d3e6676-107765

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.1)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CashAndCashEquivalentsAtCarryingValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.25)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03.(a),19)
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03.17)
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=82911808&loc=d3e14326-108349
+ Details

Name: us-gaap_CommitmentsAndContingencies

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount, after accumulated amortization, of debt issuance costs classified as current. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.8)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=114775744&loc=d3e28555-108399
+ Details

Name: us-gaap_DeferredFinanceCostsCurrentNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount, after accumulated amortization, of debt issuance costs classified as noncurrent. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=114775744&loc=d3e28555-108399

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.17)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_DeferredFinanceCostsNoncurrentNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
For a classified balance sheet, the cumulative difference between the rental income or payments required by a lease agreement and the rental income or expense recognized on a straight-line basis, or other systematic and rational basis more representative of the time pattern in which use or benefit is granted or derived from the leased property, expected to be recognized in income or expense, by the lessor or lessee, respectively, more than one year after the balance sheet date.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.26(c))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 20
-Section 25
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=77902458&loc=d3e39927-112707
+ Details

Name: us-gaap_DeferredRentCreditNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences, with jurisdictional netting and classified as noncurrent.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 45
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=84176650&loc=d3e31958-109318

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 45
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=84176650&loc=d3e31931-109318

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 45
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=84176650&loc=d3e31917-109318
+ Details

Name: us-gaap_DeferredTaxLiabilitiesNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 45
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=77989000&loc=SL49117168-202975

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266
+ Details

Name: us-gaap_Goodwill

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Carrying amount as of the balance sheet date of income taxes previously overpaid to tax authorities (such as U.S. Federal, state and local tax authorities) representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes. Also called income tax refund receivable.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(8))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(10))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910
+ Details

Name: us-gaap_IncomeTaxReceivable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph ((a)(1),(b))
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274
+ Details

Name: us-gaap_IntangibleAssetsNetExcludingGoodwill

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19-26)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_Liabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(23))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(25))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(32))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_LiabilitiesAndStockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.21)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_LiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_LiabilitiesCurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of obligation due after one year or beyond the normal operating cycle, if longer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 201.5-02(25))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(23))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(22))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 201.5-02(26))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 201.5-02(24))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_LiabilitiesNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_LiabilitiesNoncurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The carrying value as of the balance sheet date of the noncurrent portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section 45
-Paragraph 14
-URI http://asc.fasb.org/extlink&oid=99376301&loc=d3e1336-112600

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section 45
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=99376301&loc=d3e1314-112600
+ Details

Name: us-gaap_LongTermLineOfCredit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of current assets classified as other.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.8)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_OtherAssetsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of noncurrent assets classified as other.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.17)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_OtherAssetsNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.24)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_OtherLiabilitiesNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PreferredStockValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=82887183&loc=d3e6787-107765

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-Subparagraph (g)
-URI http://asc.fasb.org/extlink&oid=82887183&loc=d3e6676-107765

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 340
-SubTopic 10
-Section 05
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=68074540&loc=d3e5879-108316
+ Details

Name: us-gaap_PrepaidExpenseCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(14))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(8))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(13))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PropertyPlantAndEquipmentNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The cumulative amount of the reporting entity's undistributed earnings or deficit.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30)(a)(3))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(23)(a)(4))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770
+ Details

Name: us-gaap_RetainedEarningsAccumulatedDeficit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 4.E)
-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(31))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_StockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_StockholdersEquityAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 30
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29,30)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 30
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655
+ Details

Name: us-gaap_TreasuryStockValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

XML 27 R3.htm IDEA: XBRL DOCUMENT v3.10.0.1

Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - USD ($)
$ in Thousands

Sep. 30, 2018

Dec. 31, 2017

Accounts receivable, allowance for doubtful accounts $ 16,239 $ 14,799

Preferred stock, par value (in dollars per share) $ 0.01 $ 0.01

Preferred stock, shares authorized (in shares) 5,000,000 5,000,000

Preferred stock, shares issued (in shares) 0 0

Common stock, par value (in dollars per share) $ 0.01 $ 0.01

Common stock, shares authorized (in shares) 175,000,000 175,000,000

Common stock, shares issued (in shares) 97,588,656 96,536,251

Common stock, shares outstanding (in shares) 83,925,462 83,256,858

Treasury cost, shares (in shares) 13,663,194 13,279,393

X

- Definition
A valuation allowance for trade and other receivables due to an Entity within one year (or the normal operating cycle, whichever is longer) that are expected to be uncollectible.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=84173941&loc=d3e5074-111524

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.4)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Face amount or stated value per share of common stock.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockParOrStatedValuePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockSharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PreferredStockParOrStatedValuePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PreferredStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PreferredStockSharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29,30)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 30
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655
+ Details

Name: us-gaap_TreasuryStockShares

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

XML 28 R4.htm IDEA: XBRL DOCUMENT v3.10.0.1

Consolidated Statements of Income (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended

Sep. 30, 2018

Sep. 30, 2017

Sep. 30, 2018

Sep. 30, 2017

Revenue $ 154,246 $ 125,673 $ 442,462 $ 372,719

Cost of services:

Compensation 58,188 49,012 169,455 149,784

Information technology 12,979 12,067 39,482 33,131

Occupancy 3,500 4,332 11,897 12,109

Direct project expenses 10,661 9,548 31,652 30,092

Other operating expenses 8,567 7,446 22,183 21,212

Amortization of acquisition related software and intangible assets 7,942 8,167 25,695 21,825

Total cost of services 101,837 90,572 300,364 268,153

Selling, general and administrative expenses 28,178 22,240 86,708 73,400

Settlement expense 20,000

Total operating expenses 130,015 112,812 407,072 341,553

Operating income 24,231 12,861 35,390 31,166

Interest expense (2,880) (3,109) (8,562) (7,734)

Interest income 292 14 600 201

Income before income taxes 21,643 9,766 27,428 23,633

Income taxes 3,069 3,394 5,830 9,302

Net Income $ 18,574 $ 6,372 $ 21,598 $ 14,331

Basic income per common share:

Net income per common share -- basic (in dollars per share) $ 0.22 $ 0.08 $ 0.26 $ 0.17

Diluted income per common share:

Net income per common share -- diluted (in dollars per share) $ 0.22 $ 0.07 $ 0.25 $ 0.17

Weighted average shares:

Basic (in shares) 83,509 83,923 83,373 83,778

Diluted (in shares) 85,144 85,730 85,241 85,586

X

- Definition
Amount of expense for allocation of cost of intangible asset over its useful life directly used in production of good and rendering of service.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(b)(2))
-URI http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227
+ Details

Name: us-gaap_CostOfGoodsAndServicesSoldAmortization

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The aggregate cost of goods produced and sold and services rendered during the reporting period.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.2)
-URI http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227
+ Details

Name: us-gaap_CostOfRevenue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_CostOfRevenueAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Total costs of sales and operating expenses for the period.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03)
-URI http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227
+ Details

Name: us-gaap_CostsAndExpenses

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The aggregate direct operating costs incurred during the reporting period.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.2)
-URI http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227
+ Details

Name: us-gaap_DirectOperatingCosts

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(19))
-URI http://asc.fasb.org/extlink&oid=114873790&loc=SL114874131-224263

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109260490&loc=d3e1337-109256

Reference 3: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 55
-Paragraph 52
-URI http://asc.fasb.org/extlink&oid=109256448&loc=d3e4984-109258

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(21))
-URI http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109260490&loc=d3e1252-109256

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(23))
-URI http://asc.fasb.org/extlink&oid=114873765&loc=SL114874048-224260

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=109260490&loc=SL5780133-109256
+ Details

Name: us-gaap_EarningsPerShareBasic

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_EarningsPerShareBasicAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 55
-Paragraph 52
-URI http://asc.fasb.org/extlink&oid=109256448&loc=d3e4984-109258

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109260490&loc=d3e1252-109256

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(23))
-URI http://asc.fasb.org/extlink&oid=114873765&loc=SL114874048-224260

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109260490&loc=d3e1337-109256

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(21))
-URI http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=109260490&loc=SL5780133-109256

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(19))
-URI http://asc.fasb.org/extlink&oid=114873790&loc=SL114874131-224263
+ Details

Name: us-gaap_EarningsPerShareDiluted

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_EarningsPerShareDilutedAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=82911808&loc=d3e14326-108349
+ Details

Name: us-gaap_GainLossRelatedToLitigationSettlement

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(h)(1)(i))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690
+ Details

Name: us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (h)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 20
-Section 45
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109238882&loc=d3e38679-109324
+ Details

Name: us-gaap_IncomeTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of expenses incurred in the period for information technology and data processing products and services.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.6)
-URI http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227
+ Details

Name: us-gaap_InformationTechnologyAndDataProcessing

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of the cost of borrowed funds accounted for as interest expense.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=114775744&loc=d3e28555-108399

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (210.5-03(11))
-URI http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04.9)
-URI http://asc.fasb.org/extlink&oid=114873765&loc=SL114874048-224260
+ Details

Name: us-gaap_InterestExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.7(b))
-URI http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599
+ Details

Name: us-gaap_InvestmentIncomeInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(b)(4))
-URI http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227
+ Details

Name: us-gaap_LaborAndRelatedExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
+ References
No definition available.
+ Details

Name: us-gaap_LeaseAndRentalExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=114867106&loc=SL7669619-108580

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI http://asc.fasb.org/extlink&oid=114873765&loc=SL114874048-224260

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=114867106&loc=SL7669625-108580

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI http://asc.fasb.org/extlink&oid=114873790&loc=SL114874131-224263

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3602-108585

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257
+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The net result for the period of deducting operating expenses from operating revenues.
+ References
No definition available.
+ Details

Name: us-gaap_OperatingIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Other costs incurred during the reporting period related to other revenue generating activities.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.2)
-URI http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227
+ Details

Name: us-gaap_OtherCostOfOperatingRevenue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109196051&loc=SL49130539-203045

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=109196051&loc=SL49130545-203045

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 4
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109196051&loc=SL49130543-203045
+ Details

Name: us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 330
-SubTopic 10
-Section 30
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=68048583&loc=d3e3636-108311

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.4)
-URI http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227
+ Details

Name: us-gaap_SellingGeneralAndAdministrativeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 16
-URI http://asc.fasb.org/extlink&oid=109260490&loc=d3e1505-109256
+ Details

Name: us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=109260490&loc=d3e1448-109256

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257
+ Details

Name: us-gaap_WeightedAverageNumberOfSharesOutstandingBasic

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

XML 29 R5.htm IDEA: XBRL DOCUMENT v3.10.0.1

Consolidated Statement of Shareholders' Equity (Unaudited) - 9 months ended Sep. 30, 2018 - USD ($)
$ in Thousands

Common Stock [Member]

Additional Paid-in Capital [Member]

Retained Earnings [Member]

Treasury Stock [Member]

Total

Balance (in shares) at Dec. 31, 2017 96,536,251 13,279,393

Balance at Dec. 31, 2017 $ 965 $ 368,721 $ 366,164 $ (129,621) $ 606,229

Adoption of accounting standard (Note 1 and 3) (Accounting Standards Update 2014-09 [Member]) at Dec. 31, 2017 1,427 1,427

Net income 21,598 21,598

Stock-based compensation expense 17,645 17,645

Purchase of treasury stock (in shares) 383,801

Purchase of treasury stock $ (5,955) $ (5,955)

Exercise of stock options (in shares) 685,812 686,111

Exercise of stock options $ 7 13,626 $ 13,633

Vesting of restricted stock units, net of shares withheld for employee tax (in shares) 366,593

Vesting of restricted stock units, net of shares withheld for employee tax $ 3 (2,800) (2,797)

Balance (in shares) at Sep. 30, 2018 97,588,656 13,663,194

Balance at Sep. 30, 2018 $ 975 $ 397,192 $ 389,189 $ (135,576) $ 651,780

X

- Definition
Amount of increase to additional paid-in capital (APIC) from recognition of equity-based compensation.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 20
-Section 55
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=109196918&loc=d3e11149-113907

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5047-113901

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 20
-Section 55
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=109196918&loc=d3e11178-113907

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 35
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=79507207&loc=d3e4534-113899
+ Details

Name: us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount after tax of increase (decrease) to equity or (increase) decrease to net assets, resulting from the cumulative effect adjustment of a new accounting principle applied in the period of adoption.
+ References
No definition available.
+ Details

Name: us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=114867106&loc=SL7669619-108580

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI http://asc.fasb.org/extlink&oid=114873765&loc=SL114874048-224260

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=114867106&loc=SL7669625-108580

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI http://asc.fasb.org/extlink&oid=114873790&loc=SL114874131-224263

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3602-108585

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257
+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Number of shares issued which are neither cancelled nor held in the treasury.
+ References
No definition available.
+ Details

Name: us-gaap_SharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of share options (or share units) exercised during the current period.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(2)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644
+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644
+ Details

Name: us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Value of stock issued as a result of the exercise of stock options.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29-31)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 4.E)
-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(31))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_StockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Number of shares that have been repurchased during the period and are being held in treasury.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_TreasuryStockSharesAcquired

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the par value method.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 30
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770
+ Details

Name: us-gaap_TreasuryStockValueAcquiredParValueMethod

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201409Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 30 R6.htm IDEA: XBRL DOCUMENT v3.10.0.1

Consolidated Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended

Sep. 30, 2018

Sep. 30, 2017

Operating activities:

Net income $ 21,598,000 $ 14,331,000

Adjustments to reconcile net income to net cash provided by operating activities:

Depreciation and amortization of property, equipment and software 24,331,000 20,599,000

Amortization of intangible assets 18,889,000 15,947,000

Amortization of deferred financing costs 423,000 1,563,000

Stock-based compensation expense 17,645,000 16,761,000

Deferred income taxes (7,582,000) (726,000)

Change in fair value of contingent consideration (35,000) (2,450,000)

Release of estimated liability for appeals (8,436,000)

Changes in operating assets and liabilities:

Accounts receivable (13,038,000) 5,630,000

Prepaid expenses (237,000) 757,000

Other current assets 522,000 712,000

Other assets (66,000) 163,000

Income taxes receivable / (payable) (2,705,000) (2,731,000)

Accounts payable, accrued expenses and other liabilities 4,394,000 (15,457,000)

Estimated liability for appeals (167,000) (1,000)

Net cash provided by operating activities 55,536,000 55,098,000

Investing activities:

Acquisition of a business, net of cash acquired (171,174,000)

Purchases of property and equipment (4,333,000) (11,656,000)

Investment in capitalized software (15,100,000) (10,664,000)

Net cash used in investing activities (19,433,000) (193,494,000)

Financing activities:

Proceeds from exercise of stock options 13,633,000 2,580,000

Payments of tax withholdings on behalf of employees for net-share settlement for stock-based compensation (2,797,000) (2,898,000)

Payments on capital lease obligations (5,000)

Proceeds from credit facility 42,204,000

Purchases of treasury stock (5,955,000)

Net cash provided by financing activities 4,881,000 41,881,000

Net increase (decrease) in cash and cash equivalents 40,984,000 (96,515,000)

Cash and Cash Equivalents

Cash and cash equivalents at beginning of year 83,313,000 175,999,000

Cash and cash equivalents at end of period 124,297,000 79,484,000

Supplemental disclosure of cash flow information:

Cash paid for income taxes, net of refunds 15,501,000 12,317,000

Cash paid for interest 7,769,000 5,819,000

Supplemental disclosure of non-cash activities:

Change in balance of accrued property and equipment purchases $ 538,000 $ (414,000)

X

- Definition
The amount of gain (loss) realized by the release of estimated liability for appeals during the period.
+ References
No definition available.
+ Details

Name: hmsy_EstimatedLiabilityForAppealsGainLossIncludedInEarnings

Namespace Prefix: hmsy_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The increase (decrease) in future cash outflow to pay for purchases of fixed assets that have occurred.
+ References
No definition available.
+ Details

Name: hmsy_IncreaseDecreaseInCapitalExpendituresIncurredButNotYetPaid

Namespace Prefix: hmsy_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in the estimated liability for appeals and estimated allowance for appeals related to receivables associated with client contracts that have be received.
+ References
No definition available.
+ Details

Name: hmsy_IncreaseDecreaseInEstimatedLiabilityForAppeals

Namespace Prefix: hmsy_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of amortization expense attributable to debt issuance costs.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3602-108585

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(8))
-URI http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=114775744&loc=d3e28555-108399
+ Details

Name: us-gaap_AmortizationOfFinancingCosts

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3602-108585

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)(2)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274
+ Details

Name: us-gaap_AmortizationOfIntangibleAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of increase (decrease) in the value of right to a contingent consideration asset.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 4
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e7008-128479
+ Details

Name: us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_CashAndCashEquivalentsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3044-108585

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=82887183&loc=d3e6676-107765

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.1)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CashAndCashEquivalentsAtCarryingValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.
+ References
No definition available.
+ Details

Name: us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 6.I.7)
-URI http://asc.fasb.org/extlink&oid=34349781&loc=d3e330036-122817

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3602-108585

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319
+ Details

Name: us-gaap_DeferredIncomeTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3602-108585
+ Details

Name: us-gaap_Depreciation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=98513485&loc=d3e4297-108586
+ Details

Name: us-gaap_IncomeTaxesPaidNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3602-108585
+ Details

Name: us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3602-108585
+ Details

Name: us-gaap_IncreaseDecreaseInAccountsReceivable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3602-108585
+ Details

Name: us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_IncreaseDecreaseInOperatingCapitalAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of increase (decrease) in current assets classified as other.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3602-108585
+ Details

Name: us-gaap_IncreaseDecreaseInOtherCurrentAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of increase (decrease) in operating assets classified as other.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3602-108585
+ Details

Name: us-gaap_IncreaseDecreaseInOtherOperatingAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3602-108585
+ Details

Name: us-gaap_IncreaseDecreaseInPrepaidExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=98513485&loc=d3e4297-108586

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 17
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3367-108585

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 25
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3536-108585
+ Details

Name: us-gaap_InterestPaidNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3521-108585
+ Details

Name: us-gaap_NetCashProvidedByUsedInFinancingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3521-108585
+ Details

Name: us-gaap_NetCashProvidedByUsedInInvestingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 25
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3536-108585

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3521-108585

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3602-108585
+ Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=114867106&loc=SL7669619-108580

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI http://asc.fasb.org/extlink&oid=114873765&loc=SL114874048-224260

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=114867106&loc=SL7669625-108580

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI http://asc.fasb.org/extlink&oid=114873790&loc=SL114874131-224263

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3602-108585

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257
+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The cash outflow to reacquire common stock during the period.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 15
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3291-108585
+ Details

Name: us-gaap_PaymentsForRepurchaseOfCommonStock

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow associated with the development, modification or acquisition of software programs or applications for internal use (that is, not to be sold, leased or otherwise marketed to others) that qualify for capitalization.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 13
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3213-108585
+ Details

Name: us-gaap_PaymentsForSoftware

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of cash outflow to satisfy an employee's income tax withholding obligation as part of a net-share settlement of a share-based award.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 15
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3291-108585

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 25
-Paragraph 19A
-URI http://asc.fasb.org/extlink&oid=107668666&loc=SL79513924-113897
+ Details

Name: us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 13
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3213-108585
+ Details

Name: us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 13
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3213-108585
+ Details

Name: us-gaap_PaymentsToAcquirePropertyPlantAndEquipment

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3255-108585

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(f))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690
+ Details

Name: us-gaap_ProceedsFromLinesOfCredit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of cash inflow from exercise of stock options granted under share-based compensation arrangement.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=SL79508275-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3255-108585
+ Details

Name: us-gaap_ProceedsFromStockOptionsExercised

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash outflow for the obligation for a lease meeting the criteria for capitalization (with maturities exceeding one year or beyond the operating cycle of the entity, if longer).
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 15
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3291-108585
+ Details

Name: us-gaap_RepaymentsOfLongTermCapitalLeaseObligations

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3602-108585
+ Details

Name: us-gaap_ShareBasedCompensation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_SupplementalCashFlowInformationAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 31 R7.htm IDEA: XBRL DOCUMENT v3.10.0.1

Note 1 - Business and Summary of Significant Accounting Policies
9 Months Ended

Sep. 30, 2018

Notes to Financial Statements

Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]

1.

Business and Summary of Significant Accounting Policies

(a) Business

HMS is a leading provider of cost containment solutions in the U.S. healthcare marketplace. We use innovative technology, extensive data services and powerful analytics to deliver coordination of benefits, payment integrity and care management and consumer engagement solutions to help healthcare payers improve financial performance and clinical outcomes. We provide coordination of benefits services to government and commercial healthcare payers and sponsors to ensure that the responsible party pays healthcare claims. Our payment integrity services ensure healthcare claims billed are accurate and appropriate, and our care management and consumer engagement technology helps risk-bearing organizations to better engage with and manage the care delivered to their members. Together these various services help customers recover erroneously paid amounts from liable
third
parties; prevent future improper payments; reduce fraud, waste and abuse; better manage the care their members receive; engage healthcare consumers to improve clinical outcomes while increasing member satisfaction and retention; and achieve regulatory compliance. We currently operate as
one
business segment with a single management team that reports to our Chief Executive Officer.

The accompanying consolidated financial statements and notes are unaudited. Accordingly, they do
not
include all of the information and notes required by U.S. GAAP for complete financial statements. These statements include all adjustments (which include only normal recurring adjustments, except as disclosed) that management considers necessary to present a fair statement of the Company’s results of operations, financial position and cash flows. The results reported in these unaudited consolidated financial statements should
not
be regarded as necessarily indicative of results that
may
be expected for the entire year. It is suggested that these unaudited consolidated financial statements be read in conjunction with the Company’s consolidated financial statements as of and for the year ended
December 31, 2017
which were filed with the SEC as part of the
2017
Form
10
-K. The consolidated balance sheet as of
December 31, 2017
included herein was derived from audited financial statements, but does
not
include all disclosures required by U.S. GAAP.

The preparation of the Company’s unaudited consolidated financial statements requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities, primarily accounts receivable, intangible assets, fixed assets, accrued expenses, estimated liability for appeals, the disclosure of contingent liabilities at the date of the unaudited consolidated financial statements and the reported amounts of revenue and expenses during the reporting periods. The Company’s actual results could differ from those estimates.

These unaudited consolidated financial statements include HMS accounts and transactions and those of the Company’s wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.

(b) Summary of Significant Accounting Policies

There have been
no
material changes to the Company’s significant accounting policies that are referenced in the
2017
Form
10
-K other than as described below with respect to revenue recognition.

Recently Adopted Accounting Pronouncements

In
May 2014,
the FASB issued ASU
2014
-
09,

Revenue from Contracts with Customers
(Topic
606
) (“ASU
2014
-
09”
), which is the new comprehensive revenue recognition standard that supersedes all existing revenue recognition guidance under U.S. GAAP. The Company adopted ASU
2014
-
09
on
January 1, 2018
using the modified retrospective method and the Company recognized the cumulative effect of initially applying the new revenue standard as an adjustment to the opening balance of retained earnings. The financial information for comparative prior periods has
not
been restated and continues to be reported under the accounting standards in effect for those periods. The effect of adopting ASU
2014
-
09
in the current annual reporting period as compared with the guidance that was in effect before the change is immaterial. The Company’s internal control framework did
not
materially change, but existing internal controls were modified due to certain changes to business processes and systems to support the new revenue recognition standard as necessary. The Company continues to expect the impact of the adoption of the new standard to be immaterial to its net income and its internal control framework on an ongoing basis.

In
August 2016,
the FASB issued ASU
No.

2016
-
15,

Statements of Cash Flows (Topic
230
): Classification of Certain Cash Receipts and Cash Payments
(“ASU
2016
-
15”
)
.
ASU
2016
-
15
clarifies where certain cash receipts and cash payments are presented and classified in the statement of cash flows. The amendments are effective for annual reporting periods beginning after
December 15, 2017,
and for interim reporting periods within such annual periods. The Company adopted this guidance on
January 1, 2018.
The adoption of this guidance did
not
have an effect on the Company’s consolidated financial statements.

In
January 2017,
the FASB issued ASU
No.

2017
-
01,

Business Combinations (Topic
805
) – Clarifying the Definition of a Business
(“ASU
2017
-
01”
). ASU
2017
-
01
finalizes previous proposals regarding shareholder concerns that the definition of a business is applied too broadly. The guidance assists entities with evaluating whether transactions should be accounted for as acquisitions of assets or of businesses. The amendments are effective for annual periods beginning after
December 15, 2017,
including interim periods within those periods. The Company adopted this guidance on
January 1, 2018.
The adoption of this guidance did
not
have a material effect on the Company’s consolidated financial statements.

In
May 2017,
the FASB issued ASU
No.

2017
-
09,

Compensation – Stock Compensation (Topic
718
) – Scope of Modification Accounting,
(“ASU
2017
-
09”
). ASU
2017
-
09
requires entities to apply modification accounting to changes made to a share-based payment award. The new guidance specifies that entities will apply modification accounting to changes to a share-based payment award only if any of the following are
not
the same immediately before and after the change:
1
) The award’s fair value (or calculated value or intrinsic value, if those measurement methods are used),
2
) the award’s vesting conditions, and
3
) the award’s classification as an equity or liability instrument. ASU
2017
-
09
is effective for annual reporting periods beginning after
December 15, 2017,
including interim periods within such annual periods, with early adoption permitted. The Company adopted this guidance on
January 1, 2018.
The adoption of this guidance did
not
have a material effect on the Company’s consolidated financial statements.

Recently Issued Accounting Pronouncements

In
February 2016,
the FASB issued ASU
No.

2016
-
02,

Leases (Topic
842
)
(“ASU
2016
-
02”
). ASU
2016
-
02
will require most lessees to recognize a majority of the company’s leases on the balance sheet, which will increase reported assets and liabilities. ASU
2016
-
02
is effective for annual reporting periods beginning after
December 15, 2018
including interim periods within such annual reporting periods with early adoption permitted. The Company has
not
early adopted this guidance. The Company developed a preliminary implementation plan and has reviewed historical lease agreements in order to quantify the impact of adoption. Based upon the Company’s on-going analysis to date, the Company currently expects that there will be a material increase to total assets and total liabilities on the Company’s consolidated balance sheet upon adoption; however, the Company continues to perform the necessary additional reviews and other implementation considerations in order to appropriately quantify the changes. The Company has elected to use the FASB’s optional transition method.The Company expects to complete the on-going analysis and quantification by the end of the
fourth
quarter of
2018.

In
January 2017,
the FASB issued ASU
No.

2017
-
04,

Goodwill and Other (Topic
350
): Simplifying the Test for Goodwill Impairment
(“ASU
2017
-
04”
). This amendment simplifies the manner in which an entity is required to test for goodwill impairment by eliminating Step
2
from the goodwill impairment test. Step
2
measures goodwill impairment loss by comparing the implied fair value of a reporting unit’s goodwill with the carrying amount of that goodwill. The amendment simplifies this approach by having the entity (
1
) perform its annual or interim goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount, and (
2
) recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value, with the understanding that the loss recognized should
not
exceed the total amount of goodwill allocated to that reporting unit. The amendment is effective for public entities that are SEC filers prospectively for their annual, or any interim, goodwill impairment tests in fiscal years beginning after
December 15, 2019.
Early adoption is permitted for all entities for interim or annual goodwill impairment tests performed on testing dates after
January 1, 2017.
The Company is currently evaluating the impact on the Company’s financial statements of adopting this guidance but this guidance is
not
expected to have a material impact on the Company’s financial position, results of operations or internal control framework.

In
June 2018,
the FASB issued ASU
No.

2018
-
07,

Compensation – Stock Compensation (Topic
718
) – Improvements to Nonemployee Share-Based Payment Accounting,
(“ASU
2018
-
07”
). ASU
2018
-
07
requires entities to apply similar accounting for share-based payment transactions with non-employees as with share-based payment transactions with employees. ASU
2018
-
07
is effective for public entities for fiscal year beginning after
December 15, 2018,
including interim periods within that fiscal year. Early adoption is permitted. The Company is currently evaluating the impact on the Company’s financial statements of adopting this guidance but this guidance is
not
expected to have a material impact on the Company’s financial position, results of operations or internal control framework.

On
August 17, 2018
the SEC issued SEC Final Rule Release
No.

33
-
10532,

Disclosure Update and Simplification
(“Final Rule”). The final rule amends certain disclosure requirements to facilitate the disclosure of information to investors and simplify compliance without significantly altering the total mix of information provided to investors. The final rule is effective for public entities that are SEC filers on
November 5, 2018.
The Company is currently evaluating the impact of adopting this guidance but this guidance is
not
expected to have a material impact on the Company’s disclosures.

X

- References
No definition available.
+ Details

Name: us-gaap_DisclosureTextBlockAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-URI http://asc.fasb.org/topic&trid=2197479

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-URI http://asc.fasb.org/topic&trid=2134479

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-URI http://asc.fasb.org/topic&trid=2122394

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-URI http://asc.fasb.org/topic&trid=2122369
+ Details

Name: us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 32 R8.htm IDEA: XBRL DOCUMENT v3.10.0.1

Note 2 - Fair Value of Financial Instruments
9 Months Ended

Sep. 30, 2018

Notes to Financial Statements

Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring [Text Block]

2.

Fair Value of Financial Instruments

Financial instruments (principally cash and cash equivalents, accounts receivable, accounts payable and accrued expenses) are carried at cost, which approximates fair value due to the short-term maturity of these instruments. The Company’s long-term credit facility is carried at cost, which, due to the variable interest rate associated with the revolving credit facility, approximates its fair value. The Company has
no
Level
1
or Level
2
financial instruments and there were
no
transfers between Level
1
or Level
2
financial instruments. The Company’s contingent consideration liability of
$35,000
at
June 30, 2018
was reduced to
zero
at
September 30, 2018
and is included in Other liabilities on the unaudited Consolidated Balance Sheets. The liability is valued using a Monte Carlo simulation and includes unobservable inputs such as expected levels of revenues and discount rates. Changes in the unobservable inputs of this instrument could result in a significant change in the fair value measurement.

X

- References
No definition available.
+ Details

Name: us-gaap_DisclosureTextBlockAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure of the fair value measurement of assets and liabilities, which includes financial instruments measured at fair value that are classified in shareholders' equity, which may be measured on a recurring or nonrecurring basis.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-URI http://asc.fasb.org/topic&trid=2155941
+ Details

Name: us-gaap_FairValueMeasurementInputsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 33 R9.htm IDEA: XBRL DOCUMENT v3.10.0.1

Note 3 - Revenue Recognition
9 Months Ended

Sep. 30, 2018

Notes to Financial Statements

Revenue from Contract with Customer [Text Block]

3.

Revenue Recognition

The Company’s revenue disaggregated by product for the
three
and
nine
months ended
September 30
is as follows
(in thousands)
:

Three Months Ended

September 30

Nine Months Ended

September 30

2018

2017

2018

2017

Coordination of benefits

$

105,694

$

90,073

$

298,201

$

277,018

Analytical services

48,552

35,600

144,261

95,701

Total

$

154,246

$

125,673

$

442,462

$

372,719

Coordination of benefits

Coordination of benefits revenue is derived from contracts with state governments and Medicaid managed care plans that typically span
3
to
5
years with the option to renew. Types of service contracts could include: (a) the identification of erroneously paid claims; (b) the delivery of verified commercial insurance coverage information; (c) the identification of paid claims where another
third
party is liable; and (d) the identification and enrollment of Medicaid members who have access to affordable employer insurance. Most of these types of service contracts contain multiple promises, all of which are
not
distinct within the context of the contract. Therefore, the promises represent a single, distinct performance obligation for the types of services we offer. Revenue derived from these performance obligations is largely based on variable consideration where, based on the number of claims or amount of findings the Company identified, a contingent or fixed transaction price/recovery percentage is allocated to each distinct performance obligation. The Company utilizes the expected value method to estimate the variable consideration related to the transaction price for its service contracts. Key inputs and assumptions in determining variable consideration includes identified pricing and expected recoveries and/or savings. The expected recoveries and/or savings are based on historical experience of information received from our customers. Revenue is recognized at a point in time when our customers realize economic benefits from our services when our services are completed. Generally, coordination of benefit contract payment terms are
not
standardized within the respective contract; however, payment is typically due on demand and there is a clear and distinct history of customers making consistent payments.

Analytical services

The Company’s analytical services revenue consists mostly of payment integrity services but also care management and consumer engagement services.

Payment integrity services revenue is derived from contracts with federal and state governments, commercial health plans and other at-risk entities that can span several years with the option to renew. Types of service contracts could include: (a) services designed to ensure that healthcare payments are accurate and appropriate; and (b) the identification of over/(under)payments or inaccurate charges based on a review of medical records. Most of these types of service contracts contain multiple promises, all of which are
not
distinct within the context of the contract. Therefore, the promises represent a single, distinct performance obligation for the types of services we offer. Revenue derived from these performance obligations is largely based on variable consideration where, based on the number of claims or amount of findings the Company identified, a contingent or fixed transaction price/recovery percentage is allocated to each distinct performance obligation. The Company utilizes the expected value method to estimate the variable consideration related to the transaction price for its service contracts. Key inputs and assumptions in determining variable consideration includes identified pricing and expected recoveries and/or savings. The expected recoveries and/or savings are based on historical experience of information received from our customers. Revenue is recognized at a point in time when our customers realize economic benefits from our services when our services are completed. Generally, payment integrity contract payment terms are
not
standardized within the respective contract; however, payment is typically due on demand and there is a clear and distinct history of customers making consistent payments.

Care management and consumer engagement services revenue is derived from contracts with health plans and other risk-bearing entities that can span several years with the option to renew. Types of service contracts could include: (a) programs designed to improve member engagement; and (b) outreach services designed to improve clinical outcomes. Most of these types of service contracts contain multiple promises, all of which are
not
distinct within the context of the contract. Therefore, the promises represent a single, distinct performance obligation for the types of services we offer. Revenue derived from these services is largely based on consideration associated with prices per order/transfer and PMPM/PMPY fees. The Company believes the output method is a reasonable measure of progress for the satisfaction of our performance obligations, which are satisfied over time, as it provides a faithful depiction of (
1
) our performance toward complete satisfaction of the performance obligation under the contract and (
2
) the value transferred to the customer of the services performed under the contract. The Company has elected the right to invoice practical expedient for recognition of revenue related to its performance obligations. Additionally, certain care management and consumer engagement services contracts have distinct performance obligations related to software license and implementation fees which have historically been recognized as revenue ratably over the life of the contract. However, upon adoption of ASC
606,
revenue for software licenses is recognized at the beginning of the license period when control is transferred as the license is installed and revenue for implementation fees is recognized when control is transferred over time as the implementation is being performed. As the performance obligation is deemed to have been satisfied and control transferred to our customers for software licenses and implementation fees on or before
December 31, 2017,
the Company recorded a decrease to deferred revenue and an increase to opening retained earnings of
$1.4
million as of
January 1, 2018
for the cumulative impact of adopting ASC
606.
A portion of the Company’s care management and consumer engagement services are deferred and revenue is recognized over time. Deferred revenue of this nature was approximately
$5.2
million and
$6.4
million as of
September 30, 2018
and
December 31, 2017,
respectively, and is included in Accounts payable, accrued expenses and other liabilities in the Consolidated Balance Sheets. Generally, care management and consumer engagement contract payment terms are stated within the contract and are due within an explicitly stated time period (e.g.,
30,

45,

60
days) from the date of invoice.

Contract modifications are routine in nature and often done to account for changes in the contract specifications or requirements. In most instances, contract modifications are for services that are
not
distinct, and, therefore, modifications are accounted for as part of the existing contract.

X

- References
No definition available.
+ Details

Name: us-gaap_DisclosureTextBlockAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-URI http://asc.fasb.org/topic&trid=49130388

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-URI http://asc.fasb.org/topic&trid=2122369
+ Details

Name: us-gaap_RevenueFromContractWithCustomerTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 34 R10.htm IDEA: XBRL DOCUMENT v3.10.0.1

Note 4 - Accounts Receivable and Accounts Receivable Allowance
9 Months Ended

Sep. 30, 2018

Notes to Financial Statements

Accounts Receivable and Allowance for Doubtful Accounts [Text Block]

4.

Accounts Receivable and Accounts Receivable Allowance

The Company’s accounts receivable, net, consisted of the following
(in thousands)
:

September 30,

2018

December 31,

2017

Accounts receivable

$

218,737

$

204,259

Allowance

(16,239

)

(14,799

)

Accounts receivable, net

$

202,498

$

189,460

We record an accounts receivable allowance based on historical patterns of billing adjustments, length of operating and collection cycle and customer negotiations, behaviors and payment patterns. Changes in these estimates are recorded to revenue in the period of change. A summary of the activity in the accounts receivable allowance was as follows
(in thousands)
:

September 30,
2018

December 31,
2017

Balance--beginning of period

$

14,799

$

10,772

Provision

16,107

20,233

Charge-offs

(14,667

)

(16,206

)

Balance--end of period

$

16,239

$

14,799

X

- Definition
The entire disclosure for accounts receivable and allowance for doubtful accounts.
+ References
No definition available.
+ Details

Name: hmsy_AccountsReceivableAndAllowanceForDoubtfulAccountsTextBlock

Namespace Prefix: hmsy_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_DisclosureTextBlockAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 35 R11.htm IDEA: XBRL DOCUMENT v3.10.0.1

Note 5 - Acquisition
9 Months Ended

Sep. 30, 2018

Notes to Financial Statements

Business Combination Disclosure [Text Block]

5.

Acquisition

On
April 17, 2017,
the Company completed the acquisition of
100%
of the outstanding capital stock of Eliza Holding Corp. (“Eliza”), for a preliminary purchase price of
$171.6
million funded with available liquidity of approximately
75%
cash on hand and
25%
from the Company’s existing credit line.

The allocation of the purchase price to the fair value of the assets acquired and the liabilities assumed as of
April
17,

2017,
the effective date of the acquisition, is as follows (
in thousands
):

Cash and cash equivalents

$

435

Accounts receivable

8,902

Prepaid expenses

1,427

Property and equipment

1,146

Intangible assets

76,240

Goodwill

107,754

Other assets

63

Accounts payable

(2,620

)

Deferred tax liability

(19,681

)

Other liabilities

(2,057

)

Total purchase price

$

171,609

The purchase price allocated to the intangibles acquired was as follows (
in thousands
):

Useful Life
(in years)

Customer relationships

15

$

56,200

Intellectual property

6

19,600

Trade name

1.5

310

Restrictive covenants

1

130

Fair value of intangibles acquired

$

76,240

Acquisition costs recorded in the
second
quarter
2017
to selling, general and administrative expenses were as follows (
in thousands):

Other operating expenses - consulting fees

$

3,515

Other operating expenses - legal fees

832

Other operating expenses - transaction costs

185

Acquisition-related costs

$

4,532

The financial results of Eliza have been included in the Company’s consolidated financial statements since the date of acquisition. Eliza contributed approximately
$37.4
million in revenue to HMS results of operations for the
nine
months ended
September 30, 2018.
Eliza contributed approximately
$17.5
million in revenue to HMS results of operations from the date of acquisition through
September 30, 2017.

X

- Definition
The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-URI http://asc.fasb.org/topic&trid=2303972
+ Details

Name: us-gaap_BusinessCombinationDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_DisclosureTextBlockAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 36 R12.htm IDEA: XBRL DOCUMENT v3.10.0.1

Note 6 - Intangible Assets and Goodwill
9 Months Ended

Sep. 30, 2018

Notes to Financial Statements

Goodwill and Intangible Assets Disclosure [Text Block]

6.

Intangible Assets and Goodwill

Intangible assets consisted of the following (
in thousands, except for weighted average amortization period
):

Gross

Carrying

Amount

Accumulated

Amortization

Net Carrying

Amount

Weighted

Average

Amortization

Period (in years)

September 30, 2018

Customer relationships

$

156,790

$

(100,758

)

$

56,032

12.4

Trade names

16,246

(15,724

)

522

0.3

Intellectual property

21,700

(5,701

)

15,999

4.3

Restrictive covenants

263

(223

)

40

0.9

Total

$

194,999

$

(122,406

)

$

72,593

Gross

Carrying

Amount

Accumulated

Amortization

Net Carrying

Amount

Weighted

Average

Amortization

Period (in years)

December 31, 2017

Customer relationships

$

159,290

$

(89,106

)

$

70,184

11.3

Trade names

16,246

(13,916

)

2,330

1

Intellectual property

21,700

(2,874

)

18,826

5.2

Restrictive covenants

263

(121

)

142

1.3

Total

$

197,499

$

(106,017

)

$

91,482

Amortization expense of intangible assets is expected to approximate the following
(in thousands):

Year ending December 31,

2018

$

5,452

2019

9,195

2020

7,664

2021

7,197

2022

7,197

Thereafter

35,888

Total

$

72,593

For the
three
months ended
September 30, 2018
and
2017,
amortization expense related to intangible assets was
$6.1
million and
$6.2
million, respectively. For the
nine
months ended
September 30, 2018
and
2017,
amortization expense related to intangible assets was
$18.9
million and
$15.9
million, respectively.

The Company assesses goodwill for impairment on an annual basis as of
June
30th
of each year or more frequently if an event occurs or changes in circumstances would more likely than
not
reduce the fair value of a reporting unit below its carrying amount. Assessment of goodwill impairment is at the HMS Holdings Corp. entity level as the Company operates as a single reporting unit. The Company completed the annual impairment test as of
June 30, 2018
electing to perform the
first
step of the goodwill impairment test by comparing the fair value of the reporting unit with its carrying value, including goodwill. In calculating the fair value of the reporting unit, the Company utilized a weighting across
three
commonly accepted valuation approaches: an income approach, a guideline public company approach and a merger and acquisition approach. The income approach to determining fair value computes projections of the cash flows that the reporting unit is expected to generate converted into a present value equivalent through discounting. Significant assumptions in the income approach include income projections, a discount rate and a terminal growth value which are all level
3
inputs. The income projections include assumptions for revenue and expense growth which are based on internally developed business plans and largely reflect recent historical revenue and expense trends. The discount rate was based on a risk free rate plus a beta adjusted equity risk premium and specific company risk premium. The terminal growth value is Company specific and was determined analyzing inputs such as historical inflation and the GDP growth rate. The guideline public company approach and merger and acquisition approach are based on pricing multiples observed for similar publicly traded companies or similar market companies that were sold. The results of the annual impairment assessment provide that the fair value of the reporting unit was significantly in excess of the Company’s carrying value; therefore,
no
impairment was indicated and step
two
was
not
performed. If actual results are
not
consistent with our estimates or assumptions, the Company
may
be exposed to an impairment charge that could materially adversely impact our consolidated financial position and results of operations.

There were
no

impairment charges related to goodwill during the years ended
December 31, 2017,
2016
or
2015.
There were
no
changes in the carrying amount of goodwill for the
nine
-months ended
September 30, 2018.

X

- References
No definition available.
+ Details

Name: us-gaap_DisclosureTextBlockAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for goodwill and intangible assets.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-URI http://asc.fasb.org/topic&trid=2144416
+ Details

Name: us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 37 R13.htm IDEA: XBRL DOCUMENT v3.10.0.1

Note 7 - Accounts Payable, Accrued Expenses and Other Liabilities
9 Months Ended

Sep. 30, 2018

Notes to Financial Statements

Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]

7.

Accounts Payable, Accrued Expenses and Other Liabilities

Accounts payable, accrued expenses and other liabilities consisted of the following
(in thousands)
:

September 30,

2018

December 31,

2017

Accounts payable, trade

$

13,850

$

19,330

Accrued compensation and other

32,372

24,072

Accrued operating expenses

18,073

18,498

Total accounts payable, accrued expenses and other liabilities

$

64,295

$

61,900

X

- Definition
The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.
+ References
No definition available.
+ Details

Name: us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_DisclosureTextBlockAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 38 R14.htm IDEA: XBRL DOCUMENT v3.10.0.1

Note 8 - Income Taxes
9 Months Ended

Sep. 30, 2018

Notes to Financial Statements

Income Tax Disclosure [Text Block]

8.

Income Taxes

The Company’s effective tax rate decreased to
21.3%
for the
nine
months ended
September 30, 2018
from
39.4%
for the
nine
months ended
September 30, 2017.
The
nine
months ended
September 30, 2018
effective tax rate includes discrete tax expense items related to a previously disclosed legal settlement, interest on uncertain tax benefits, state tax refunds and net stock compensation in addition to a net federal tax reform benefit comprised of a federal tax rate decrease, net of state impact, offset by tax increases for officer compensation deduction limits and loss of the domestic manufacturing deduction. For the
nine
months ended
September 30, 2018,
the differences between the federal statutory rate and our effective tax rate are discrete tax expense items related to the previously disclosed legal settlement, state taxes, equity compensation impacts, unrecognized tax benefits, including interest, officer compensation deduction limits, research and development tax credits, and other permanent differences.

The effective tax rate for the
nine
months ended
September 30, 2018
represents the Company’s best estimate using information available to the Company as of
November 5, 2018.
The Company anticipates U.S. regulatory agencies will issue further regulations over the next
three
months which
may
alter this estimate. The Company is still evaluating, among other things, the application of limitations for executive compensation related to contracts existing prior to
November 2, 2017
.
The Company will refine its estimates to incorporate new or better information as it becomes available through the filing date of its
2017
U.S. income tax returns in the
fourth
quarter of
2018.

Included in Other Liabilities on the Consolidated Balance Sheets, are the total amount of unrecognized tax benefits of approximately
$8.9
million and
$8.2
million, as of
September 30, 2018
and
December 31, 2017,
respectively, (net of the federal benefit for state issues) that, if recognized, would favorably affect the Company’s future effective tax rate. Also included in Other Liabilities on the Consolidated Balance Sheets, are accrued liabilities for interest expense and penalties related to unrecognized tax benefits of
$1.0
million and
$0.6
million as of
September 30, 2018
and
December 31, 2017,
respectively. HMS includes interest expense and penalties in the provision for income taxes in the unaudited Consolidated Statements of Income. The amount of interest expense (net of federal and state income tax benefits) and penalties in the unaudited Consolidated Statements of Income for the
nine
months ended
September 30, 2018
and
2017
was
$0.4
million and an immaterial amount, respectively. The Company believes it is reasonably possible that the amount of unrecognized tax benefits
may
decrease by
$3.5
million over the next
twelve
months, due to the expiration of the statute of limitations in federal and various state jurisdictions.

HMS files income tax returns with the U.S. Federal government and various state, territory, and local jurisdictions. HMS is
no
longer subject to U.S. Federal income tax examinations for years before
2012.
The Company is currently under audit by the Internal Revenue Service for years
2013
and
2014
and
no
adjustments have been received to date. HMS operates in a number of state and local jurisdictions. Accordingly, HMS is subject to state and local income tax examinations based on the various statutes of limitations in each jurisdiction. Previously recognized state apportionment benefits were adjusted by the state resulting in additional benefits, net of federal tax, of
$0.5
million relating to the current period and
$2.4
million relating to prior periods.

X

- References
No definition available.
+ Details

Name: us-gaap_DisclosureTextBlockAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-URI http://asc.fasb.org/topic&trid=2144680
+ Details

Name: us-gaap_IncomeTaxDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 39 R15.htm IDEA: XBRL DOCUMENT v3.10.0.1

Note 9 - Estimated Liability for Appeals
9 Months Ended

Sep. 30, 2018

Notes to Financial Statements

Estimated Liability and Allowance for Appeals [Text Block]

9.

Estimated Liability For Appeals

Under the Company’s contracts with certain commercial health plan customers and its Medicare RAC contracts with CMS (included within the Company’s analytical services product revenue), providers have the right to appeal HMS claim findings and to pursue additional appeals if the initial appeal is found in favor of HMS’s customer. The appeal process established under the Medicare RAC contract with CMS includes
five
levels of appeals, and resolution of appeals can take substantial time to resolve. HMS records a) a return obligation liability for findings which have been adjudicated in favor of providers and b) an estimated return obligation liability based on the amount of revenue that is subject to appeals and which are probable of being adjudicated in favor of providers following their successful appeal. The Company’s estimate is based on the Company’s historical experience. To the extent the amount to be returned to providers following a successful appeal exceeds or is less than the amount recorded, revenue in the applicable period would be reduced or increased by such amount. Any future changes to any of the Company’s customer contracts, including modifications to the Medicare RAC contract,
may
require the Company to apply different assumptions that could materially affect both the Company’s revenue and estimated liability for appeals in future periods.

The Company’s original Medicare RAC contract with CMS expired on
January 31, 2018.
As a result of the contract expiration, the Company’s contractual obligation with respect to any appeals resolved in favor of providers subsequent to the expiration date have ceased and therefore the Company released its estimated liability and increased revenue by
$8.4
million during the
first
quarter of
2018.
The Company continues to assess the remaining Medicare RAC liability to determine management’s best estimate of liability for any findings which have been previously adjudicated prior to the expiration of the contract.

The total estimated liability for appeals balance of
$22.2
million and
$30.8
million as of
September 30, 2018
and
December 31, 2017,
respectively, includes
$19.4
million and
$19.3
million, respectively, of Medicare RAC claim findings which have been adjudicated in favor of providers, and
$0.0
million and
$8.5
million, respectively, of the Company’s estimate of the potential amount of Medicare RAC repayments that are probable of being adjudicated in favor of providers following a successful appeal. Additionally, the total estimated liability for appeals balance includes
$2.8
million and
$3.2
million related to commercial customers claim appeals. The provision included in the estimated liability for appeals is an offset to revenue in the Company’s Consolidated Statements of Income.

A summary of the activity in the estimated liability for appeals related to the Company’s original Medicare RAC contract was as follows
(in thousands)
:

September 30,

2018

Balance--beginning of period

$

8,544

Provision

-

Appeals found in providers favor

(108

)

Release of liability

(8,436

)

Balance--end of period

$

-

X

- Definition
The entire disclosure for estimated liability and allowance for appeals.
+ References
No definition available.
+ Details

Name: hmsy_EstimatedLiabilityAndAllowanceForAppealsTextBlock

Namespace Prefix: hmsy_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_DisclosureTextBlockAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 40 R16.htm IDEA: XBRL DOCUMENT v3.10.0.1

Note 10 - Credit Agreement
9 Months Ended

Sep. 30, 2018

Notes to Financial Statements

Debt Disclosure [Text Block]

10.

Credit Agreement

In
December 2017,
the Company entered into an amendment to its Credit Agreement, which, among other things, extended the maturity of its then existing
$500
million revolving credit facility by
five
years to
December 2022 (
the “Amended Revolving Facility”). The availability of funds under the Amended Revolving Facility includes sublimits for (a) up to
$50
million for the issuance of letters of credit and (b) up to
$25
million for swingline loans. In addition, the Company
may
increase the commitments under the Amended Revolving Facility and/or add
one
or more incremental term loan facilities, provided that such incremental facilities do
not
exceed in the aggregate the sum of (i) the greater of
$120
million and
100%
of Consolidated EBITDA (as defined in the Credit Agreement) and (ii) an additional amount so long as our
first
lien leverage ratio (as defined in the Credit Agreement) on a pro forma basis is
not
greater than
3.00:1.00,
subject to obtaining commitments from lenders therefor and meeting certain other conditions.

As of
September 30, 2018
and
December 31, 2017,
the outstanding principal balance due on the Amended Revolving Facility was
$240.0
million.
No
principal payments were made against the Company’s Amended Revolving Facility during the
nine
months ended
September 30, 2018.

Borrowings under the Amended Revolving Facility bear interest at a rate equal to, at the Company’s election (except with respect to swingline borrowings, which will accrue interest based only at the base rate), either:

▪

a base rate determined by reference to the greatest of (a) the prime or base commercial lending rate of the administrative agent as in effect on the relevant date, (b) the federal funds effective rate plus
0.50%
and (c) the
one
-month LIBO Rate plus
1.00%,

plus
an interest margin ranging from
0.50%
to
1.00%
based on the Company’s consolidated leverage ratio for the applicable period; or

▪

an adjusted LIBO Rate, equal to the LIBO Rate for the applicable interest period multiplied by the statutory reserve rate (equal to (
x
)
one
divided by (y)
one
minus the aggregate of the maximum reserve percentage (including any marginal, special, emergency or supplemental reserves) established by the Board of Governors of the Federal Reserve System of the United States),
plus
an interest margin ranging from
1.50%
to
2.00%
based on the Company’s consolidated leverage ratio for the applicable period.

In addition to paying interest on the outstanding principal, the Company is required to pay unused commitment fees on the Amended Revolving Facility during the term of the Credit Agreement ranging from
0.375%
to
0.250%
per annum based on the Company’s consolidated leverage ratio and letter of credit fees equal to
0.125%
per annum on the aggregate face amount of each letter of credit, as well as customary agency fees.

The Amended Revolving Facility is secured, subject to certain customary carve-outs and exceptions, by a
first
priority lien and security interest in substantially all tangible and intangible assets of the Company and certain subsidiaries of the Company. The Amended Revolving Facility contains certain restrictive covenants, which affect, among other things, the ability of the Company and its subsidiaries to incur indebtedness, create liens, make investments, sell or otherwise dispose of assets, engage in mergers or consolidations with other entities, and pay dividends or repurchase stock. The Company is also required to comply, on a quarterly basis, with
two
financial covenants: (i) a minimum interest coverage ratio of
3:00:1:00,
and (ii) a maximum consolidated leverage ratio of
4.75:1.00
through
December 2019
and
4.25:1.00
from and after
January 2020.
The consolidated leverage ratio is subject to a step-up to
5.25:1.00
for
four
full consecutive fiscal quarters following a permitted acquisition or similar investment. As of
September 30, 2018,
the Company was in compliance with all terms of the Credit Agreement.

Interest expense and the commitment fees on the unused portion of the Company’s revolving credit facility were as follows (
in thousands
):

Three Months Ended

September 30,

Nine Months Ended

September 30,

2018

2017

2018

2017

Interest expense

$

2,527

$

2,230

$

7,224

$

5,072

Commitment fees

211

325

688

1,036

As of
September 30, 2018
and
December 31, 2017,
the unamortized balance of deferred origination fees and debt issuance costs was
$2.4
million and
$2.8
million, respectively. For the
nine
month periods ended
September 30, 2018
and
2017,
HMS amortized
$0.4
million and
$1.0
million, respectively, of interest expense related to the Company’s deferred origination fees and debt issue costs.

Although HMS expects that operating cash flows will continue to be a primary source of liquidity for the Company’s operating needs, the Amended Revolving Facility
may
be used for general corporate purposes, including, but
not
limited to acquisitions, if necessary.

X

- Definition
The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-URI http://asc.fasb.org/topic&trid=2208564
+ Details

Name: us-gaap_DebtDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_DisclosureTextBlockAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 41 R17.htm IDEA: XBRL DOCUMENT v3.10.0.1

Note 11 - Earnings Per Share
9 Months Ended

Sep. 30, 2018

Notes to Financial Statements

Earnings Per Share [Text Block]

11.

Earnings Per Share

The following table reconciles the basic to diluted weighted average common shares outstanding using the treasury stock method
(in thousands, except per share amounts)
:

Three Months Ended

September 30,

Nine Months Ended

September 30,

2018

2017

2018

2017

Net income

$

18,574

$

6,372

$

21,598

$

14,331

Weighted average common shares outstanding-basic

83,509

83,923

83,373

83,778

Plus: net effect of dilutive stock options and restricted stock units

1,635

1,807

1,868

1,808

Weighted average common shares outstanding-diluted

85,144

85,730

85,241

85,586

Net income per common share-basic

$

0.22

$

0.08

$

0.26

$

0.17

Net income per common share-diluted

$

0.22

$

0.07

$

0.25

$

0.17

For the
three
months ended
September 30, 2018
and
2017,

21,105
and
2,642,548
stock options, respectively, were
not
included in the diluted earnings per share calculation because the effect would have been anti-dilutive. For the
three
months ended
September 30, 2018
and
2017,
restricted stock units representing
202
and
84,360
shares of common stock, respectively, were
not
included in the diluted earnings per share calculation because the effect would have been anti-dilutive.

For the
nine
months ended
September 30, 2018
and
2017,

531,378
and
2,132,017
stock options, respectively, were
not
included in the diluted earnings per share calculation because the effect would have been anti-dilutive. For the
nine
months ended
September 30, 2018
and
2017,
restricted stock units representing
595
and
63,452
shares of common stock, respectively, were
not
included in the diluted earnings per share calculation because the effect would have been anti-dilutive.

X

- References
No definition available.
+ Details

Name: us-gaap_DisclosureTextBlockAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for earnings per share.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-URI http://asc.fasb.org/topic&trid=2144383
+ Details

Name: us-gaap_EarningsPerShareTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 42 R18.htm IDEA: XBRL DOCUMENT v3.10.0.1

Note 12 - Stock-based Compensation
9 Months Ended

Sep. 30, 2018

Notes to Financial Statements

Disclosure of Compensation Related Costs, Share-based Payments [Text Block]

12.

Stock-Based Compensation

(a)

Stock-Based Compensation Expense

Total stock-based compensation expense in the Company’s unaudited Consolidated Statements of Income related to the Company’s long-term incentive award plans was as follows
(in thousands)
:

Three Months Ended

September 30,

Nine Months Ended

September 30,

2018

2017

2018

2017

Cost of services-compensation

$

1,537

$

1,851

$

5,802

$

5,353

Selling, general and administrative

1,900

5,531

11,843

11,408

Total

$

3,437

$

7,382

$

17,645

$

16,761

(b)

Stock Options

Stock-based compensation expense related to stock options was approximately
$1.6
million and
$3.2
million for the
three
months ended
September 30, 2018
and
2017,
respectively. Stock-based compensation expense related to stock options was approximately
$7.6
million and
$7.1
million for the
nine
months ended
September 30, 2018
and
2017,
respectively.

Presented below is a summary of stock option activity for the
nine
months ended
September 30, 2018 (
in thousands except for weighted average exercise price and weighted average remaining contractual terms
):

Number

of

Options

Weighted

Average

Exercise

Price

Weighted

Average

Remaining

Contractual

Terms

Aggregate

Intrinsic

Value

Outstanding balance at December 31, 2017

5,554

$

17.35

Granted

1,010

19.58

Exercised

(686

)

21.13

Forfeitures

(100

)

17.64

Expired

(30

)

22.21

Outstanding balance at September 30, 2018

5,748

17.33

5.41

$

88,909

Expected to vest at September 30, 2018

1,561

17.65

7.79

$

23,669

Exercisable at September 30, 2018

3,373

$

17.13

3.76

$

52,900

During the
three
months ended
September 30, 2018
and
2017,
the Company issued
535,077
and
40,734
shares, respectively, of the Company’s common stock upon the exercise of outstanding stock options and received proceeds of
$12.1
million and
$0.8
million, respectively. The total intrinsic value of stock options exercised during the
three
months ended
September 30, 2018
and
2017
was
$4.0
million and
$0.3
million, respectively. During the
nine
months ended
September 30, 2018
and
2017,
the Company issued
686,111
and
173,539
shares, respectively, of the Company’s common stock upon the exercise of outstanding stock options and received proceeds of
$13.7
million and
$2.7
million, respectively. The total intrinsic value of stock options exercised during the
nine
months ended
September 30, 2018
and
2017
was
$4.7
million and
$0.6
million, respectively.

As of
September 30, 2018,
there was approximately
$7.6
million of total unrecognized compensation cost related to stock options outstanding, which is expected to be recognized over a weighted average period of
2.1
years.

The weighted-average grant date fair value per share of the stock options granted during the
nine
months ended
September 30, 2018
and
2017
was
$7.52
and
$7.68,
respectively. HMS estimated the fair value of each stock option grant on the date of grant using a Black-Scholes option pricing model and weighted–average assumptions set forth in the following table:

Nine Months

Ended September 30,

2018

2017

Expected dividend yield

0

%

0

%

Risk-free interest rate

2.68

%

1.74

%

Expected volatility

42.43

%

44.23

%

Expected life (years)

6.00

5.00

The total tax benefits recognized on stock-based compensation for the
three
and
nine
months ended
September 30, 2018
was
$1.0
million and
$3.5
million, respectively. The total tax benefits recognized on stock-based compensation for the
three
and
nine
months ended
September 30, 2017
was
$0.0
and
$3.6
million, respectively.

(c)

Restricted Stock Units

Stock-based compensation expense related to restricted stock units was approximately
$1.9
million and
$4.2
million for the
three
months ended
September 30, 2018
and
2017,
respectively. Stock-based compensation expense related to restricted stock units was approximately
$10.0
million and
$9.7
million for the
nine
months ended
September 30, 2018
and
2017,
respectively.

Presented below is a summary of restricted stock units activity for the
nine
months ended
September 30, 2018
(in thousands, except for weighted average grant date fair value per unit):

Number of

Units

Weighted
Average

Grant Date Fair

Value per Unit

Outstanding balance at December 31, 2017

1,346

$

17.65

Granted

763

16.76

Vesting of restricted stock units, net of units withheld for taxes

(367

)

17.00

Units withheld for taxes

(163

)

17.00

Forfeitures

(70

)

17.26

Outstanding balance at September 30, 2018

1,509

$

19.98

For the
three
months ended
September 30, 2018
and
2017,
HMS granted
1,794
and
59,784
restricted stock units, respectively, with an aggregate fair market value of
$58,861
and
$1.0
million, respectively. For the
nine
months ended
September 30, 2018
and
2017,
HMS granted
762,877
and
599,441
restricted stock units, respectively, with an aggregate fair market value of
$12.8
million and
$11.3
million, respectively.

As of
September 30, 2018,
1,281,206
restricted stock units remained unvested and there was approximately
$11.3
million of unrecognized compensation cost related to restricted stock units, which is expected to be recognized over a weighted average vesting period of
1.13
years.

X

- Definition
The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-URI http://asc.fasb.org/topic&trid=2228938

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 50
-URI http://asc.fasb.org/subtopic&trid=2208855
+ Details

Name: us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_DisclosureTextBlockAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 43 R19.htm IDEA: XBRL DOCUMENT v3.10.0.1

Note 13 - Commitments and Contingencies
9 Months Ended

Sep. 30, 2018

Notes to Financial Statements

Commitments and Contingencies Disclosure [Text Block]

13.

Commitments and Contingencies

In
July 2012,
Dennis Demetre and Lori Lewis (the “Plaintiffs”), filed an action in the Supreme Court of the State of New York against HMS Holdings Corp., claiming an undetermined amount of damages alleging that various actions by HMS unlawfully deprived the Plaintiffs of the acquisition earn-out portion of the purchase price for Allied Management Group Special Investigation Unit (“AMG”) under the applicable Stock Purchase Agreement (the “SPA”) and that HMS had breached certain contractual provisions under the SPA. The Plaintiffs filed a
second
amended complaint with
two
causes of action for breach of contract and
one
cause of action for breach of implied covenant of good faith and fair dealing. HMS asserted a counterclaim against Plaintiffs for breach of contract based on contractual indemnification costs, including attorneys’ fees arising out of the Company’s defense of AMG in Kern Health Systems v. AMG, Dennis Demetre and Lori Lewis (the “California Action”), which are recoverable under the SPA. In
June 2016,
Kern Health Systems and AMG entered into a settlement agreement that resolved all claims in the California Action. In
July 2017,
the Court issued a decision on the Company’s motion for partial summary judgment and granted the motion in part, dismissing
one
of Plaintiffs’ breach of contract causes of action against HMS. On
November 3, 2017,
following a jury trial, a verdict was returned in favor of the Plaintiffs on a breach of contract claim, and the jury awarded
$60
million in damages to the Plaintiffs. On
March 14, 2018,
the Court held a hearing on the Company’s post-trial motion for an order granting it judgment notwithstanding the verdict or, alternatively, setting aside the jury’s award of damages. On
June 27, 2018,
prior to the Court issuing a decision on the motion, the Company entered into a Settlement Agreement (the “Settlement Agreement”) with the Plaintiffs, John Alfred Lewis and Christopher Brandon Lewis. Pursuant to the terms of the Settlement Agreement, the Company paid
$20
million to resolve all matters in controversy pertaining to the lawsuit. On
July 5, 2018,
the Court entered an order to discontinue the lawsuit pursuant to the Stipulation of Discontinuance with Prejudice filed by the parties.

In
February 2018,
the Company received a Civil Investigative Demand (“CID”) from the Texas Attorney General, purporting to investigate possible unspecified violations of the Texas Medicaid Fraud Prevention Act. The Company has provided certain documents and information in
March 2018
in response to the CID and continues to cooperate with the government. HMS has
not
received any further requests for information in connection with this CID.

On
September 11, 2018,
a former employee filed an action in the New York County Supreme Court entitled
Christopher Frey v. Health Management Systems, Inc.
alleging retaliation under New York law. The complaint seeks recovery of an unspecified amount of monetary damages, including back pay and other compensatory and equitable relief. The Company believes this claim is without merit and intends to vigorously defend this matter.

From time to time, HMS
may
be subject to investigations, legal proceedings and other disputes arising in the ordinary course of the Company’s business, including but
not
limited to regulatory audits, billing and contractual disputes, employment-related matters and post-closing disputes related to acquisitions. Due to the Company’s contractual relationships, including those with federal and state government entities, HMS’s operations, billing and business practices are subject to scrutiny and audit by those entities and other multiple agencies and levels of government, as well as to frequent transitions and changes in the personnel responsible for oversight of the Company’s contractual performance. HMS
may
have contractual disputes with its customers arising from differing interpretations of contractual provisions that define the Company’s rights, obligations, scope of work or terms of payment, and with associated claims of liability for inaccurate or improper billing for reimbursement of contract fees, or for sanctions or damages for alleged performance deficiencies. Resolution of such disputes
may
involve litigation or
may
require that HMS accept some amount of loss or liability in order to avoid customer abrasion, negative marketplace perceptions and other disadvantageous results that could affect the Company’s business, financial condition, results of operations and cash flows.

HMS records accruals for outstanding legal matters when it believes it is probable that a loss will be incurred and the amount can be reasonably estimated. The Company evaluates, on a quarterly basis, developments in legal matters that could affect the amount of any accrual and developments that would make a loss contingency both probable and reasonably estimable. If a loss contingency is
not
both probable and estimable, HMS does
not
establish an accrued liability.

X

- Definition
The entire disclosure for commitments and contingencies.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-URI http://asc.fasb.org/topic&trid=2127136

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 440
-URI http://asc.fasb.org/topic&trid=2144648
+ Details

Name: us-gaap_CommitmentsAndContingenciesDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_DisclosureTextBlockAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 44 R20.htm IDEA: XBRL DOCUMENT v3.10.0.1

Note 14 - Subsequent Events
9 Months Ended

Sep. 30, 2018

Notes to Financial Statements

Subsequent Events [Text Block]

14.

Subsequent Events

In connection with the preparation of these unaudited Consolidated Financial Statements, an evaluation of subsequent events was performed through the date of filing and there were
no
events that have occurred that would require adjustments to the financial statements or disclosures.

X

- References
No definition available.
+ Details

Name: us-gaap_DisclosureTextBlockAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 855
-URI http://asc.fasb.org/topic&trid=2122774
+ Details

Name: us-gaap_SubsequentEventsTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 45 R21.htm IDEA: XBRL DOCUMENT v3.10.0.1

Significant Accounting Policies (Policies)
9 Months Ended

Sep. 30, 2018

Accounting Policies [Abstract]

New Accounting Pronouncements, Policy [Policy Text Block]
Recently Adopted Accounting Pronouncements

In
May 2014,
the FASB issued ASU
2014
-
09,

Revenue from Contracts with Customers
(Topic
606
) (“ASU
2014
-
09”
), which is the new comprehensive revenue recognition standard that supersedes all existing revenue recognition guidance under U.S. GAAP. The Company adopted ASU
2014
-
09
on
January 1, 2018
using the modified retrospective method and the Company recognized the cumulative effect of initially applying the new revenue standard as an adjustment to the opening balance of retained earnings. The financial information for comparative prior periods has
not
been restated and continues to be reported under the accounting standards in effect for those periods. The effect of adopting ASU
2014
-
09
in the current annual reporting period as compared with the guidance that was in effect before the change is immaterial. The Company’s internal control framework did
not
materially change, but existing internal controls were modified due to certain changes to business processes and systems to support the new revenue recognition standard as necessary. The Company continues to expect the impact of the adoption of the new standard to be immaterial to its net income and its internal control framework on an ongoing basis.

In
August 2016,
the FASB issued ASU
No.

2016
-
15,

Statements of Cash Flows (Topic
230
): Classification of Certain Cash Receipts and Cash Payments
(“ASU
2016
-
15”
)
.
ASU
2016
-
15
clarifies where certain cash receipts and cash payments are presented and classified in the statement of cash flows. The amendments are effective for annual reporting periods beginning after
December 15, 2017,
and for interim reporting periods within such annual periods. The Company adopted this guidance on
January 1, 2018.
The adoption of this guidance did
not
have an effect on the Company’s consolidated financial statements.

In
January 2017,
the FASB issued ASU
No.

2017
-
01,

Business Combinations (Topic
805
) – Clarifying the Definition of a Business
(“ASU
2017
-
01”
). ASU
2017
-
01
finalizes previous proposals regarding shareholder concerns that the definition of a business is applied too broadly. The guidance assists entities with evaluating whether transactions should be accounted for as acquisitions of assets or of businesses. The amendments are effective for annual periods beginning after
December 15, 2017,
including interim periods within those periods. The Company adopted this guidance on
January 1, 2018.
The adoption of this guidance did
not
have a material effect on the Company’s consolidated financial statements.

In
May 2017,
the FASB issued ASU
No.

2017
-
09,

Compensation – Stock Compensation (Topic
718
) – Scope of Modification Accounting,
(“ASU
2017
-
09”
). ASU
2017
-
09
requires entities to apply modification accounting to changes made to a share-based payment award. The new guidance specifies that entities will apply modification accounting to changes to a share-based payment award only if any of the following are
not
the same immediately before and after the change:
1
) The award’s fair value (or calculated value or intrinsic value, if those measurement methods are used),
2
) the award’s vesting conditions, and
3
) the award’s classification as an equity or liability instrument. ASU
2017
-
09
is effective for annual reporting periods beginning after
December 15, 2017,
including interim periods within such annual periods, with early adoption permitted. The Company adopted this guidance on
January 1, 2018.
The adoption of this guidance did
not
have a material effect on the Company’s consolidated financial statements.

Recently Issued Accounting Pronouncements

In
February 2016,
the FASB issued ASU
No.

2016
-
02,

Leases (Topic
842
)
(“ASU
2016
-
02”
). ASU
2016
-
02
will require most lessees to recognize a majority of the company’s leases on the balance sheet, which will increase reported assets and liabilities. ASU
2016
-
02
is effective for annual reporting periods beginning after
December 15, 2018
including interim periods within such annual reporting periods with early adoption permitted. The Company has
not
early adopted this guidance. The Company developed a preliminary implementation plan and has reviewed historical lease agreements in order to quantify the impact of adoption. Based upon the Company’s on-going analysis to date, the Company currently expects that there will be a material increase to total assets and total liabilities on the Company’s consolidated balance sheet upon adoption; however, the Company continues to perform the necessary additional reviews and other implementation considerations in order to appropriately quantify the changes. The Company has elected to use the FASB’s optional transition method.The Company expects to complete the on-going analysis and quantification by the end of the
fourth
quarter of
2018.

In
January 2017,
the FASB issued ASU
No.

2017
-
04,

Goodwill and Other (Topic
350
): Simplifying the Test for Goodwill Impairment
(“ASU
2017
-
04”
). This amendment simplifies the manner in which an entity is required to test for goodwill impairment by eliminating Step
2
from the goodwill impairment test. Step
2
measures goodwill impairment loss by comparing the implied fair value of a reporting unit’s goodwill with the carrying amount of that goodwill. The amendment simplifies this approach by having the entity (
1
) perform its annual or interim goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount, and (
2
) recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value, with the understanding that the loss recognized should
not
exceed the total amount of goodwill allocated to that reporting unit. The amendment is effective for public entities that are SEC filers prospectively for their annual, or any interim, goodwill impairment tests in fiscal years beginning after
December 15, 2019.
Early adoption is permitted for all entities for interim or annual goodwill impairment tests performed on testing dates after
January 1, 2017.
The Company is currently evaluating the impact on the Company’s financial statements of adopting this guidance but this guidance is
not
expected to have a material impact on the Company’s financial position, results of operations or internal control framework.

In
June 2018,
the FASB issued ASU
No.

2018
-
07,

Compensation – Stock Compensation (Topic
718
) – Improvements to Nonemployee Share-Based Payment Accounting,
(“ASU
2018
-
07”
). ASU
2018
-
07
requires entities to apply similar accounting for share-based payment transactions with non-employees as with share-based payment transactions with employees. ASU
2018
-
07
is effective for public entities for fiscal year beginning after
December 15, 2018,
including interim periods within that fiscal year. Early adoption is permitted. The Company is currently evaluating the impact on the Company’s financial statements of adopting this guidance but this guidance is
not
expected to have a material impact on the Company’s financial position, results of operations or internal control framework.

On
August 17, 2018
the SEC issued SEC Final Rule Release
No.

33
-
10532,

Disclosure Update and Simplification
(“Final Rule”). The final rule amends certain disclosure requirements to facilitate the disclosure of information to investors and simplify compliance without significantly altering the total mix of information provided to investors. The final rule is effective for public entities that are SEC filers on
November 5, 2018.
The Company is currently evaluating the impact of adopting this guidance but this guidance is
not
expected to have a material impact on the Company’s disclosures.

X

- References
No definition available.
+ Details

Name: us-gaap_AccountingPoliciesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.
+ References
No definition available.
+ Details

Name: us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 46 R22.htm IDEA: XBRL DOCUMENT v3.10.0.1

Note 3 - Revenue Recognition (Tables)
9 Months Ended

Sep. 30, 2018

Notes Tables

Disaggregation of Revenue [Table Text Block]

Three Months Ended

September 30

Nine Months Ended

September 30

2018

2017

2018

2017

Coordination of benefits

$

105,694

$

90,073

$

298,201

$

277,018

Analytical services

48,552

35,600

144,261

95,701

Total

$

154,246

$

125,673

$

442,462

$

372,719

X

- Definition
Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=109196051&loc=SL49130545-203045
+ Details

Name: us-gaap_DisaggregationOfRevenueTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_TableTextBlock

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 47 R23.htm IDEA: XBRL DOCUMENT v3.10.0.1

Note 4 - Accounts Receivable and Accounts Receivable Allowance (Tables)
9 Months Ended

Sep. 30, 2018

Notes Tables

Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]

September 30,

2018

December 31,

2017

Accounts receivable

$

218,737

$

204,259

Allowance

(16,239

)

(14,799

)

Accounts receivable, net

$

202,498

$

189,460

Movement in Valuation Allowances and Reserves Roll Forward [Table Text Block]

September 30,
2018

December 31,
2017

Balance--beginning of period

$

14,799

$

10,772

Provision

16,107

20,233

Charge-offs

(14,667

)

(16,206

)

Balance--end of period

$

16,239

$

14,799

X

- Definition
Represents the schedule of movement in valuation allowances and reserves roll forward.
+ References
No definition available.
+ Details

Name: hmsy_MovementInValuationAllowancesAndReservesRollForwardTableTextBlock

Namespace Prefix: hmsy_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.3,4)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_TableTextBlock

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 48 R24.htm IDEA: XBRL DOCUMENT v3.10.0.1

Note 5 - Acquisition (Tables)
9 Months Ended

Sep. 30, 2018

Notes Tables

Schedule of Business Acquisitions, by Acquisition [Table Text Block]

Cash and cash equivalents

$

435

Accounts receivable

8,902

Prepaid expenses

1,427

Property and equipment

1,146

Intangible assets

76,240

Goodwill

107,754

Other assets

63

Accounts payable

(2,620

)

Deferred tax liability

(19,681

)

Other liabilities

(2,057

)

Total purchase price

$

171,609

Schedule of Acquired Finite-Lived Intangible Assets by Major Class [Table Text Block]

Useful Life
(in years)

Customer relationships

15

$

56,200

Intellectual property

6

19,600

Trade name

1.5

310

Restrictive covenants

1

130

Fair value of intangibles acquired

$

76,240

Business Combination, Separately Recognized Transactions [Table Text Block]

Other operating expenses - consulting fees

$

3,515

Other operating expenses - legal fees

832

Other operating expenses - transaction costs

185

Acquisition-related costs

$

4,532

X

- Definition
Tabular disclosure of transactions that are recognized separately from the acquisition of assets and assumptions of liabilities in the business combination.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463
+ Details

Name: us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the characteristics, including initial carrying value, residual amount, weighted average useful life, of finite-lived intangible assets acquired during the period by major class. A major class is composed of intangible assets that can be grouped together because they are similar, either by nature or by their use in the operations of the company.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275
+ Details

Name: us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463
+ Details

Name: us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_TableTextBlock

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 49 R25.htm IDEA: XBRL DOCUMENT v3.10.0.1

Note 6 - Intangible Assets and Goodwill (Tables)
9 Months Ended

Sep. 30, 2018

Notes Tables

Schedule of Finite-Lived Intangible Assets [Table Text Block]

Gross

Carrying

Amount

Accumulated

Amortization

Net Carrying

Amount

Weighted

Average

Amortization

Period (in years)

September 30, 2018

Customer relationships

$

156,790

$

(100,758

)

$

56,032

12.4

Trade names

16,246

(15,724

)

522

0.3

Intellectual property

21,700

(5,701

)

15,999

4.3

Restrictive covenants

263

(223

)

40

0.9

Total

$

194,999

$

(122,406

)

$

72,593

Gross

Carrying

Amount

Accumulated

Amortization

Net Carrying

Amount

Weighted

Average

Amortization

Period (in years)

December 31, 2017

Customer relationships

$

159,290

$

(89,106

)

$

70,184

11.3

Trade names

16,246

(13,916

)

2,330

1

Intellectual property

21,700

(2,874

)

18,826

5.2

Restrictive covenants

263

(121

)

142

1.3

Total

$

197,499

$

(106,017

)

$

91,482

Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]

Year ending December 31,

2018

$

5,452

2019

9,195

2020

7,664

2021

7,197

2022

7,197

Thereafter

35,888

Total

$

72,593

X

- Definition
Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275
+ Details

Name: us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275
+ Details

Name: us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_TableTextBlock

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 50 R26.htm IDEA: XBRL DOCUMENT v3.10.0.1

Note 7 - Accounts Payable, Accrued Expenses and Other Liabilities (Tables)
9 Months Ended

Sep. 30, 2018

Notes Tables

Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]

September 30,

2018

December 31,

2017

Accounts payable, trade

$

13,850

$

19,330

Accrued compensation and other

32,372

24,072

Accrued operating expenses

18,073

18,498

Total accounts payable, accrued expenses and other liabilities

$

64,295

$

61,900

X

- Definition
Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.
+ References
No definition available.
+ Details

Name: us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_TableTextBlock

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 51 R27.htm IDEA: XBRL DOCUMENT v3.10.0.1

Note 9 - Estimated Liability for Appeals (Tables)
9 Months Ended

Sep. 30, 2018

Notes Tables

Valuation and Qualifying Accounts Disclosure [Table Text Block]

September 30,

2018

Balance--beginning of period

$

8,544

Provision

-

Appeals found in providers favor

(108

)

Release of liability

(8,436

)

Balance--end of period

$

-

X

- Definition
A schedule of allowance and reserve accounts including their beginning and ending balances, as well as a reconciliation by type of activity during the period. Alternatively, disclosure of the required information may be within the footnotes to the financial statements or a supplemental schedule to the financial statements.
+ References
No definition available.
+ Details

Name: hmsy_ValuationAndQualifyingAccountsDisclosureTableTextBlock

Namespace Prefix: hmsy_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_TableTextBlock

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 52 R28.htm IDEA: XBRL DOCUMENT v3.10.0.1

Note 10 - Credit Agreement (Tables)
9 Months Ended

Sep. 30, 2018

Notes Tables

Schedule of Interest Expense and Commitment Fees on Debt Instrument [Table Text Block]

Three Months Ended

September 30,

Nine Months Ended

September 30,

2018

2017

2018

2017

Interest expense

$

2,527

$

2,230

$

7,224

$

5,072

Commitment fees

211

325

688

1,036

X

- Definition
Tabular disclosure of interest expense and commitment fees related to debt instrument.
+ References
No definition available.
+ Details

Name: hmsy_ScheduleOfInterestExpenseAndCommitmentFeesOnDebtInstrumentTableTextBlock

Namespace Prefix: hmsy_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_TableTextBlock

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 53 R29.htm IDEA: XBRL DOCUMENT v3.10.0.1

Note 11 - Earnings Per Share (Tables)
9 Months Ended

Sep. 30, 2018

Notes Tables

Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]

Three Months Ended

September 30,

Nine Months Ended

September 30,

2018

2017

2018

2017

Net income

$

18,574

$

6,372

$

21,598

$

14,331

Weighted average common shares outstanding-basic

83,509

83,923

83,373

83,778

Plus: net effect of dilutive stock options and restricted stock units

1,635

1,807

1,868

1,808

Weighted average common shares outstanding-diluted

85,144

85,730

85,241

85,586

Net income per common share-basic

$

0.22

$

0.08

$

0.26

$

0.17

Net income per common share-diluted

$

0.22

$

0.07

$

0.25

$

0.17

X

- Definition
Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257
+ Details

Name: us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_TableTextBlock

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 54 R30.htm IDEA: XBRL DOCUMENT v3.10.0.1

Note 12 - Stock-based Compensation (Tables)
9 Months Ended

Sep. 30, 2018

Notes Tables

Schedule of Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs by Plan [Table Text Block]

Three Months Ended

September 30,

Nine Months Ended

September 30,

2018

2017

2018

2017

Cost of services-compensation

$

1,537

$

1,851

$

5,802

$

5,353

Selling, general and administrative

1,900

5,531

11,843

11,408

Total

$

3,437

$

7,382

$

17,645

$

16,761

Share-based Compensation, Stock Options, Activity [Table Text Block]

Number

of

Options

Weighted

Average

Exercise

Price

Weighted

Average

Remaining

Contractual

Terms

Aggregate

Intrinsic

Value

Outstanding balance at December 31, 2017

5,554

$

17.35

Granted

1,010

19.58

Exercised

(686

)

21.13

Forfeitures

(100

)

17.64

Expired

(30

)

22.21

Outstanding balance at September 30, 2018

5,748

17.33

5.41

$

88,909

Expected to vest at September 30, 2018

1,561

17.65

7.79

$

23,669

Exercisable at September 30, 2018

3,373

$

17.13

3.76

$

52,900

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]

Nine Months

Ended September 30,

2018

2017

Expected dividend yield

0

%

0

%

Risk-free interest rate

2.68

%

1.74

%

Expected volatility

42.43

%

44.23

%

Expected life (years)

6.00

5.00

Schedule of Share-based Compensation, Restricted Stock Units Award Activity [Table Text Block]

Number of

Units

Weighted
Average

Grant Date Fair

Value per Unit

Outstanding balance at December 31, 2017

1,346

$

17.65

Granted

763

16.76

Vesting of restricted stock units, net of units withheld for taxes

(367

)

17.00

Units withheld for taxes

(163

)

17.00

Forfeitures

(70

)

17.26

Outstanding balance at September 30, 2018

1,509

$

19.98

X

- Definition
Tabular disclosure of the amount of total share-based compensation cost, including the amounts attributable to each share-based compensation plan and any related tax benefits.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (h)(1)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901
+ Details

Name: us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901
+ Details

Name: us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901
+ Details

Name: us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901
+ Details

Name: us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_TableTextBlock

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 55 R31.htm IDEA: XBRL DOCUMENT v3.10.0.1

Note 1 - Business and Summary of Significant Accounting Policies (Details Textual)

Sep. 30, 2018

Number of Businesses 1

X

- Definition
Represents number of businesses.
+ References
No definition available.
+ Details

Name: hmsy_NumberOfBusinesses

Namespace Prefix: hmsy_

Data Type: xbrli:integerItemType

Balance Type: na

Period Type: instant

XML 56 R32.htm IDEA: XBRL DOCUMENT v3.10.0.1

Note 2 - Fair Value of Financial Instruments (Details Textual) - USD ($)

Sep. 30, 2018

Jun. 30, 2018

Other Liabilities [Member] | Fair Value, Inputs, Level 3 [Member]

Business Combination, Contingent Consideration, Liability, Total $ 0 $ 35,000

X

- Definition
Amount of liability recognized arising from contingent consideration in a business combination.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 35
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=6911338&loc=d3e6819-128478

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 25
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476
+ Details

Name: us-gaap_BusinessCombinationContingentConsiderationLiability

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 57 R33.htm IDEA: XBRL DOCUMENT v3.10.0.1

Note 3 - Revenue Recognition (Details Textual) - USD ($)
$ in Thousands
9 Months Ended

Sep. 30, 2018

Jan. 01, 2018

Dec. 31, 2017

Retained Earnings (Accumulated Deficit), Ending Balance $ 389,189 $ 366,164

Care Management and Consumer Engagement Services [Member] | Transferred over Time [Member] | Accounts payable, Accrued Expenses and Other liabilities [Member]

Revenue, Remaining Performance Obligation, Amount $ 5,200 $ 6,400

Accounting Standards Update 2014-09 [Member]

Retained Earnings (Accumulated Deficit), Ending Balance $ 1,400

Minimum [Member]

Contracts With Customers, Term 3 years

Maximum [Member]

Contracts With Customers, Term 5 years

X

- Definition
The term of contracts the company enters with customers.
+ References
No definition available.
+ Details

Name: hmsy_ContractsWithCustomersTerm

Namespace Prefix: hmsy_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
The cumulative amount of the reporting entity's undistributed earnings or deficit.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30)(a)(3))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(23)(a)(4))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770
+ Details

Name: us-gaap_RetainedEarningsAccumulatedDeficit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of transaction price allocated to performance obligation that has not been recognized as revenue.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109196051&loc=SL49130556-203045
+ Details

Name: us-gaap_RevenueRemainingPerformanceObligation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: srt_ProductOrServiceAxis=hmsy_CareManagementAndConsumerEngagementServicesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredOverTimeMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_BalanceSheetLocationAxis=hmsy_AccountsPayableAccruedExpensesAndOtherLiabilitiesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201409Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_RangeAxis=srt_MinimumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_RangeAxis=srt_MaximumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 58 R34.htm IDEA: XBRL DOCUMENT v3.10.0.1

Note 3 - Revenue Recognition - Revenues Disaggregated by Revenue Source (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended

Sep. 30, 2018

Sep. 30, 2017

Sep. 30, 2018

Sep. 30, 2017

Revenues $ 154,246 $ 125,673 $ 442,462 $ 372,719

Coordination of Benefits [Member]

Revenues 105,694 90,073 298,201 277,018

Analytical Services [Member]

Revenues $ 48,552 $ 35,600 $ 144,261 $ 95,701

X

- Definition
Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109196051&loc=SL49130539-203045

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=109196051&loc=SL49130545-203045

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 4
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109196051&loc=SL49130543-203045
+ Details

Name: us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: srt_ProductOrServiceAxis=hmsy_CoordinationOfBenefitsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_ProductOrServiceAxis=hmsy_AnalyticalServicesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 59 R35.htm IDEA: XBRL DOCUMENT v3.10.0.1

Note 4 - Accounts Receivable and Accounts Receivable Allowance - Accounts Receivable, Net (Details) - USD ($)
$ in Thousands

Sep. 30, 2018

Dec. 31, 2017

Dec. 31, 2016

Accounts receivable $ 218,737 $ 204,259

Allowance (16,239) (14,799) $ (10,772)

Accounts receivable, net $ 202,498 $ 189,460

X

- Definition
Amounts due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer) for goods or services (including trade receivables) that have been delivered or sold in the normal course of business.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(3))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(5))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910
+ Details

Name: us-gaap_AccountsReceivableGrossCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 8
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109196051&loc=SL49130549-203045

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(3))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_AccountsReceivableNetCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
A valuation allowance for trade and other receivables due to an Entity within one year (or the normal operating cycle, whichever is longer) that are expected to be uncollectible.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=84173941&loc=d3e5074-111524

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.4)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

XML 60 R36.htm IDEA: XBRL DOCUMENT v3.10.0.1

Note 4 - Accounts Receivable and Accounts Receivable Allowance - Activity in Allowance for Doubtful Accounts (Details) - USD ($)
$ in Thousands
9 Months Ended 12 Months Ended

Sep. 30, 2018

Dec. 31, 2017

Balance--beginning of period $ 14,799 $ 10,772

Provision 16,107 20,233

Charge-offs (14,667) (16,206)

Balance--end of period $ 16,239 $ 14,799

X

- Definition
A valuation allowance for trade and other receivables due to an Entity within one year (or the normal operating cycle, whichever is longer) that are expected to be uncollectible.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=84173941&loc=d3e5074-111524

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.4)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of direct write-downs of accounts receivable charged against the allowance.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=84173941&loc=d3e5074-111524

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.4)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of expense related to write-down of receivables to the amount expected to be collected. Includes, but is not limited to, accounts receivable and notes receivable.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.5)
-URI http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 45
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=82913815&loc=SL49130534-203044
+ Details

Name: us-gaap_ProvisionForDoubtfulAccounts

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

XML 61 R37.htm IDEA: XBRL DOCUMENT v3.10.0.1

Note 5 - Acquisition (Details Textual) - Eliza Holding Corp [Member] - USD ($)
$ in Millions
9 Months Ended

Apr. 17, 2017

Sep. 30, 2018

Sep. 30, 2017

Business Acquisition, Percentage of Voting Interests Acquired 100.00%

Payments to Acquire Businesses, Gross $ 171.6

Business Acquisition, Funding Source, Cash on Hand, Percentage 75.00%

Business Acquisition, Funding Source, Existing Credit Line, Percentage 25.00%

Business Acquisition, Pro Forma Revenue $ 37.4 $ 17.5

X

- Definition
The percentage of the purchase price using cash on hand as the source of funding for a business acquisition.
+ References
No definition available.
+ Details

Name: hmsy_BusinessAcquisitionFundingSourceCashOnHandPercentage

Namespace Prefix: hmsy_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
The percentage of the purchase price using an existing credit line as the source of funding for a business acquisition.
+ References
No definition available.
+ Details

Name: hmsy_BusinessAcquisitionFundingSourceExistingCreditLinePercentage

Namespace Prefix: hmsy_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
Percentage of voting equity interests acquired at the acquisition date in the business combination.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463
+ Details

Name: us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (h)(2)
-URI http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (h)(3)
-URI http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463
+ Details

Name: us-gaap_BusinessAcquisitionsProFormaRevenue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (b)(1)
-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 13
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3213-108585
+ Details

Name: us-gaap_PaymentsToAcquireBusinessesGross

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_BusinessAcquisitionAxis=hmsy_ElizaHoldingCorpMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 62 R38.htm IDEA: XBRL DOCUMENT v3.10.0.1

Note 5 - Acquisition - Preliminary Allocation of the Purchase Price (Details) - USD ($)
$ in Thousands

Sep. 30, 2018

Dec. 31, 2017

Apr. 17, 2017

Goodwill $ 487,617 $ 487,617

Eliza Holding Corp [Member]

Cash and cash equivalents $ 435

Accounts receivable 8,902

Prepaid expenses 1,427

Property and equipment 1,146

Intangible assets 76,240

Goodwill 107,754

Other assets 63

Accounts payable (2,620)

Deferred tax liability (19,681)

Other liabilities (2,057)

Total purchase price $ 171,609

X

- Definition
Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=84161108&loc=d3e4845-128472
+ Details

Name: us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=84161108&loc=d3e4845-128472
+ Details

Name: us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=84161108&loc=d3e4845-128472
+ Details

Name: us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=84161108&loc=d3e4845-128472
+ Details

Name: us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 45
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=84176650&loc=d3e31917-109318

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=84161108&loc=d3e4845-128472
+ Details

Name: us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of intangible assets, excluding goodwill, acquired at the acquisition date.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=84161108&loc=d3e4845-128472
+ Details

Name: us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=84161108&loc=d3e4845-128472
+ Details

Name: us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=84161108&loc=d3e4845-128472
+ Details

Name: us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The amount of property, plant, and equipment recognized as of the acquisition date.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 55
-Paragraph 37
-URI http://asc.fasb.org/extlink&oid=108330185&loc=d3e2207-128464

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=84161108&loc=d3e4845-128472
+ Details

Name: us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=84161108&loc=d3e4845-128472
+ Details

Name: us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 45
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=77989000&loc=SL49117168-202975

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266
+ Details

Name: us-gaap_Goodwill

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: us-gaap_BusinessAcquisitionAxis=hmsy_ElizaHoldingCorpMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 63 R39.htm IDEA: XBRL DOCUMENT v3.10.0.1

Note 5 - Acquisition - Preliminary Purchase Price Allocated to the Intangibles Acquired (Details) - Eliza Holding Corp [Member]
$ in Thousands

Apr. 17, 2017

USD ($)

Fair value of intangibles acquired $ 76,240

Customer Relationships [Member]

Intangibles acquired, useful life (Year) 15 years

Fair value of intangibles acquired $ 56,200

Intellectual Property [Member]

Intangibles acquired, useful life (Year) 6 years

Fair value of intangibles acquired $ 19,600

Trade Names [Member]

Intangibles acquired, useful life (Year) 1 year 182 days

Fair value of intangibles acquired $ 310

Restrictive Covenant [Member]

Intangibles acquired, useful life (Year) 1 year

Fair value of intangibles acquired $ 130

X

- Definition
Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (a)(3)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275
+ Details

Name: us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275
+ Details

Name: us-gaap_FinitelivedIntangibleAssetsAcquired1

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_BusinessAcquisitionAxis=hmsy_ElizaHoldingCorpMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_IntellectualPropertyMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=hmsy_RestrictiveCovenantMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 64 R40.htm IDEA: XBRL DOCUMENT v3.10.0.1

Note 5 - Acquisition - Acquisition Costs (Details) - Cost of Services [Member] - Eliza Holding Corp [Member]
$ in Thousands

Apr. 17, 2017

USD ($)

Acquisition-related costs $ 4,532

Other Operating Expenses, Consulting Fees [Member]

Acquisition-related costs 3,515

Other Operating Expenses, Legal Fees [Member]

Acquisition-related costs 832

Other Operating Expenses, Transaction Costs [Member]

Acquisition-related costs $ 185

X

- Definition
For transactions that are recognized separately from the acquisition of assets and assumptions of liabilities in the business combination, such as related to pre-existing relationships with the acquiree, this element represents the disclosure of the amount of acquisition related costs.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463
+ Details

Name: us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: us-gaap_IncomeStatementLocationAxis=hmsy_CostOfServicesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_BusinessAcquisitionAxis=hmsy_ElizaHoldingCorpMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis=hmsy_OtherOperatingExpensesConsultingFeesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis=hmsy_OtherOperatingExpensesLegalFeesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis=hmsy_OtherOperatingExpensesTransactionCostsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 65 R41.htm IDEA: XBRL DOCUMENT v3.10.0.1

Note 6 - Intangible Assets and Goodwill (Details Textual) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended

Sep. 30, 2018

Sep. 30, 2017

Sep. 30, 2018

Sep. 30, 2017

Dec. 31, 2017

Dec. 31, 2016

Dec. 31, 2015

Amortization of Intangible Assets, Total $ 6,100 $ 6,200 $ 18,889 $ 15,947

Goodwill, Impairment Loss $ 0 $ 0 $ 0

Goodwill, Period Increase (Decrease), Total $ 0

X

- Definition
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3602-108585

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)(2)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274
+ Details

Name: us-gaap_AmortizationOfIntangibleAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 2
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=108376223&loc=d3e13854-109267

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3602-108585

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266
+ Details

Name: us-gaap_GoodwillImpairmentLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of increase (decrease) of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267
+ Details

Name: us-gaap_GoodwillPeriodIncreaseDecrease

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

XML 66 R42.htm IDEA: XBRL DOCUMENT v3.10.0.1

Note 6 - Intangible Assets and Goodwill - Summary of Intangible Assets (Details) - USD ($)
$ in Thousands
9 Months Ended 12 Months Ended

Sep. 30, 2018

Dec. 31, 2017

Gross Carrying Amount $ 194,999 $ 197,499

Accumulated Amortization (122,406) (106,017)

Net Carrying Amount 72,593 91,482

Customer Relationships [Member]

Gross Carrying Amount 156,790 159,290

Accumulated Amortization (100,758) (89,106)

Net Carrying Amount $ 56,032 $ 70,184

Useful life (Year) 12 years 146 days 11 years 109 days

Trade Names [Member]

Gross Carrying Amount $ 16,246 $ 16,246

Accumulated Amortization (15,724) (13,916)

Net Carrying Amount $ 522 $ 2,330

Useful life (Year) 109 days 1 year

Intellectual Property [Member]

Gross Carrying Amount $ 21,700 $ 21,700

Accumulated Amortization (5,701) (2,874)

Net Carrying Amount $ 15,999 $ 18,826

Useful life (Year) 4 years 109 days 5 years 73 days

Restrictive Covenant [Member]

Gross Carrying Amount $ 263 $ 263

Accumulated Amortization (223) (121)

Net Carrying Amount $ 40 $ 142

Useful life (Year) 328 days 1 year 109 days

X

- Definition
Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
No definition available.
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetUsefulLife

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 928
-SubTopic 340
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsGross

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_IntellectualPropertyMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=hmsy_RestrictiveCovenantMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 67 R43.htm IDEA: XBRL DOCUMENT v3.10.0.1

Note 6 - Intangible Assets and Goodwill - Estimated Amortization Expense of Intangible Assets (Details) - USD ($)
$ in Thousands

Sep. 30, 2018

Dec. 31, 2017

2018 $ 5,452

2019 9,195

2020 7,664

2021 7,197

2022 7,197

Thereafter 35,888

Total $ 72,593 $ 91,482

X

- Definition
Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
No definition available.
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized in the remainder of the fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
No definition available.
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)(3)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)(3)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)(3)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)(3)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

XML 68 R44.htm IDEA: XBRL DOCUMENT v3.10.0.1

Note 7 - Accounts Payable, Accrued Expenses and Other Liabilities - Summary of Accounts Payable, Accrued Expenses and Other Liabilities (Details) - USD ($)
$ in Thousands

Sep. 30, 2018

Dec. 31, 2017

Accounts payable, trade $ 13,850 $ 19,330

Accrued compensation and other 32,372 24,072

Accrued operating expenses 18,073 18,498

Total accounts payable, accrued expenses and other liabilities $ 64,295 $ 61,900

X

- Definition
Carrying value as of the balance sheet date of obligations incurred through that date and payable for operating expenses.
+ References
No definition available.
+ Details

Name: hmsy_AccruedOperatingExpenses

Namespace Prefix: hmsy_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits, and also accrued liabilities classified as other. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
+ References
No definition available.
+ Details

Name: hmsy_EmployeeRelatedLiabilitiesAndOtherLiabilitiesCurrent

Namespace Prefix: hmsy_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of liabilities incurred and payable to vendors for goods and services received, and accrued liabilities classified as other.
+ References
No definition available.
+ Details

Name: us-gaap_AccountsPayableAndOtherAccruedLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19(a))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=82887183&loc=d3e6935-107765
+ Details

Name: us-gaap_AccountsPayableTradeCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

XML 69 R45.htm IDEA: XBRL DOCUMENT v3.10.0.1

Note 8 - Income Taxes (Details Textual) - USD ($)
$ in Millions
9 Months Ended

Sep. 30, 2018

Sep. 30, 2017

Dec. 31, 2017

Effective Income Tax Rate Reconciliation, Percent, Total 21.30% 39.40%

Unrecognized Tax Benefits that Would Impact Effective Tax Rate $ 8.9 $ 8.2

Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued, Total 1.0 $ 0.6

Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense, Total 0.4 $ 0.4

Decrease in Unrecognized Tax Benefits is Reasonably Possible 3.5

State and Local Income Tax Expense (Benefit), Continuing Operations, Total $ (2.4)

Earliest Tax Year [Member] | Domestic Tax Authority [Member] | Internal Revenue Service (IRS) [Member]

Income Tax Examination, Year under Examination 2013

Latest Tax Year [Member] | Domestic Tax Authority [Member] | Internal Revenue Service (IRS) [Member]

Income Tax Examination, Year under Examination 2014

X

- Definition
Amount of decrease reasonably possible in the next twelve months for the unrecognized tax benefit.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 15
-Subparagraph (d)(3)
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319
+ Details

Name: us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(h)(2))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32698-109319
+ Details

Name: us-gaap_EffectiveIncomeTaxRateContinuingOperations

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Tax year being audited in the income tax examination, in CCYY format.
+ References
No definition available.
+ Details

Name: us-gaap_IncomeTaxExaminationYearUnderExamination

Namespace Prefix: us-gaap_

Data Type: us-types:gYearListItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of state and local current and deferred income tax expense (benefit) attributable to continuing operations.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-Subparagraph (a)-(b)
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(h)(1))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB TOPIC 6.I.7)
-URI http://asc.fasb.org/extlink&oid=34349781&loc=d3e330036-122817
+ Details

Name: us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 15
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319
+ Details

Name: us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 15
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319
+ Details

Name: us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 15A
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319
+ Details

Name: us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_TaxPeriodAxis=us-gaap_EarliestTaxYearMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_InternalRevenueServiceIRSMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_TaxPeriodAxis=us-gaap_LatestTaxYearMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 70 R46.htm IDEA: XBRL DOCUMENT v3.10.0.1

Note 9 - Estimated Liability for Appeals (Details Textual) - USD ($)
3 Months Ended 9 Months Ended

Mar. 31, 2018

Sep. 30, 2018

Sep. 30, 2017

Dec. 31, 2017

Estimated Liability for Appeals Gain (Loss) Included in Earnings $ 8,400,000 $ 8,436,000

Estimated Liability for Appeals 22,184,000 $ 30,787,000

Estimated Liability for Appeals, Amount Adjudicated 19,400,000 19,300,000

Estimated Liability for Appeals, Amount Probable of Being Returned 0 8,500,000

Estimated Liability for Appeals, Commercial Customers Claim Findings, Adjudicated in Favor of Providers $ 2,800,000 $ 3,200,000

X

- Definition
Liability as of the balance sheet date for the estimated liability for appeals and estimated allowance for appeals related to receivables associated with client contracts that have be received on or before the balance sheet date.
+ References
No definition available.
+ Details

Name: hmsy_EstimatedLiabilityForAppeals

Namespace Prefix: hmsy_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The adjudicated portion amount of estimated liability for appeals and estimated allowance for appeals.
+ References
No definition available.
+ Details

Name: hmsy_EstimatedLiabilityForAppealsAmountAdjudicated

Namespace Prefix: hmsy_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The estimate of claims that are probable of being returned to providers following a successful appeal.
+ References
No definition available.
+ Details

Name: hmsy_EstimatedLiabilityForAppealsAmountProbableOfBeingReturned

Namespace Prefix: hmsy_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Represents the portion of the estimated liability for appeals attributable to commercial customers claim findings which have been adjudicated in favor of providers and the Company’s estimate of the potential amount of commercial customers repayments that are probable of being adjudicated in favor of providers following a successful appeal.
+ References
No definition available.
+ Details

Name: hmsy_EstimatedLiabilityForAppealsCommercialCustomersClaimFindingsAdjudicatedInFavorOfProviders

Namespace Prefix: hmsy_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount of gain (loss) realized by the release of estimated liability for appeals during the period.
+ References
No definition available.
+ Details

Name: hmsy_EstimatedLiabilityForAppealsGainLossIncludedInEarnings

Namespace Prefix: hmsy_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

XML 71 R47.htm IDEA: XBRL DOCUMENT v3.10.0.1

Note 9 - Estimated Liability for Appeals - Activity in Estimated Liability for Appeals (Details) - USD ($)
3 Months Ended 9 Months Ended

Mar. 31, 2018

Sep. 30, 2018

Sep. 30, 2017

Release of liability $ (8,400,000) $ (8,436,000)

Estimated Liability for Appeals and Estimated Allowance for Appeals [Member]

Balance--beginning of period $ 8,544,000 8,544,000

Provision

Appeals found in providers favor (108,000)

Release of liability (8,436,000)

Balance--end of period

X

- Definition
The amount of gain (loss) realized by the release of estimated liability for appeals during the period.
+ References
No definition available.
+ Details

Name: hmsy_EstimatedLiabilityForAppealsGainLossIncludedInEarnings

Namespace Prefix: hmsy_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Represents deductions in a given period to allowances and reserves due to appeals found in providers favor.
+ References
No definition available.
+ Details

Name: hmsy_ValuationAllowancesAndReservesAppealsFoundInProvidersFavor

Namespace Prefix: hmsy_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of valuation and qualifying accounts and reserves.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 4
-Subparagraph (SX 210.12-09)
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e24092-122690
+ Details

Name: us-gaap_ValuationAllowancesAndReservesBalance

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 4
-Subparagraph (SX 210.12-09)
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e24092-122690
+ Details

Name: us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_ValuationAllowancesAndReservesTypeAxis=hmsy_EstimatedLiabilityForAppealsAndEstimatedAllowanceForAppealsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 72 R48.htm IDEA: XBRL DOCUMENT v3.10.0.1

Note 10 - Credit Agreement (Details Textual)
$ in Thousands
9 Months Ended

Dec. 19, 2017

USD ($)

Sep. 30, 2018

USD ($)

Sep. 30, 2017

USD ($)

Dec. 31, 2017

USD ($)

Dec. 18, 2017

USD ($)

Amortization of Debt Issuance Costs $ 423 $ 1,563

Credit Agreement [Member]

Line of Credit Facility, Maximum Borrowing Capacity $ 500,000

Line of Credit Facility, Expiration Period 5 years

Debt Agreement, Maximum Borrowing Capacity $ 120,000

Debt Agreement, Maximum Borrowing Capacity, Percent of Consolidated EBITDA 100.00%

Credit Agreement [Member] | Letter of Credit [Member]

Line of Credit Facility, Maximum Borrowing Capacity $ 50,000

Line of Credit Facility, Unused Capacity, Commitment Fee Percentage 0.125%

Credit Agreement [Member] | Swingline Loans [Member]

Line of Credit Facility, Maximum Borrowing Capacity $ 25,000

Credit Agreement [Member] | Revolving Credit Facility [Member]

Long-term Line of Credit, Total 240,000 $ 240,000

Repayments of Long-term Lines of Credit 0

Debt Instrument, Secured Leverage Ratio 5.25

Debt Issuance Costs, Net, Total 2,400 $ 2,800

Amortization of Debt Issuance Costs $ 400 $ 1,000

Credit Agreement [Member] | Revolving Credit Facility [Member] | Federal Funds Effective Swap Rate [Member]

Debt Instrument, Basis Spread on Variable Rate 0.50%

Credit Agreement [Member] | Revolving Credit Facility [Member] | London Interbank Offered Rate (LIBOR) [Member]

Debt Instrument, Basis Spread on Variable Rate 1.00%

Credit Agreement [Member] | Revolving Credit Facility [Member] | Minimum [Member]

Debt Instrument, Covenant, Interest Coverage Ratio 3

Line of Credit Facility, Unused Capacity, Commitment Fee Percentage 0.375%

Credit Agreement [Member] | Revolving Credit Facility [Member] | Minimum [Member] | London Interbank Offered Rate (LIBOR) [Member]

Debt Instrument, Basis Spread on Variable Rate 0.50%

Credit Agreement [Member] | Revolving Credit Facility [Member] | Minimum [Member] | One-month LIBOR Rate [Member]

Debt Instrument, Basis Spread on Variable Rate 1.50%

Credit Agreement [Member] | Revolving Credit Facility [Member] | Maximum [Member]

Line of Credit Facility, Unused Capacity, Commitment Fee Percentage 0.25%

Debt Instrument, Secured Leverage Ratio 3

Credit Agreement [Member] | Revolving Credit Facility [Member] | Maximum [Member] | Through December 2019 [Member]

Debt Instrument, Secured Leverage Ratio 4.75

Credit Agreement [Member] | Revolving Credit Facility [Member] | Maximum [Member] | From and After January 2020 [Member]

Debt Instrument, Secured Leverage Ratio 4.25

Credit Agreement [Member] | Revolving Credit Facility [Member] | Maximum [Member] | London Interbank Offered Rate (LIBOR) [Member]

Debt Instrument, Basis Spread on Variable Rate 1.00%

Credit Agreement [Member] | Revolving Credit Facility [Member] | Maximum [Member] | One-month LIBOR Rate [Member]

Debt Instrument, Basis Spread on Variable Rate 2.00%

X

- Definition
Maximum borrowing capacity under a debt agreement on the amount that could be borrowed with a combination of, but not limited to, a line of credit and term loan.
+ References
No definition available.
+ Details

Name: hmsy_DebtAgreementMaximumBorrowingCapacity

Namespace Prefix: hmsy_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Maximum borrowing capacity under a debt agreement on the amount that could be borrowed with a combination of, but not limited to, a line of credit and term loan, reflected as a percentage of consolidated EBITDA.
+ References
No definition available.
+ Details

Name: hmsy_DebtAgreementMaximumBorrowingCapacityPercentOfConsolidatedEBITDA

Namespace Prefix: hmsy_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
Represents the ratio of adjusted earnings before interest, taxes, depreciation and amortization to interest expense, which is necessary to be maintained under the terms of the senior credit facilities' covenants.
+ References
No definition available.
+ Details

Name: hmsy_DebtInstrumentCovenantInterestCoverageRatio

Namespace Prefix: hmsy_

Data Type: xbrli:pureItemType

Balance Type: na

Period Type: duration

X

- Definition
Represents the total secured leverage ratio, calculated giving pro forma effect to the requested incremental borrowing and other customary and appropriate pro forma adjustment events, including any permitted acquisitions.
+ References
No definition available.
+ Details

Name: hmsy_DebtInstrumentSecuredLeverageRatio

Namespace Prefix: hmsy_

Data Type: xbrli:pureItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of amortization expense attributable to debt issuance costs.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3602-108585

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(8))
-URI http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=114775744&loc=d3e28555-108399
+ Details

Name: us-gaap_AmortizationOfFinancingCosts

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Percentage points added to the reference rate to compute the variable rate on the debt instrument.
+ References
No definition available.
+ Details

Name: us-gaap_DebtInstrumentBasisSpreadOnVariableRate1

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.17)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=114775744&loc=d3e28555-108399
+ Details

Name: us-gaap_DeferredFinanceCostsNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(22))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(16))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(16))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910
+ Details

Name: us-gaap_LineOfCredit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Period remaining on line of credit facility before it terminates, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
No definition available.
+ Details

Name: us-gaap_LineOfCreditFacilityExpirationPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19(b),22(b))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility.
+ References
No definition available.
+ Details

Name: us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
The cash outflow for the settlement of obligation drawn from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 15
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3291-108585
+ Details

Name: us-gaap_RepaymentsOfLongTermLinesOfCredit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_DebtInstrumentAxis=hmsy_CreditAgreementMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_CreditFacilityAxis=hmsy_SwinglineLoansMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_VariableRateAxis=us-gaap_FederalFundsEffectiveSwapRateMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_RangeAxis=srt_MinimumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_VariableRateAxis=hmsy_OneMonthLIBORRateMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_RangeAxis=srt_MaximumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementScenarioAxis=hmsy_ThroughDecember2019Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementScenarioAxis=hmsy_FromAndAfterJanuary2020Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 73 R49.htm IDEA: XBRL DOCUMENT v3.10.0.1

Note 10 - Credit Agreement - Summary of Interest Expense and Commitment Fees on Unused Portion of Revolving Credit Facility (Details) - Revolving Credit Facility [Member] - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended

Sep. 30, 2018

Sep. 30, 2017

Sep. 30, 2018

Sep. 30, 2017

Interest expense $ 2,527 $ 2,230 $ 7,224 $ 5,072

Commitment fees $ 211 $ 325 $ 688 $ 1,036

X

- Definition
Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph 8
-URI http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227
+ Details

Name: us-gaap_InterestExpenseDebtExcludingAmortization

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of the fee for available but unused credit capacity under the credit facility.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19(b),22(b))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_LineOfCreditFacilityCommitmentFeeAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 74 R50.htm IDEA: XBRL DOCUMENT v3.10.0.1

Note 11 - Earnings Per Share (Details Textual) - shares
3 Months Ended 9 Months Ended

Sep. 30, 2018

Sep. 30, 2017

Sep. 30, 2018

Sep. 30, 2017

Employee Stock Option [Member]

Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 21,105 2,642,548 531,378 2,132,017

Restricted Stock [Member]

Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 202 84,360 595 63,452

X

- Definition
Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257
+ Details

Name: us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 75 R51.htm IDEA: XBRL DOCUMENT v3.10.0.1

Note 11 - Earnings Per Share - Summary of Basic and Diluted Earnings Per Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended

Sep. 30, 2018

Sep. 30, 2017

Sep. 30, 2018

Sep. 30, 2017

Net income $ 18,574 $ 6,372 $ 21,598 $ 14,331

Basic (in shares) 83,509 83,923 83,373 83,778

Plus: net effect of dilutive stock options and restricted stock units (in shares) 1,635 1,807 1,868 1,808

Weighted average common shares outstanding-diluted (in shares) 85,144 85,730 85,241 85,586

Net income per common share -- basic (in dollars per share) $ 0.22 $ 0.08 $ 0.26 $ 0.17

Net income per common share -- diluted (in dollars per share) $ 0.22 $ 0.07 $ 0.25 $ 0.17

X

- Definition
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(19))
-URI http://asc.fasb.org/extlink&oid=114873790&loc=SL114874131-224263

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109260490&loc=d3e1337-109256

Reference 3: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 55
-Paragraph 52
-URI http://asc.fasb.org/extlink&oid=109256448&loc=d3e4984-109258

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(21))
-URI http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109260490&loc=d3e1252-109256

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(23))
-URI http://asc.fasb.org/extlink&oid=114873765&loc=SL114874048-224260

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=109260490&loc=SL5780133-109256
+ Details

Name: us-gaap_EarningsPerShareBasic

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 55
-Paragraph 52
-URI http://asc.fasb.org/extlink&oid=109256448&loc=d3e4984-109258

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109260490&loc=d3e1252-109256

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(23))
-URI http://asc.fasb.org/extlink&oid=114873765&loc=SL114874048-224260

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109260490&loc=d3e1337-109256

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(21))
-URI http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=109260490&loc=SL5780133-109256

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(19))
-URI http://asc.fasb.org/extlink&oid=114873790&loc=SL114874131-224263
+ Details

Name: us-gaap_EarningsPerShareDiluted

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 28A
-URI http://asc.fasb.org/extlink&oid=109260490&loc=d3e1500-109256

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257
+ Details

Name: us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=114867106&loc=SL7669619-108580

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI http://asc.fasb.org/extlink&oid=114873765&loc=SL114874048-224260

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=114867106&loc=SL7669625-108580

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI http://asc.fasb.org/extlink&oid=114873790&loc=SL114874131-224263

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3602-108585

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257
+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 16
-URI http://asc.fasb.org/extlink&oid=109260490&loc=d3e1505-109256
+ Details

Name: us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=109260490&loc=d3e1448-109256

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257
+ Details

Name: us-gaap_WeightedAverageNumberOfSharesOutstandingBasic

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

XML 76 R52.htm IDEA: XBRL DOCUMENT v3.10.0.1

Note 12 - Stock-based Compensation (Details Textual) - USD ($)
3 Months Ended 9 Months Ended

Sep. 30, 2018

Sep. 30, 2017

Sep. 30, 2018

Sep. 30, 2017

Allocated Share-based Compensation Expense, Total $ 3,437,000 $ 7,382,000 $ 17,645,000 $ 16,761,000

Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 535,077 40,734 686,111 173,539

Proceeds from Stock Options Exercised $ 12,100,000 $ 800,000 $ 13,633,000 $ 2,580,000

Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 4,000,000 300,000 4,700,000 $ 600,000

Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options 7,600,000 $ 7,600,000

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value $ 7.52 $ 7.68

Income Tax Expense (Benefit), Total 3,069,000 3,394,000 $ 5,830,000 $ 9,302,000

Employee Stock Option [Member]

Allocated Share-based Compensation Expense, Total 1,600,000 3,200,000 $ 7,600,000 7,100,000

Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition 2 years 36 days

Income Tax Expense (Benefit), Total 1,000,000 3,500,000 $ 0 3,600,000

Restricted Stock Units (RSUs) [Member]

Allocated Share-based Compensation Expense, Total $ 1,900,000 $ 4,200,000 $ 10,000,000 $ 9,700,000

Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition 1 year 47 days

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 1,794 59,784 762,877 599,441

Stock Granted, Value, Share-based Compensation, Gross $ 58,861 $ 1,000,000 $ 12,800,000 $ 11,300,000

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number, Ending Balance 1,281,206 1,281,206

Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Share-based Awards Other than Options $ 11,300,000 $ 11,300,000

X

- Definition
Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5047-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 14.F)
-URI http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (h)(1)(i)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901
+ Details

Name: us-gaap_AllocatedShareBasedCompensationExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Weighted average period over which unrecognized compensation is expected to be recognized for equity-based compensation plans, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (i)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901
+ Details

Name: us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Unrecognized cost of unvested share-based awards, other than options, awarded to employees as compensation.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (i)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901
+ Details

Name: us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Unrecognized cost of unvested options awarded to employees as compensation.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (i)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901
+ Details

Name: us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (h)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 20
-Section 45
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109238882&loc=d3e38679-109324
+ Details

Name: us-gaap_IncomeTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of cash inflow from exercise of stock options granted under share-based compensation arrangement.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=SL79508275-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3255-108585
+ Details

Name: us-gaap_ProceedsFromStockOptionsExercised

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(1)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(i)-(ii)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (d)(2)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (d)(1)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Value, before forfeitures, of stock or other type of equity granted of any equity-based compensation plan other than an employee stock ownership plan (ESOP).
+ References
No definition available.
+ Details

Name: us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Number of share options (or share units) exercised during the current period.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(2)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644
+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 77 R53.htm IDEA: XBRL DOCUMENT v3.10.0.1

Note 12 - Stock-based Compensation - Summary of Stock-based Compensation Expense (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended

Sep. 30, 2018

Sep. 30, 2017

Sep. 30, 2018

Sep. 30, 2017

Allocated Share-based Compensation Expense $ 3,437 $ 7,382 $ 17,645 $ 16,761

Cost of Sales [Member]

Allocated Share-based Compensation Expense 1,537 1,851 5,802 5,353

Selling, General and Administrative Expenses [Member]

Allocated Share-based Compensation Expense $ 1,900 $ 5,531 $ 11,843 $ 11,408

X

- Definition
Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5047-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 14.F)
-URI http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (h)(1)(i)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901
+ Details

Name: us-gaap_AllocatedShareBasedCompensationExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 78 R54.htm IDEA: XBRL DOCUMENT v3.10.0.1

Note 12 - Stock-based Compensation - Stock Option Activity (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended

Sep. 30, 2018

Sep. 30, 2017

Sep. 30, 2018

Sep. 30, 2017

Beginning Balance, Shares (in shares) 5,554,000

Beginning Balance, Weighted Average Exercise Price (in dollars per share) $ 17.35

Granted, Shares (in shares) 1,010,000

Granted, Weighted Average Exercise Price (in dollars per share) $ 19.58

Exercised, Shares (in shares) (535,077) (40,734) (686,111) (173,539)

Exercised, Weighted Average Exercise Price (in dollars per share) $ 21.13

Forfeitures, Shares (in shares) (100,000)

Forfeitures, Weighted Average Exercise Price (in dollars per share) $ 17.64

Expired, Shares (in shares) (30,000)

Expired, Weighted Average Exercise Price (in dollars per share) $ 22.21

Ending Balance, Shares (in shares) 5,748,000 5,748,000

Ending Balance, Weighted Average Exercise Price (in dollars per share) $ 17.33 $ 17.33

Ending Balance, Weighted Average Remaining Contractual Terms (Year) 5 years 149 days

Outstanding, Aggregate intrinsic value $ 88,909 $ 88,909

Expected to Vest, Shares (in shares) 1,561,000 1,561,000

Expected to Vest, Weighted Average Exercise Price (in dollars per share) $ 17.65 $ 17.65

Expected to Vest, Weighted Average Remaining Contractual Terms (Year) 7 years 288 days

Expected to Vest, Aggregate Intrinsic Value $ 23,669 $ 23,669

Exercisable, Shares (in shares) 3,373,000 3,373,000

Exercisable, Weighted Average Exercise Price (in dollars per share) $ 17.13 $ 17.13

Exercisable, Weighted Average Remaining Contractual Terms (Year) 3 years 277 days

Exercisable, Aggregate Intrinsic Value $ 52,900 $ 52,900

X

- Definition
The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iii)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iii)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(4)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(3)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Gross number of share options (or share units) granted during the period.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Number of options outstanding, including both vested and non-vested options.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(i)-(ii)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(i)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (e)(1)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (e)(1)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
Weighted average price at which option holders acquired shares when converting their stock options into shares.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901
+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901
+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (e)(1)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901
+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (e)(1)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901
+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of share options (or share units) exercised during the current period.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(2)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644
+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

XML 79 R55.htm IDEA: XBRL DOCUMENT v3.10.0.1

Note 12 - Stock-based Compensation - Weighted Average Assumptions Used in Valuation of Stock Options (Details) - Employee Stock Option [Member] - Black Scholes Model [Member]
9 Months Ended

Sep. 30, 2018

Sep. 30, 2017

Expected dividend yield 0.00% 0.00%

Risk-free interest rate 2.68% 1.74%

Expected volatility 42.43% 44.23%

Expected life (Year) 6 years 5 years

X

- Definition
The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(iii)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(ii)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
The risk-free interest rate assumption that is used in valuing an option on its own shares.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(iv)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Expected term of share-based compensation awards, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(i)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 14.D.2)
-URI http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809
+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ValuationTechniqueAxis=hmsy_BlackScholesModelMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 80 R56.htm IDEA: XBRL DOCUMENT v3.10.0.1

Note 12 - Stock-based Compensation - Summary of Restricted Stock Units (Details) - Restricted Stock Units (RSUs) [Member] - $ / shares
3 Months Ended 9 Months Ended

Sep. 30, 2018

Sep. 30, 2017

Sep. 30, 2018

Sep. 30, 2017

Beginning balance, shares (in shares) 1,346,000

Beginning balance, weighted average grant date fair value per unit (in dollars per share) $ 17.65

Granted, shares (in shares) 1,794 59,784 762,877 599,441

Granted, weighted average grant date fair value per unit (in dollars per share) $ 16.76

Vesting of restricted stock units, net of units withheld for taxes (in shares) (367,000)

Vesting of restricted stock units, net of units withheld for taxes, weighted average grant date fair value per unit (in dollars per share) $ 17

Units withheld for taxes (in shares) (163,000)

Units withheld for taxes, weighted average grant date fair value per unit (in dollars per share) $ 17

Forfeitures, shares (in shares) (70,000)

Forfeitures, weighted average grant date fair value per unit (in dollars per share) $ 17.26

Ending balance, shares (in shares) 1,509,000 1,509,000

Ending balance, weighted average grant date fair value per unit (in dollars per share) $ 19.98 $ 19.98

X

- Definition
Fair value of net-share settlement of share-based awards when the employer settles employees' income tax withholding obligations. This element represents the weighted average grant date fair value of shares the employees use to repay the employer.
+ References
No definition available.
+ Details

Name: hmsy_FairValueOfSharesPaidForTaxWithholdingForShareBasedCompensation

Namespace Prefix: hmsy_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(3)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(3)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(1)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(1)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
The weighted average fair value of nonvested awards on equity-based plans excluding option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, revenue or profit achievement stock award plan) for which the employer is contingently obligated to issue equity instruments or transfer assets to an employee who has not yet satisfied service or performance criteria necessary to gain title to proceeds from the sale of the award or underlying shares or units.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(i)-(ii)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(2)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(2)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of equity instruments other than options outstanding, including both vested and non-vested instruments.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(ii)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(i)
-URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
For net-share settlement of share-based awards when the employer settles employees' income tax withholding obligations, this element represents the number of shares the employees use to repay the employer.
+ References
No definition available.
+ Details

Name: us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 81 R57.htm IDEA: XBRL DOCUMENT v3.10.0.1

Note 13 - Commitments and Contingencies (Details Textual) - Suit Against HMS Holdings Related to the Acquisition of Allied Management Group [Member] - USD ($)
$ in Millions

Jun. 27, 2018

Nov. 03, 2017

Loss Contingency, Damages Awarded, Value $ 60

Litigation Settlement, Amount Awarded to Other Party $ 20

X

- Definition
Amount awarded to other party in judgment or settlement of litigation.
+ References
No definition available.
+ Details

Name: us-gaap_LitigationSettlementAmountAwardedToOtherParty

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of damages awarded to the plaintiff in the legal matter.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 9
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=82911808&loc=d3e14557-108349

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 4
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=82911808&loc=d3e14435-108349

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=82911808&loc=d3e14326-108349
+ Details

Name: us-gaap_LossContingencyDamagesAwardedValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: srt_LitigationCaseAxis=hmsy_SuitAgainstHMSHoldingsRelatedToTheAcquisitionOfAlliedManagementGroupMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

EXCEL 82 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 83 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 84 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 86 FilingSummary.xml IDEA: XBRL DOCUMENT 3.10.0.1 html 129 255 1 false 44 0 false 4 false false R1.htm 000 - Document - Document And Entity Information Sheet http://hms.com/20180930/role/statement-document-and-entity-information Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Consolidated Balance Sheets (Current Period Unaudited) Sheet http://hms.com/20180930/role/statement-consolidated-balance-sheets-current-period-unaudited Consolidated Balance Sheets (Current Period Unaudited) Statements 2 false false R3.htm 002 - Statement - Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) Sheet http://hms.com/20180930/role/statement-consolidated-balance-sheets-current-period-unaudited-parentheticals Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) Statements 3 false false R4.htm 003 - Statement - Consolidated Statements of Income (Unaudited) Sheet http://hms.com/20180930/role/statement-consolidated-statements-of-income-unaudited Consolidated Statements of Income (Unaudited) Statements 4 false false R5.htm 004 - Statement - Consolidated Statement of Shareholders' Equity (Unaudited) Sheet http://hms.com/20180930/role/statement-consolidated-statement-of-shareholders-equity-unaudited Consolidated Statement of Shareholders' Equity (Unaudited) Statements 5 false false R6.htm 005 - Statement - Consolidated Statements of Cash Flows (Unaudited) Sheet http://hms.com/20180930/role/statement-consolidated-statements-of-cash-flows-unaudited Consolidated Statements of Cash Flows (Unaudited) Statements 6 false false R7.htm 006 - Disclosure - Note 1 - Business and Summary of Significant Accounting Policies Sheet http://hms.com/20180930/role/statement-note-1-business-and-summary-of-significant-accounting-policies Note 1 - Business and Summary of Significant Accounting Policies Notes 7 false false R8.htm 007 - Disclosure - Note 2 - Fair Value of Financial Instruments Sheet http://hms.com/20180930/role/statement-note-2-fair-value-of-financial-instruments Note 2 - Fair Value of Financial Instruments Notes 8 false false R9.htm 008 - Disclosure - Note 3 - Revenue Recognition Sheet http://hms.com/20180930/role/statement-note-3-revenue-recognition Note 3 - Revenue Recognition Notes 9 false false R10.htm 009 - Disclosure - Note 4 - Accounts Receivable and Accounts Receivable Allowance Sheet http://hms.com/20180930/role/statement-note-4-accounts-receivable-and-accounts-receivable-allowance Note 4 - Accounts Receivable and Accounts Receivable Allowance Notes 10 false false R11.htm 010 - Disclosure - Note 5 - Acquisition Sheet http://hms.com/20180930/role/statement-note-5-acquisition Note 5 - Acquisition Notes 11 false false R12.htm 011 - Disclosure - Note 6 - Intangible Assets and Goodwill Sheet http://hms.com/20180930/role/statement-note-6-intangible-assets-and-goodwill Note 6 - Intangible Assets and Goodwill Notes 12 false false R13.htm 012 - Disclosure - Note 7 - Accounts Payable, Accrued Expenses and Other Liabilities Sheet http://hms.com/20180930/role/statement-note-7-accounts-payable-accrued-expenses-and-other-liabilities Note 7 - Accounts Payable, Accrued Expenses and Other Liabilities Notes 13 false false R14.htm 013 - Disclosure - Note 8 - Income Taxes Sheet http://hms.com/20180930/role/statement-note-8-income-taxes Note 8 - Income Taxes Notes 14 false false R15.htm 014 - Disclosure - Note 9 - Estimated Liability for Appeals Sheet http://hms.com/20180930/role/statement-note-9-estimated-liability-for-appeals Note 9 - Estimated Liability for Appeals Notes 15 false false R16.htm 015 - Disclosure - Note 10 - Credit Agreement Sheet http://hms.com/20180930/role/statement-note-10-credit-agreement Note 10 - Credit Agreement Notes 16 false false R17.htm 016 - Disclosure - Note 11 - Earnings Per Share Sheet http://hms.com/20180930/role/statement-note-11-earnings-per-share Note 11 - Earnings Per Share Notes 17 false false R18.htm 017 - Disclosure - Note 12 - Stock-based Compensation Sheet http://hms.com/20180930/role/statement-note-12-stockbased-compensation Note 12 - Stock-based Compensation Notes 18 false false R19.htm 018 - Disclosure - Note 13 - Commitments and Contingencies Sheet http://hms.com/20180930/role/statement-note-13-commitments-and-contingencies Note 13 - Commitments and Contingencies Notes 19 false false R20.htm 019 - Disclosure - Note 14 - Subsequent Events Sheet http://hms.com/20180930/role/statement-note-14-subsequent-events Note 14 - Subsequent Events Notes 20 false false R21.htm 020 - Disclosure - Significant Accounting Policies (Policies) Sheet http://hms.com/20180930/role/statement-significant-accounting-policies-policies Significant Accounting Policies (Policies) Policies http://hms.com/20180930/role/statement-note-1-business-and-summary-of-significant-accounting-policies 21 false false R22.htm 021 - Disclosure - Note 3 - Revenue Recognition (Tables) Sheet http://hms.com/20180930/role/statement-note-3-revenue-recognition-tables Note 3 - Revenue Recognition (Tables) Tables http://hms.com/20180930/role/statement-note-3-revenue-recognition 22 false false R23.htm 022 - Disclosure - Note 4 - Accounts Receivable and Accounts Receivable Allowance (Tables) Sheet http://hms.com/20180930/role/statement-note-4-accounts-receivable-and-accounts-receivable-allowance-tables Note 4 - Accounts Receivable and Accounts Receivable Allowance (Tables) Tables http://hms.com/20180930/role/statement-note-4-accounts-receivable-and-accounts-receivable-allowance 23 false false R24.htm 023 - Disclosure - Note 5 - Acquisition (Tables) Sheet http://hms.com/20180930/role/statement-note-5-acquisition-tables Note 5 - Acquisition (Tables) Tables http://hms.com/20180930/role/statement-note-5-acquisition 24 false false R25.htm 024 - Disclosure - Note 6 - Intangible Assets and Goodwill (Tables) Sheet http://hms.com/20180930/role/statement-note-6-intangible-assets-and-goodwill-tables Note 6 - Intangible Assets and Goodwill (Tables) Tables http://hms.com/20180930/role/statement-note-6-intangible-assets-and-goodwill 25 false false R26.htm 025 - Disclosure - Note 7 - Accounts Payable, Accrued Expenses and Other Liabilities (Tables) Sheet http://hms.com/20180930/role/statement-note-7-accounts-payable-accrued-expenses-and-other-liabilities-tables Note 7 - Accounts Payable, Accrued Expenses and Other Liabilities (Tables) Tables http://hms.com/20180930/role/statement-note-7-accounts-payable-accrued-expenses-and-other-liabilities 26 false false R27.htm 026 - Disclosure - Note 9 - Estimated Liability for Appeals (Tables) Sheet http://hms.com/20180930/role/statement-note-9-estimated-liability-for-appeals-tables Note 9 - Estimated Liability for Appeals (Tables) Tables http://hms.com/20180930/role/statement-note-9-estimated-liability-for-appeals 27 false false R28.htm 027 - Disclosure - Note 10 - Credit Agreement (Tables) Sheet http://hms.com/20180930/role/statement-note-10-credit-agreement-tables Note 10 - Credit Agreement (Tables) Tables http://hms.com/20180930/role/statement-note-10-credit-agreement 28 false false R29.htm 028 - Disclosure - Note 11 - Earnings Per Share (Tables) Sheet http://hms.com/20180930/role/statement-note-11-earnings-per-share-tables Note 11 - Earnings Per Share (Tables) Tables http://hms.com/20180930/role/statement-note-11-earnings-per-share 29 false false R30.htm 029 - Disclosure - Note 12 - Stock-based Compensation (Tables) Sheet http://hms.com/20180930/role/statement-note-12-stockbased-compensation-tables Note 12 - Stock-based Compensation (Tables) Tables http://hms.com/20180930/role/statement-note-12-stockbased-compensation 30 false false R31.htm 030 - Disclosure - Note 1 - Business and Summary of Significant Accounting Policies (Details Textual) Sheet http://hms.com/20180930/role/statement-note-1-business-and-summary-of-significant-accounting-policies-details-textual Note 1 - Business and Summary of Significant Accounting Policies (Details Textual) Details 31 false false R32.htm 031 - Disclosure - Note 2 - Fair Value of Financial Instruments (Details Textual) Sheet http://hms.com/20180930/role/statement-note-2-fair-value-of-financial-instruments-details-textual Note 2 - Fair Value of Financial Instruments (Details Textual) Details http://hms.com/20180930/role/statement-note-2-fair-value-of-financial-instruments 32 false false R33.htm 032 - Disclosure - Note 3 - Revenue Recognition (Details Textual) Sheet http://hms.com/20180930/role/statement-note-3-revenue-recognition-details-textual Note 3 - Revenue Recognition (Details Textual) Details http://hms.com/20180930/role/statement-note-3-revenue-recognition-tables 33 false false R34.htm 033 - Disclosure - Note 3 - Revenue Recognition - Revenues Disaggregated by Revenue Source (Details) Sheet http://hms.com/20180930/role/statement-note-3-revenue-recognition-revenues-disaggregated-by-revenue-source-details Note 3 - Revenue Recognition - Revenues Disaggregated by Revenue Source (Details) Details 34 false false R35.htm 034 - Disclosure - Note 4 - Accounts Receivable and Accounts Receivable Allowance - Accounts Receivable, Net (Details) Sheet http://hms.com/20180930/role/statement-note-4-accounts-receivable-and-accounts-receivable-allowance-accounts-receivable-net-details Note 4 - Accounts Receivable and Accounts Receivable Allowance - Accounts Receivable, Net (Details) Details 35 false false R36.htm 035 - Disclosure - Note 4 - Accounts Receivable and Accounts Receivable Allowance - Activity in Allowance for Doubtful Accounts (Details) Sheet http://hms.com/20180930/role/statement-note-4-accounts-receivable-and-accounts-receivable-allowance-activity-in-allowance-for-doubtful-accounts-details Note 4 - Accounts Receivable and Accounts Receivable Allowance - Activity in Allowance for Doubtful Accounts (Details) Details 36 false false R37.htm 036 - Disclosure - Note 5 - Acquisition (Details Textual) Sheet http://hms.com/20180930/role/statement-note-5-acquisition-details-textual Note 5 - Acquisition (Details Textual) Details http://hms.com/20180930/role/statement-note-5-acquisition-tables 37 false false R38.htm 037 - Disclosure - Note 5 - Acquisition - Preliminary Allocation of the Purchase Price (Details) Sheet http://hms.com/20180930/role/statement-note-5-acquisition-preliminary-allocation-of-the-purchase-price-details Note 5 - Acquisition - Preliminary Allocation of the Purchase Price (Details) Details 38 false false R39.htm 038 - Disclosure - Note 5 - Acquisition - Preliminary Purchase Price Allocated to the Intangibles Acquired (Details) Sheet http://hms.com/20180930/role/statement-note-5-acquisition-preliminary-purchase-price-allocated-to-the-intangibles-acquired-details Note 5 - Acquisition - Preliminary Purchase Price Allocated to the Intangibles Acquired (Details) Details 39 false false R40.htm 039 - Disclosure - Note 5 - Acquisition - Acquisition Costs (Details) Sheet http://hms.com/20180930/role/statement-note-5-acquisition-acquisition-costs-details Note 5 - Acquisition - Acquisition Costs (Details) Details 40 false false R41.htm 040 - Disclosure - Note 6 - Intangible Assets and Goodwill (Details Textual) Sheet http://hms.com/20180930/role/statement-note-6-intangible-assets-and-goodwill-details-textual Note 6 - Intangible Assets and Goodwill (Details Textual) Details http://hms.com/20180930/role/statement-note-6-intangible-assets-and-goodwill-tables 41 false false R42.htm 041 - Disclosure - Note 6 - Intangible Assets and Goodwill - Summary of Intangible Assets (Details) Sheet http://hms.com/20180930/role/statement-note-6-intangible-assets-and-goodwill-summary-of-intangible-assets-details Note 6 - Intangible Assets and Goodwill - Summary of Intangible Assets (Details) Details 42 false false R43.htm 042 - Disclosure - Note 6 - Intangible Assets and Goodwill - Estimated Amortization Expense of Intangible Assets (Details) Sheet http://hms.com/20180930/role/statement-note-6-intangible-assets-and-goodwill-estimated-amortization-expense-of-intangible-assets-details Note 6 - Intangible Assets and Goodwill - Estimated Amortization Expense of Intangible Assets (Details) Details 43 false false R44.htm 043 - Disclosure - Note 7 - Accounts Payable, Accrued Expenses and Other Liabilities - Summary of Accounts Payable, Accrued Expenses and Other Liabilities (Details) Sheet http://hms.com/20180930/role/statement-note-7-accounts-payable-accrued-expenses-and-other-liabilities-summary-of-accounts-payable-accrued-expenses-and-other-liabilities-details Note 7 - Accounts Payable, Accrued Expenses and Other Liabilities - Summary of Accounts Payable, Accrued Expenses and Other Liabilities (Details) Details 44 false false R45.htm 044 - Disclosure - Note 8 - Income Taxes (Details Textual) Sheet http://hms.com/20180930/role/statement-note-8-income-taxes-details-textual Note 8 - Income Taxes (Details Textual) Details http://hms.com/20180930/role/statement-note-8-income-taxes 45 false false R46.htm 045 - Disclosure - Note 9 - Estimated Liability for Appeals (Details Textual) Sheet http://hms.com/20180930/role/statement-note-9-estimated-liability-for-appeals-details-textual Note 9 - Estimated Liability for Appeals (Details Textual) Details http://hms.com/20180930/role/statement-note-9-estimated-liability-for-appeals-tables 46 false false R47.htm 046 - Disclosure - Note 9 - Estimated Liability for Appeals - Activity in Estimated Liability for Appeals (Details) Sheet http://hms.com/20180930/role/statement-note-9-estimated-liability-for-appeals-activity-in-estimated-liability-for-appeals-details Note 9 - Estimated Liability for Appeals - Activity in Estimated Liability for Appeals (Details) Details 47 false false R48.htm 047 - Disclosure - Note 10 - Credit Agreement (Details Textual) Sheet http://hms.com/20180930/role/statement-note-10-credit-agreement-details-textual Note 10 - Credit Agreement (Details Textual) Details http://hms.com/20180930/role/statement-note-10-credit-agreement-tables 48 false false R49.htm 048 - Disclosure - Note 10 - Credit Agreement - Summary of Interest Expense and Commitment Fees on Unused Portion of Revolving Credit Facility (Details) Sheet http://hms.com/20180930/role/statement-note-10-credit-agreement-summary-of-interest-expense-and-commitment-fees-on-unused-portion-of-revolving-credit-facility-details Note 10 - Credit Agreement - Summary of Interest Expense and Commitment Fees on Unused Portion of Revolving Credit Facility (Details) Details 49 false false R50.htm 049 - Disclosure - Note 11 - Earnings Per Share (Details Textual) Sheet http://hms.com/20180930/role/statement-note-11-earnings-per-share-details-textual Note 11 - Earnings Per Share (Details Textual) Details http://hms.com/20180930/role/statement-note-11-earnings-per-share-tables 50 false false R51.htm 050 - Disclosure - Note 11 - Earnings Per Share - Summary of Basic and Diluted Earnings Per Share (Details) Sheet http://hms.com/20180930/role/statement-note-11-earnings-per-share-summary-of-basic-and-diluted-earnings-per-share-details Note 11 - Earnings Per Share - Summary of Basic and Diluted Earnings Per Share (Details) Details 51 false false R52.htm 051 - Disclosure - Note 12 - Stock-based Compensation (Details Textual) Sheet http://hms.com/20180930/role/statement-note-12-stockbased-compensation-details-textual Note 12 - Stock-based Compensation (Details Textual) Details http://hms.com/20180930/role/statement-note-12-stockbased-compensation-tables 52 false false R53.htm 052 - Disclosure - Note 12 - Stock-based Compensation - Summary of Stock-based Compensation Expense (Details) Sheet http://hms.com/20180930/role/statement-note-12-stockbased-compensation-summary-of-stockbased-compensation-expense-details Note 12 - Stock-based Compensation - Summary of Stock-based Compensation Expense (Details) Details 53 false false R54.htm 053 - Disclosure - Note 12 - Stock-based Compensation - Stock Option Activity (Details) Sheet http://hms.com/20180930/role/statement-note-12-stockbased-compensation-stock-option-activity-details Note 12 - Stock-based Compensation - Stock Option Activity (Details) Details 54 false false R55.htm 054 - Disclosure - Note 12 - Stock-based Compensation - Weighted Average Assumptions Used in Valuation of Stock Options (Details) Sheet http://hms.com/20180930/role/statement-note-12-stockbased-compensation-weighted-average-assumptions-used-in-valuation-of-stock-options-details Note 12 - Stock-based Compensation - Weighted Average Assumptions Used in Valuation of Stock Options (Details) Details 55 false false R56.htm 055 - Disclosure - Note 12 - Stock-based Compensation - Summary of Restricted Stock Units (Details) Sheet http://hms.com/20180930/role/statement-note-12-stockbased-compensation-summary-of-restricted-stock-units-details Note 12 - Stock-based Compensation - Summary of Restricted Stock Units (Details) Details 56 false false R57.htm 056 - Disclosure - Note 13 - Commitments and Contingencies (Details Textual) Sheet http://hms.com/20180930/role/statement-note-13-commitments-and-contingencies-details-textual Note 13 - Commitments and Contingencies (Details Textual) Details http://hms.com/20180930/role/statement-note-13-commitments-and-contingencies 57 false false All Reports Book All Reports hmsy-20180930.xml hmsy-20180930.xsd hmsy-20180930_cal.xml hmsy-20180930_def.xml hmsy-20180930_lab.xml hmsy-20180930_pre.xml http://xbrl.sec.gov/dei/2018-01-31 http://fasb.org/srt/2018-01-31 http://fasb.org/us-gaap/2018-01-31 true true ZIP 88 0001171843-18-007598-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001171843-18-007598-xbrl.zip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

Document And Entity Information - shares	9 Months Ended
Document And Entity Information - shares	Sep. 30, 2018	Nov. 02, 2018
Document Information [Line Items]
Entity Registrant Name	HMS HOLDINGS CORP
Entity Central Index Key	0001196501
Trading Symbol	hmsy
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Entity Current Reporting Status	Yes
Entity Emerging Growth Company	false
Entity Small Business	false
Entity Common Stock, Shares Outstanding (in shares)		83,907,132
Document Type	10-Q
Document Period End Date	Sep. 30, 2018
Document Fiscal Year Focus	2018
Document Fiscal Period Focus	Q3
Amendment Flag	false

Consolidated Balance Sheets (Current Period Unaudited) - USD ($) $ in Thousands	Sep. 30, 2018	Dec. 31, 2017
Current assets:
Cash and cash equivalents	$ 124,297	$ 83,313
Accounts receivable, net of allowance of $16,239 and $14,799, at September 30, 2018 and December 31, 2017, respectively	202,498	189,460
Prepaid expenses	16,826	16,589
Income tax receivable	4,597	1,892
Deferred financing costs, net	564	564
Other current assets	314	836
Total current assets	349,096	292,654
Property and equipment, net	93,145	98,581
Goodwill	487,617	487,617
Intangible assets, net	72,593	91,482
Deferred financing costs, net	1,814	2,237
Other assets	2,655	2,589
Total assets	1,006,920	975,160
Current liabilities:
Accounts payable, accrued expenses and other liabilities	64,295	61,900
Estimated liability for appeals	22,184	30,787
Total current liabilities	86,479	92,687
Long-term liabilities:
Revolving credit facility	240,000	240,000
Net deferred tax liabilities	14,407	21,989
Deferred rent	4,329	4,852
Other liabilities	9,925	9,403
Total long-term liabilities	268,661	276,244
Total liabilities	355,140	368,931
Commitments and contingencies
Shareholders' equity:
Preferred stock -- $0.01 par value; 5,000,000 shares authorized; none issued	0	0
Common stock -- $0.01 par value; 175,000,000 shares authorized; 97,588,656 shares issued and 83,925,462 shares outstanding at September 30, 2018; 96,536,251 shares issued and 83,256,858 shares outstanding at December 31, 2017	975	965
Capital in excess of par value	397,192	368,721
Retained earnings	389,189	366,164
Treasury stock, at cost: 13,663,194 shares at September 30, 2018 and 13,279,393 shares at December 31, 2017	(135,576)	(129,621)
Total shareholders' equity	651,780	606,229
Total liabilities and shareholders' equity	$ 1,006,920	$ 975,160

Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - USD ($) $ in Thousands	Sep. 30, 2018	Dec. 31, 2017
Accounts receivable, allowance for doubtful accounts	$ 16,239	$ 14,799
Preferred stock, par value (in dollars per share)	$ 0.01	$ 0.01
Preferred stock, shares authorized (in shares)	5,000,000	5,000,000
Preferred stock, shares issued (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized (in shares)	175,000,000	175,000,000
Common stock, shares issued (in shares)	97,588,656	96,536,251
Common stock, shares outstanding (in shares)	83,925,462	83,256,858
Treasury cost, shares (in shares)	13,663,194	13,279,393

Consolidated Statements of Income (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Revenue	$ 154,246	$ 125,673	$ 442,462	$ 372,719
Cost of services:
Compensation	58,188	49,012	169,455	149,784
Information technology	12,979	12,067	39,482	33,131
Occupancy	3,500	4,332	11,897	12,109
Direct project expenses	10,661	9,548	31,652	30,092
Other operating expenses	8,567	7,446	22,183	21,212
Amortization of acquisition related software and intangible assets	7,942	8,167	25,695	21,825
Total cost of services	101,837	90,572	300,364	268,153
Selling, general and administrative expenses	28,178	22,240	86,708	73,400
Settlement expense			20,000
Total operating expenses	130,015	112,812	407,072	341,553
Operating income	24,231	12,861	35,390	31,166
Interest expense	(2,880)	(3,109)	(8,562)	(7,734)
Interest income	292	14	600	201
Income before income taxes	21,643	9,766	27,428	23,633
Income taxes	3,069	3,394	5,830	9,302
Net Income	$ 18,574	$ 6,372	$ 21,598	$ 14,331
Basic income per common share:
Net income per common share -- basic (in dollars per share)	$ 0.22	$ 0.08	$ 0.26	$ 0.17
Diluted income per common share:
Net income per common share -- diluted (in dollars per share)	$ 0.22	$ 0.07	$ 0.25	$ 0.17
Weighted average shares:
Basic (in shares)	83,509	83,923	83,373	83,778
Diluted (in shares)	85,144	85,730	85,241	85,586

Consolidated Statement of Shareholders' Equity (Unaudited) - 9 months ended Sep. 30, 2018 - USD ($) $ in Thousands	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Treasury Stock [Member]	Total
Balance (in shares) at Dec. 31, 2017	96,536,251			13,279,393
Balance at Dec. 31, 2017	$ 965	$ 368,721	$ 366,164	$ (129,621)	$ 606,229
Adoption of accounting standard (Note 1 and 3) (Accounting Standards Update 2014-09 [Member]) at Dec. 31, 2017			1,427		1,427
Net income			21,598		21,598
Stock-based compensation expense		17,645			17,645
Purchase of treasury stock (in shares)				383,801
Purchase of treasury stock				$ (5,955)	$ (5,955)
Exercise of stock options (in shares)	685,812				686,111
Exercise of stock options	$ 7	13,626			$ 13,633
Vesting of restricted stock units, net of shares withheld for employee tax (in shares)	366,593
Vesting of restricted stock units, net of shares withheld for employee tax	$ 3	(2,800)			(2,797)
Balance (in shares) at Sep. 30, 2018	97,588,656			13,663,194
Balance at Sep. 30, 2018	$ 975	$ 397,192	$ 389,189	$ (135,576)	$ 651,780

Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
Operating activities:
Net income	$ 21,598,000	$ 14,331,000
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization of property, equipment and software	24,331,000	20,599,000
Amortization of intangible assets	18,889,000	15,947,000
Amortization of deferred financing costs	423,000	1,563,000
Stock-based compensation expense	17,645,000	16,761,000
Deferred income taxes	(7,582,000)	(726,000)
Change in fair value of contingent consideration	(35,000)	(2,450,000)
Release of estimated liability for appeals	(8,436,000)
Changes in operating assets and liabilities:
Accounts receivable	(13,038,000)	5,630,000
Prepaid expenses	(237,000)	757,000
Other current assets	522,000	712,000
Other assets	(66,000)	163,000
Income taxes receivable / (payable)	(2,705,000)	(2,731,000)
Accounts payable, accrued expenses and other liabilities	4,394,000	(15,457,000)
Estimated liability for appeals	(167,000)	(1,000)
Net cash provided by operating activities	55,536,000	55,098,000
Investing activities:
Acquisition of a business, net of cash acquired		(171,174,000)
Purchases of property and equipment	(4,333,000)	(11,656,000)
Investment in capitalized software	(15,100,000)	(10,664,000)
Net cash used in investing activities	(19,433,000)	(193,494,000)
Financing activities:
Proceeds from exercise of stock options	13,633,000	2,580,000
Payments of tax withholdings on behalf of employees for net-share settlement for stock-based compensation	(2,797,000)	(2,898,000)
Payments on capital lease obligations		(5,000)
Proceeds from credit facility		42,204,000
Purchases of treasury stock	(5,955,000)
Net cash provided by financing activities	4,881,000	41,881,000
Net increase (decrease) in cash and cash equivalents	40,984,000	(96,515,000)
Cash and Cash Equivalents
Cash and cash equivalents at beginning of year	83,313,000	175,999,000
Cash and cash equivalents at end of period	124,297,000	79,484,000
Supplemental disclosure of cash flow information:
Cash paid for income taxes, net of refunds	15,501,000	12,317,000
Cash paid for interest	7,769,000	5,819,000
Supplemental disclosure of non-cash activities:
Change in balance of accrued property and equipment purchases	$ 538,000	$ (414,000)

Significant Accounting Policies (Policies)	9 Months Ended
Significant Accounting Policies (Policies)	Sep. 30, 2018
Accounting Policies [Abstract]
New Accounting Pronouncements, Policy [Policy Text Block]	Recently Adopted Accounting Pronouncements In May 2014, the FASB issued ASU 2014 - 09, Revenue from Contracts with Customers (Topic 606 ) (“ASU 2014 - 09” ), which is the new comprehensive revenue recognition standard that supersedes all existing revenue recognition guidance under U.S. GAAP. The Company adopted ASU 2014 - 09 on January 1, 2018 using the modified retrospective method and the Company recognized the cumulative effect of initially applying the new revenue standard as an adjustment to the opening balance of retained earnings. The financial information for comparative prior periods has not been restated and continues to be reported under the accounting standards in effect for those periods. The effect of adopting ASU 2014 - 09 in the current annual reporting period as compared with the guidance that was in effect before the change is immaterial. The Company’s internal control framework did not materially change, but existing internal controls were modified due to certain changes to business processes and systems to support the new revenue recognition standard as necessary. The Company continues to expect the impact of the adoption of the new standard to be immaterial to its net income and its internal control framework on an ongoing basis. In August 2016, the FASB issued ASU No. 2016 - 15, Statements of Cash Flows (Topic 230 ): Classification of Certain Cash Receipts and Cash Payments (“ASU 2016 - 15” ) . ASU 2016 - 15 clarifies where certain cash receipts and cash payments are presented and classified in the statement of cash flows. The amendments are effective for annual reporting periods beginning after December 15, 2017, and for interim reporting periods within such annual periods. The Company adopted this guidance on January 1, 2018. The adoption of this guidance did not have an effect on the Company’s consolidated financial statements. In January 2017, the FASB issued ASU No. 2017 - 01, Business Combinations (Topic 805 ) – Clarifying the Definition of a Business (“ASU 2017 - 01” ). ASU 2017 - 01 finalizes previous proposals regarding shareholder concerns that the definition of a business is applied too broadly. The guidance assists entities with evaluating whether transactions should be accounted for as acquisitions of assets or of businesses. The amendments are effective for annual periods beginning after December 15, 2017, including interim periods within those periods. The Company adopted this guidance on January 1, 2018. The adoption of this guidance did not have a material effect on the Company’s consolidated financial statements. In May 2017, the FASB issued ASU No. 2017 - 09, Compensation – Stock Compensation (Topic 718 ) – Scope of Modification Accounting, (“ASU 2017 - 09” ). ASU 2017 - 09 requires entities to apply modification accounting to changes made to a share-based payment award. The new guidance specifies that entities will apply modification accounting to changes to a share-based payment award only if any of the following are not the same immediately before and after the change: 1 ) The award’s fair value (or calculated value or intrinsic value, if those measurement methods are used), 2 ) the award’s vesting conditions, and 3 ) the award’s classification as an equity or liability instrument. ASU 2017 - 09 is effective for annual reporting periods beginning after December 15, 2017, including interim periods within such annual periods, with early adoption permitted. The Company adopted this guidance on January 1, 2018. The adoption of this guidance did not have a material effect on the Company’s consolidated financial statements. Recently Issued Accounting Pronouncements In February 2016, the FASB issued ASU No. 2016 - 02, Leases (Topic 842 ) (“ASU 2016 - 02” ). ASU 2016 - 02 will require most lessees to recognize a majority of the company’s leases on the balance sheet, which will increase reported assets and liabilities. ASU 2016 - 02 is effective for annual reporting periods beginning after December 15, 2018 including interim periods within such annual reporting periods with early adoption permitted. The Company has not early adopted this guidance. The Company developed a preliminary implementation plan and has reviewed historical lease agreements in order to quantify the impact of adoption. Based upon the Company’s on-going analysis to date, the Company currently expects that there will be a material increase to total assets and total liabilities on the Company’s consolidated balance sheet upon adoption; however, the Company continues to perform the necessary additional reviews and other implementation considerations in order to appropriately quantify the changes. The Company has elected to use the FASB’s optional transition method.The Company expects to complete the on-going analysis and quantification by the end of the fourth quarter of 2018. In January 2017, the FASB issued ASU No. 2017 - 04, Goodwill and Other (Topic 350 ): Simplifying the Test for Goodwill Impairment (“ASU 2017 - 04” ). This amendment simplifies the manner in which an entity is required to test for goodwill impairment by eliminating Step 2 from the goodwill impairment test. Step 2 measures goodwill impairment loss by comparing the implied fair value of a reporting unit’s goodwill with the carrying amount of that goodwill. The amendment simplifies this approach by having the entity ( 1 ) perform its annual or interim goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount, and ( 2 ) recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value, with the understanding that the loss recognized should not exceed the total amount of goodwill allocated to that reporting unit. The amendment is effective for public entities that are SEC filers prospectively for their annual, or any interim, goodwill impairment tests in fiscal years beginning after December 15, 2019. Early adoption is permitted for all entities for interim or annual goodwill impairment tests performed on testing dates after January 1, 2017. The Company is currently evaluating the impact on the Company’s financial statements of adopting this guidance but this guidance is not expected to have a material impact on the Company’s financial position, results of operations or internal control framework. In June 2018, the FASB issued ASU No. 2018 - 07, Compensation – Stock Compensation (Topic 718 ) – Improvements to Nonemployee Share-Based Payment Accounting, (“ASU 2018 - 07” ). ASU 2018 - 07 requires entities to apply similar accounting for share-based payment transactions with non-employees as with share-based payment transactions with employees. ASU 2018 - 07 is effective for public entities for fiscal year beginning after December 15, 2018, including interim periods within that fiscal year. Early adoption is permitted. The Company is currently evaluating the impact on the Company’s financial statements of adopting this guidance but this guidance is not expected to have a material impact on the Company’s financial position, results of operations or internal control framework. On August 17, 2018 the SEC issued SEC Final Rule Release No. 33 - 10532, Disclosure Update and Simplification (“Final Rule”). The final rule amends certain disclosure requirements to facilitate the disclosure of information to investors and simplify compliance without significantly altering the total mix of information provided to investors. The final rule is effective for public entities that are SEC filers on November 5, 2018. The Company is currently evaluating the impact of adopting this guidance but this guidance is not expected to have a material impact on the Company’s disclosures.

Note 2 - Fair Value of Financial Instruments (Details Textual) - USD ($)	Sep. 30, 2018	Jun. 30, 2018
Other Liabilities [Member] \| Fair Value, Inputs, Level 3 [Member]
Business Combination, Contingent Consideration, Liability, Total	$ 0	$ 35,000

Note 3 - Revenue Recognition (Details Textual) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2018	Jan. 01, 2018	Dec. 31, 2017
Retained Earnings (Accumulated Deficit), Ending Balance	$ 389,189		$ 366,164
Care Management and Consumer Engagement Services [Member] \| Transferred over Time [Member] \| Accounts payable, Accrued Expenses and Other liabilities [Member]
Revenue, Remaining Performance Obligation, Amount	$ 5,200		$ 6,400
Accounting Standards Update 2014-09 [Member]
Retained Earnings (Accumulated Deficit), Ending Balance		$ 1,400
Minimum [Member]
Contracts With Customers, Term	3 years
Maximum [Member]
Contracts With Customers, Term	5 years

Note 4 - Accounts Receivable and Accounts Receivable Allowance - Accounts Receivable, Net (Details) - USD ($) $ in Thousands	Sep. 30, 2018	Dec. 31, 2017	Dec. 31, 2016
Accounts receivable	$ 218,737	$ 204,259
Allowance	(16,239)	(14,799)	$ (10,772)
Accounts receivable, net	$ 202,498	$ 189,460

Note 5 - Acquisition (Details Textual) - Eliza Holding Corp [Member] - USD ($) $ in Millions		9 Months Ended
	Apr. 17, 2017	Sep. 30, 2018	Sep. 30, 2017
Business Acquisition, Percentage of Voting Interests Acquired	100.00%
Payments to Acquire Businesses, Gross	$ 171.6
Business Acquisition, Funding Source, Cash on Hand, Percentage	75.00%
Business Acquisition, Funding Source, Existing Credit Line, Percentage	25.00%
Business Acquisition, Pro Forma Revenue		$ 37.4	$ 17.5

Note 5 - Acquisition - Preliminary Allocation of the Purchase Price (Details) - USD ($) $ in Thousands	Sep. 30, 2018	Dec. 31, 2017	Apr. 17, 2017
Goodwill	$ 487,617	$ 487,617
Eliza Holding Corp [Member]
Cash and cash equivalents			$ 435
Accounts receivable			8,902
Prepaid expenses			1,427
Property and equipment			1,146
Intangible assets			76,240
Goodwill			107,754
Other assets			63
Accounts payable			(2,620)
Deferred tax liability			(19,681)
Other liabilities			(2,057)
Total purchase price			$ 171,609

Note 5 - Acquisition - Preliminary Purchase Price Allocated to the Intangibles Acquired (Details) - Eliza Holding Corp [Member] $ in Thousands	Apr. 17, 2017 USD ($)
Fair value of intangibles acquired	$ 76,240
Customer Relationships [Member]
Intangibles acquired, useful life (Year)	15 years
Fair value of intangibles acquired	$ 56,200
Intellectual Property [Member]
Intangibles acquired, useful life (Year)	6 years
Fair value of intangibles acquired	$ 19,600
Trade Names [Member]
Intangibles acquired, useful life (Year)	1 year 182 days
Fair value of intangibles acquired	$ 310
Restrictive Covenant [Member]
Intangibles acquired, useful life (Year)	1 year
Fair value of intangibles acquired	$ 130

Note 5 - Acquisition - Acquisition Costs (Details) - Cost of Services [Member] - Eliza Holding Corp [Member] $ in Thousands	Apr. 17, 2017 USD ($)
Acquisition-related costs	$ 4,532
Other Operating Expenses, Consulting Fees [Member]
Acquisition-related costs	3,515
Other Operating Expenses, Legal Fees [Member]
Acquisition-related costs	832
Other Operating Expenses, Transaction Costs [Member]
Acquisition-related costs	$ 185

Note 6 - Intangible Assets and Goodwill - Summary of Intangible Assets (Details) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2018	Dec. 31, 2017
Gross Carrying Amount	$ 194,999	$ 197,499
Accumulated Amortization	(122,406)	(106,017)
Net Carrying Amount	72,593	91,482
Customer Relationships [Member]
Gross Carrying Amount	156,790	159,290
Accumulated Amortization	(100,758)	(89,106)
Net Carrying Amount	$ 56,032	$ 70,184
Useful life (Year)	12 years 146 days	11 years 109 days
Trade Names [Member]
Gross Carrying Amount	$ 16,246	$ 16,246
Accumulated Amortization	(15,724)	(13,916)
Net Carrying Amount	$ 522	$ 2,330
Useful life (Year)	109 days	1 year
Intellectual Property [Member]
Gross Carrying Amount	$ 21,700	$ 21,700
Accumulated Amortization	(5,701)	(2,874)
Net Carrying Amount	$ 15,999	$ 18,826
Useful life (Year)	4 years 109 days	5 years 73 days
Restrictive Covenant [Member]
Gross Carrying Amount	$ 263	$ 263
Accumulated Amortization	(223)	(121)
Net Carrying Amount	$ 40	$ 142
Useful life (Year)	328 days	1 year 109 days

Note 6 - Intangible Assets and Goodwill - Estimated Amortization Expense of Intangible Assets (Details) - USD ($) $ in Thousands	Sep. 30, 2018	Dec. 31, 2017
2018	$ 5,452
2019	9,195
2020	7,664
2021	7,197
2022	7,197
Thereafter	35,888
Total	$ 72,593	$ 91,482

Note 7 - Accounts Payable, Accrued Expenses and Other Liabilities - Summary of Accounts Payable, Accrued Expenses and Other Liabilities (Details) - USD ($) $ in Thousands	Sep. 30, 2018	Dec. 31, 2017
Accounts payable, trade	$ 13,850	$ 19,330
Accrued compensation and other	32,372	24,072
Accrued operating expenses	18,073	18,498
Total accounts payable, accrued expenses and other liabilities	$ 64,295	$ 61,900

Note 9 - Estimated Liability for Appeals (Details Textual) - USD ($)	3 Months Ended	9 Months Ended
	Mar. 31, 2018	Sep. 30, 2018	Sep. 30, 2017	Dec. 31, 2017
Estimated Liability for Appeals Gain (Loss) Included in Earnings	$ 8,400,000	$ 8,436,000
Estimated Liability for Appeals		22,184,000		$ 30,787,000
Estimated Liability for Appeals, Amount Adjudicated		19,400,000		19,300,000
Estimated Liability for Appeals, Amount Probable of Being Returned		0		8,500,000
Estimated Liability for Appeals, Commercial Customers Claim Findings, Adjudicated in Favor of Providers		$ 2,800,000		$ 3,200,000

Note 10 - Credit Agreement (Details Textual) $ in Thousands		9 Months Ended
Note 10 - Credit Agreement (Details Textual) $ in Thousands	Dec. 19, 2017 USD ($)	Sep. 30, 2018 USD ($)	Sep. 30, 2017 USD ($)	Dec. 31, 2017 USD ($)	Dec. 18, 2017 USD ($)
Amortization of Debt Issuance Costs		$ 423	$ 1,563
Credit Agreement [Member]
Line of Credit Facility, Maximum Borrowing Capacity					$ 500,000
Line of Credit Facility, Expiration Period	5 years
Debt Agreement, Maximum Borrowing Capacity	$ 120,000
Debt Agreement, Maximum Borrowing Capacity, Percent of Consolidated EBITDA	100.00%
Credit Agreement [Member] \| Letter of Credit [Member]
Line of Credit Facility, Maximum Borrowing Capacity	$ 50,000
Line of Credit Facility, Unused Capacity, Commitment Fee Percentage	0.125%
Credit Agreement [Member] \| Swingline Loans [Member]
Line of Credit Facility, Maximum Borrowing Capacity	$ 25,000
Credit Agreement [Member] \| Revolving Credit Facility [Member]
Long-term Line of Credit, Total		240,000		$ 240,000
Repayments of Long-term Lines of Credit		0
Debt Instrument, Secured Leverage Ratio	5.25
Debt Issuance Costs, Net, Total		2,400		$ 2,800
Amortization of Debt Issuance Costs		$ 400	$ 1,000
Credit Agreement [Member] \| Revolving Credit Facility [Member] \| Federal Funds Effective Swap Rate [Member]
Debt Instrument, Basis Spread on Variable Rate	0.50%
Credit Agreement [Member] \| Revolving Credit Facility [Member] \| London Interbank Offered Rate (LIBOR) [Member]
Debt Instrument, Basis Spread on Variable Rate	1.00%
Credit Agreement [Member] \| Revolving Credit Facility [Member] \| Minimum [Member]
Debt Instrument, Covenant, Interest Coverage Ratio	3
Line of Credit Facility, Unused Capacity, Commitment Fee Percentage	0.375%
Credit Agreement [Member] \| Revolving Credit Facility [Member] \| Minimum [Member] \| London Interbank Offered Rate (LIBOR) [Member]
Debt Instrument, Basis Spread on Variable Rate	0.50%
Credit Agreement [Member] \| Revolving Credit Facility [Member] \| Minimum [Member] \| One-month LIBOR Rate [Member]
Debt Instrument, Basis Spread on Variable Rate	1.50%
Credit Agreement [Member] \| Revolving Credit Facility [Member] \| Maximum [Member]
Line of Credit Facility, Unused Capacity, Commitment Fee Percentage	0.25%
Debt Instrument, Secured Leverage Ratio	3
Credit Agreement [Member] \| Revolving Credit Facility [Member] \| Maximum [Member] \| Through December 2019 [Member]
Debt Instrument, Secured Leverage Ratio	4.75
Credit Agreement [Member] \| Revolving Credit Facility [Member] \| Maximum [Member] \| From and After January 2020 [Member]
Debt Instrument, Secured Leverage Ratio	4.25
Credit Agreement [Member] \| Revolving Credit Facility [Member] \| Maximum [Member] \| London Interbank Offered Rate (LIBOR) [Member]
Debt Instrument, Basis Spread on Variable Rate	1.00%
Credit Agreement [Member] \| Revolving Credit Facility [Member] \| Maximum [Member] \| One-month LIBOR Rate [Member]
Debt Instrument, Basis Spread on Variable Rate	2.00%

Note 11 - Earnings Per Share (Details Textual) - shares	3 Months Ended		9 Months Ended
Note 11 - Earnings Per Share (Details Textual) - shares	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Employee Stock Option [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	21,105	2,642,548	531,378	2,132,017
Restricted Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	202	84,360	595	63,452

Note 13 - Commitments and Contingencies (Details Textual) - Suit Against HMS Holdings Related to the Acquisition of Allied Management Group [Member] - USD ($) $ in Millions	Jun. 27, 2018	Nov. 03, 2017
Loss Contingency, Damages Awarded, Value		$ 60
Litigation Settlement, Amount Awarded to Other Party	$ 20